{
	"data": [["10-005","10-005","10-005.","STRING","PATIENT"],["10q-","10q-","10q-","STRING","SAMPLE"],["11q-","11q-","11q-","STRING","SAMPLE"],["12_245","12-245","12-245","STRING","PATIENT"],["12p+","12p+","12p+","STRING","SAMPLE"],["14q-","14q-","14q-","STRING","SAMPLE"],["17q+","17q+","17q+","STRING","SAMPLE"],["1p-","1p-","1p-","STRING","SAMPLE"],["1q+","1q+","1q+","STRING","SAMPLE"],["2p+","2p+","2p+","STRING","SAMPLE"],["34BE12CK_STAIN","34BE12CK STAIN","34BE12CK STAIN","STRING","SAMPLE"],["3p-","3p-","3p-","STRING","SAMPLE"],["4p-","4p-","4p-","STRING","SAMPLE"],["6q-","6q-","6q-","STRING","SAMPLE"],["7q+","7q+","7q+","STRING","SAMPLE"],["8Q_GAIN","8q Gain","8Q gain","STRING","SAMPLE"],["9p-","9p-","9p-","STRING","SAMPLE"],["A>C","A>C","A>C","STRING","SAMPLE"],["A>G","A>G","A>G","STRING","SAMPLE"],["A>T","A>T","A>T","STRING","SAMPLE"],["C>A","C>A","C>A","STRING","SAMPLE"],["C>G","C>G","C>G","STRING","SAMPLE"],["C>T","C>T","C>T","STRING","SAMPLE"],["CC>TT","CC>TT","CC>TT","STRING","SAMPLE"],["OTHER_DNP","other DNP","other DNP","STRING","SAMPLE"],["ABERRANT_CELL_FRACTION","Aberrant Cell Fraction","Aberrant Cell Fraction","STRING","SAMPLE"],["ABNORMAL_LYMPHOCYTE_PERCENT","Abnormal Lymphocyte Percent","Abnormal Lymphocyte Percent","NUMBER","SAMPLE"],["ABSOLUTE_CANCER_DNA_FRACTION","Absolute cancer dna fraction","Absolute cancer dna fraction","NUMBER","SAMPLE"],["ABSOLUTE_EXTRACT_PLOIDY","Absolute Extract Ploidy","Absolute extract ploidy.","NUMBER","SAMPLE"],["ABSOLUTE_EXTRACT_PURITY","Absolute Extract Purity","Absolute extract purity.","NUMBER","SAMPLE"],["ACGH_DATA","ACGH Data","ACGH Data.","STRING","SAMPLE"],["ADJUVANT_CHEMO","Adjuvant Chemotherapy","Adjuvant Chemotherapy","STRING","PATIENT"],["ADJUVANT_HORMONE_THERAPY","Adjuvant Hormone Therapy","Adjuvant Hormone Therapy","STRING","PATIENT"],["ADJUVANT_TX","Adjuvant Treatment","Adjuvant treatment.","STRING","PATIENT"],["AE1","AE1","AE1","STRING","SAMPLE"],["AFP_AT_PROCUREMENT","AFP At Procurement","Alpha Fetoprotein At Procurement","STRING","SAMPLE"],["AFP_NORM_RANGE_LOWER","AFP Normal Range Lower Bound","AFP Normal Range Lower Bound","STRING","SAMPLE"],["AFP_NORM_RANGE_UPPER","AFP Normal Range Higher Bound","AFP Normal Range Higher Bound","STRING","SAMPLE"],["AGE","Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER","PATIENT"],["AGE_AT_PROCUREMENT","Age At Procurement","Age At Procurement Of The Submitted Specimen","NUMBER","PATIENT"],["AGE_AT_SURGERY","Age At Surgery","Age at surgery.","NUMBER","PATIENT"],["AGE_CLASS","Age Class","Age Class","NUMBER","PATIENT"],["AGENT","AGENT","AGENT","STRING","PATIENT"],["AJCC_METASTASIS_CLINICAL_CM","Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING","PATIENT"],["AJCC_METASTASIS_PATHOLOGIC_PM","American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING","PATIENT"],["AJCC_NODES_CLINICAL_CN","American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING","PATIENT"],["AJCC_NODES_CLINICAL_CT","American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING","PATIENT"],["AJCC_NODES_PATHOLOGIC_PN","Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING","PATIENT"],["AJCC_CLINICAL_TUMOR_STAGE","Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING","PATIENT"],["AJCC_PATHOLOGIC_TUMOR_STAGE","Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING","PATIENT"],["AJCC_STAGING_EDITION","American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING","PATIENT"],["AJCC_TUMOR_CLINICAL_CT","American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING","PATIENT"],["AJCC_TUMOR_PATHOLOGIC_PT","American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING","PATIENT"],["AKT1_MUTATION","AKT1 Mutation","AKT1 Mutation","STRING","SAMPLE"],["ALB_(g/dL)","alb (g/dl)","alb (g/dl)","STRING","SAMPLE"],["ALCOHOL_EXPOSURE_INTENSITY","Alcohol Exposure Intensity","Alcohol Exposure Intensity","STRING","PATIENT"],["ALCOHOL_CONSUMPTION_FREQUENCY","Alcohol Consumption Frequency","Alcohol Consumption Frequency","STRING","PATIENT"],["ALCOHOL_HISTORY_DOCUMENTED","Alcohol History Documented ","Alcohol History Documented","STRING","PATIENT"],["ALK_ANALYSIS_TYPE","ALK Analysis Type","ALK Analysis Type","STRING","SAMPLE"],["ALK_TRANSLOCATION_STATUS","ALK Translocation Status","ALK Translocation Status","STRING","SAMPLE"],["ALK_TRANSLOCATION_VARIANT","ALK Translocation Variant","ALK Translocation Variant","STRING","SAMPLE"],["ALLELE_FREQUENCY_CELLULARITY","Cllularity based on allele frequency","Cllularity based on allele frequency","NUMBER","SAMPLE"],["ALLERGIES","Allergies","Allergies","STRING","PATIENT"],["ALP_(U/L)","alp (u/l)","alp (u/l)","STRING","SAMPLE"],["AML_IN_SKIN_PERCENTAGE","AML in Skin Percentage","AML in skin, determined by WGS.","NUMBER","PATIENT"],["AMPLIFICATION_STATUS","Amplification Status","Amplification Status","STRING","SAMPLE"],["ANALYSIS_ID","analysis id","analysis id","STRING","SAMPLE"],["ANAPLASTIC_PERCENTAGE","Anaplastic Percentage","Anaplastic Percentage","STRING","PATIENT"],["ANATOMIC_REGION","Anatomic Region","Anatomic Region.","STRING","PATIENT"],["ANATOMICAL_SUBTYPE","Anatomical Subtype","Anatomical Subtype","STRING","SAMPLE"],["ANGIOLYMPHATIC_INVASION","Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING","PATIENT"],["ANIMAL_INSECT_ALLERGY_AGE","Animal Insect Allergy Age","Animal Insect Allergy Age","NUMBER","PATIENT"],["ANIMAL_INSECT_ALLERGY_HIST","Animal Insect Allergy History","Animal insect allergy history.","STRING","PATIENT"],["ANIMAL_INSECT_ALLERGY_TYPES","Animal Insect Allergy Types","Animal insect allergy types.","STRING","PATIENT"],["ANTI_O_VIVERRINI_IGG","anti_O_viverrini_IgG","anti_O_viverrini_IgG","STRING","SAMPLE"],["ANTIREFLUX_TREATMENT","Anti-reflux Treatment","Anti-reflux treatment.","STRING","PATIENT"],["ANTIREFLUX_TREATMENT_TYPE","Anti-reflux Treatment Type","Anti-reflux treatment type.","STRING","PATIENT"],["AR_EXPRESSION","AR Expression","AR Expression","NUMBER","SAMPLE"],["AR_HIGH","AR High","AR High","STRING","SAMPLE"],["AR_SCORE","AR Score","AR score","NUMBER","SAMPLE"],["AR_STATUS","AR Status","AR Status.","STRING","SAMPLE"],["ARHGAP26_ARHGAP6_CLDN18_REARRANGEMENT","ARHGAP26-ARHGAP6-CLDN18 Rearrangement","ARHGAP26-ARHGAP6-CLDN18 Rearrangement.","STRING","SAMPLE"],["ARID1A_MUTATION","ARID1A Mutation","ARID1A mutation is present.","STRING","SAMPLE"],["ASG_5ME","ASG_5ME","ASG 5ME.","STRING","SAMPLE"],["ASSOCIATED_BORDERLINE_OVARIAN_TUMOR","Associated Borderline Ovarian Tumor","Associated Borderline Ovarian Tumor","STRING","PATIENT"],["ASTHMA_ECZEMA_ALLERGY_FIRST_DIAGNOSIS","First Diagnosis of Asthma Eczema Allergy","First Diagnosis of Asthma Eczema Allergy","STRING","PATIENT"],["ASTHMA_HISTORY","Asthma History","Asthma history.","STRING","PATIENT"],["ALTERATIONS","Alterations","Alterations","STRING","SAMPLE"],["ATRA_EXPOSURE","Atra Exposure","Atra Exposure","STRING","SAMPLE"],["ATRX_DELETION","ATRX Deletion","ATRX Deletion","STRING","SAMPLE"],["AVE_DNA_PURITY","Average DNA Purity","Average DNA Purity","NUMBER","SAMPLE"],["AVE_PLOIDY","Average Ploidy ","Average ploidy ","NUMBER","SAMPLE"],["AVE_RNA_PURITY","Average RNA Purity ","Average RNA Purity ","NUMBER","SAMPLE"],["B_CELL_GENOTYPE_METHOD","B Cell Genotype Method","B Cell Genotype Method","STRING","SAMPLE"],["BARRETTS_ESOPHAGUS","Barretts Esophagus","Barretts esophagus.","STRING","PATIENT"],["BASOPHILS_COUNT","Basophils Cell Count","Basophils Cell Count","NUMBER","SAMPLE"],["BATCH_NUMBER","Batch Number","Batch number.","STRING","SAMPLE"],["BCR_FREE_MONTHS","BCR Free Months","BCR Free Time in months","NUMBER","PATIENT"],["BCR_STATUS","BCR Status","BCR status.","STRING","PATIENT"],["BIND","BIND","BIND.","STRING","SAMPLE"],["BIOCHEMICAL_RECURRENCE_INDICATOR","Biochemical Recurrence Indicator ","Biochemical Recurrence Indicator ","STRING","PATIENT"],["BIOPSY_FROM_IRRADIATED_SITE","Biopsy From Irradiated Site","Biopsy From Irradiated Site","STRING","PATIENT"],["BIOPSY_GLEASON_SCORE","BIOPSY GLEASON SCORE ","BIOPSY GLEASON SCORE ","STRING","SAMPLE"],["BIOPSY_GLEASON_SCORE_1","BIOPSY GLEASON SCORE 1","BIOPSY GLEASON SCORE 1","STRING","SAMPLE"],["BIOPSY_GLEASON_SCORE_2","BIOPSY GLEASON SCORE 2","BIOPSY GLEASON SCORE 2","STRING","SAMPLE"],["BIOPSY_PROCEDURE","Biopsy Procedure","Biopsy procedure.","STRING","PATIENT"],["BIRTH_COUNTRY","Birth Country","Birth Country","STRING","PATIENT"],["BLAST_COUNT","Blast Count","Blast Count","NUMBER","SAMPLE"],["BLOCK","Block","Block.","NUMBER","SAMPLE"],["BLOCK_ACCESSION","block accession","block accession","STRING","PATIENT"],["BLOCK_ID","BLOCK ID","BLOCK ID","STRING","SAMPLE"],["BM_BLAST_PERCENTAGE","Bone Marrow Blast Percentage","Bone marrow blast percentage.","STRING","PATIENT"],["BM_DAY_29","BM Day 29","BM day 29.","STRING","PATIENT"],["BM_DAY_8","BM Day 8","BM day 8.","STRING","PATIENT"],["BMI","BMI","Body Mass Index","NUMBER","PATIENT"],["BONE_MARROW_BIOPSY_PERFORMED","Bone Marrow Biopsy Performed","Bone Marrow Biopsy Performed","STRING","SAMPLE"],["BONE_MARROW_INVOLVEMENT","Bone Marrow Involvement","Bone Marrow Involvement","STRING","SAMPLE"],["BONE_MARROW_LEUKEMIC_BLAST_PERCENTAGE","Bone Marrow Leukemic Blast Percentage","Bone marrow leukemic percentage.","NUMBER","PATIENT"],["BONE_MARROW_SAMPLE_HISTOLOGY","Bone Marrow Sample Histology","Bone Marrow Sample Histology","STRING","SAMPLE"],["BONE_SCAN_RESULT","Bone Scan Result","Bone scan result.","STRING","PATIENT"],["BORRMANN_CLASSIFICATION","Borrmann classification","Borrmann classification","STRING","PATIENT"],["BRAC2_GERMLINE","BRAC2 GERMLINE","BRAC2 GERMLINE","STRING","SAMPLE"],["BRAF_FUSION","BRAF Fusion","BRAF Fusion","STRING","SAMPLE"],["BRAF_MUTATION","BRAF mutation","BRAF mutation","STRING","SAMPLE"],["BRAF_STATUS","Braf Status","Braf Status","STRING","SAMPLE"],["BRAIN_METS","BRAIN METS","Brain Metatstasis","STRING","PATIENT"],["BRCA1_GERMLINE","BRCA1 GERMLINE","BRCA1 GERMLINE","STRING","SAMPLE"],["BRCA1_HOMDEL","BRCA1 HOMDEL","BRCA1 HOMDEL","STRING","SAMPLE"],["BRCA1_MUTATION","BRCA1 Mutation","BRCA1 Mutation is present","STRING","SAMPLE"],["BRCA2_HOMDEL","BRCA2 HOMDEL","BRCA2 HOMDEL","STRING","SAMPLE"],["BRCA2_MUTATION","BRCA2 Mutation","BRCA2 Mutation is present","STRING","SAMPLE"],["BREAST_CANCER_RECEPTOR_STATUS","Breast Cancer Receptor Status","Breast Cancer Receptor Status","STRING","SAMPLE"],["BRESLOW_DEPTH","breslow depth","breslow depth","STRING","SAMPLE"],["BRONCHOSCOPY","Bronchoscopy","Bronchoscopy","STRING","PATIENT"],["C_SAMP_METH_K3","C Samp METH K3","C samp meth K3.","STRING","SAMPLE"],["C_SAMP_MIRNA_K4","C Samp MIRNA K4","C samp mirna K4.","STRING","SAMPLE"],["C_SAMP_MIRNA_K6","C Samp MIRNA K6","C samp mirna K6.","STRING","SAMPLE"],["C_SAMP_MRNA_K4","C Samp MRNA K4","C samp mrna K4.","STRING","SAMPLE"],["C_SAMP_SCNA_CLUSTER","C Samp SCNA Cluster","C samp scna cluster.","STRING","SAMPLE"],["CABAZI","Cabazi","Cabazi.","STRING","SAMPLE"],["CAM_5.2","CAM 5.2","CAM 5.2","STRING","SAMPLE"],["CANCER_PROCUREMENT_STATE_PROVINCE","Cancer Procurement State Province","Cancer Procurement State Province","STRING","SAMPLE"],["CANCER_TYPE","Cancer Type","Disease type","STRING","SAMPLE"],["CANCER_TYPE_DETAILED","Cancer Type Detailed","Cancer Type Detailed","STRING","SAMPLE"],["CAPSULAR_INVASION","CAPSULAR INVASION","CAPSULAR INVASION","STRING","SAMPLE"],["CARBO","Carbo","Carbo.","STRING","SAMPLE"],["CDKN2A_SILENCING","CDKN2A Silencing","Epigenetic silencing status of CDKN2A.","STRING","SAMPLE"],["CDKN2A_MUTATION","CDKN2A Mutation","CDKN2A Mutation","STRING","SAMPLE"],["CDKN2A_MET","CDKN2A Methylation","CDKN2A Methylation","STRING","SAMPLE"],["CEBPA_MUTATION","CEBPA Mutation","CEBPA mutation.","STRING","SAMPLE"],["CELL_DIFFERENTIATION","Cell Differentiation","Cell Differentiation","STRING","SAMPLE"],["CENSORED","Censored","Survival Time Censored; True or False","STRING","SAMPLE"],["CG_1P","CG_1P","CG_1P","STRING","SAMPLE"],["CGH_ID","CGH Id","CGH Id.","STRING","SAMPLE"],["CHD1_MUTATION","CHD1 Mutation","CHD1 Mutation is present","STRING","SAMPLE"],["CHEMO_DETAILS","Chemotherapy Details","Chemotherapy details","STRING","PATIENT"],["CHEMO_EXPOSURE","Chemo Exposure","Chemo Exposure","STRING","PATIENT"],["CHEMO_FIRST_LINE","Chemo First Line","Chemo First Line","STRING","PATIENT"],["CHEMO_FOURTH_LINE","Chemi Fourth Line","Chemi Fourth Line","STRING","PATIENT"],["CHEMO_SECOND_LINE","Chemo Second Line","Chemo Second Line","STRING","PATIENT"],["CHEMO_THIRD_LINE","Chemo Third Line","Chemo Third Line","STRING","PATIENT"],["CHEMOTHERAPY","Chemotherapy","Chemotherapy.","STRING","PATIENT"],["CHEMOTHERAPY_FIRST_LINE_PLATINUM_ETOPOSIDE","Chemotherapy First Line Platinum Etoposide","Chemotherapy First Line Platinum Etoposide","STRING","PATIENT"],["CHEMOTHERAPY_RESPONSE","Chemotherapy Response","Chemotherapy response","STRING","PATIENT"],["CHLOROMA","Chloroma","Chloroma","STRING","PATIENT"],["CHROMOTRYPSIS_V2","CHROMOTRYPSIS V2","CHROMOTRYPSIS V2","STRING","SAMPLE"],["CHRONIC_INFLAMATION","Chronic Inflamation","Chronic inflamation.","STRING","PATIENT"],["CIMP_CATEGORY","CIMP Category","CIMP category.","STRING","SAMPLE"],["CIRRHOSIS","Cirrhosis","Cirrhosis.","STRING","PATIENT"],["CIS","CIS","CIS.","STRING","PATIENT"],["CISPLATIN","Cisplatin","Cisplatin.","STRING","PATIENT"],["CITY_OF_PROCUREMENT","City of Procurement","City of procurement.","STRING","PATIENT"],["CK18_STAIN","CK18 stain","CK18 stain","STRING","SAMPLE"],["CK7_STAIN","CK7 stain","CK7 stain","STRING","SAMPLE"],["CKIT_EXON_MUTATION","CKIT Exon Mutation","CKIT exon mutation.","STRING","SAMPLE"],["CKIT_MUTATION","CKIT Mutation","CKIT mutation.","STRING","SAMPLE"],["CLIN_M_STAGE","Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING","PATIENT"],["CLIN_N_STAGE","Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING","PATIENT"],["CLIN_T_STAGE","Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING","PATIENT"],["CLINICAL_ASSOCIATION","Clinical Assocation","Clinical association.","STRING","PATIENT"],["CLINICAL_DATA","Clinical Data","Clinical data.","STRING","PATIENT"],["CLINICAL_DIAGNOSIS_AND_HISTORY","Clinical Diagnosis And History","Clinical Diagnosis And History","STRING","PATIENT"],["CLINICAL_GLEASON","Clinical Gleason","Clinical Gleason","STRING","SAMPLE"],["CLINICAL_GLEASON_CATEGORY","Clinical Gleason category","Clinical Gleason category","STRING","SAMPLE"],["CLINICAL_GLEASON_SUM","Clinical Gleason Sum","Clinical Gleason Sum","NUMBER","SAMPLE"],["CLINICAL_STAGE","Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING","PATIENT"],["CLINICAL_TRIAL","Clinical Trial","Clinical Trial","STRING","PATIENT"],["CN_CLUSTER","CN Cluster","CN cluster.","STRING","SAMPLE"],["CNA_CLUSTER_K4","CNA Cluster K4","CNA cluster K4.","STRING","SAMPLE"],["CNA_DATA","CNA Data","CNA data.","STRING","SAMPLE"],["CNE","Conserved Noncoding Element","Conserved Noncoding Element","NUMBER","SAMPLE"],["CNS_DISEASE","CNS Disease","CNS disease.","STRING","PATIENT"],["CNS_STATUS","CNS Status","CNS status.","STRING","PATIENT"],["COCA_CLUSTER","COCA Cluster","COCA Cluster","STRING","SAMPLE"],["COHORT","Cohort","Cohort.","STRING","PATIENT"],["COLLAB_ID","Collaboration Id","Collaboration id.","STRING","SAMPLE"],["COLONOSCOPY","Colonoscopy","Colonoscopy","STRING","PATIENT"],["COMMENTS","Comments","Comments.","STRING","PATIENT"],["COMPLETE_DATA","Complete Data","Complete data.","STRING","SAMPLE"],["COMPLETE_TCGA_ID","Complete TCGA ID","Complete TCGA ID","STRING","SAMPLE"],["COMPLETE_TURBT","Complete TURBT","Complete TURBT","STRING","SAMPLE"],["COMPLEXITY","Complexity","Complexity.","STRING","PATIENT"],["CONCOMITANT_CIS","Concomitant Carcinoma in situ","Concomitant Carcinoma in situ","STRING","SAMPLE"],["CONCURRENT _CHEMO_DETAILS","Concurrent Chemo Text","Concurrent Chemo Text","STRING","PATIENT"],["CONCURRENT_CHEMO","Concurrent chemo","Concurrent chemo","STRING","PATIENT"],["CONGENITAL_ABNORMALITY","Congenital Abnormality","Congentital abnormality.","STRING","PATIENT"],["CONVERTED_STAGE","Converted Stage","Converted Stage","STRING","SAMPLE"],["COPY_NUMBER","Copy Number","Copy Number","STRING","SAMPLE"],["COPY_NUMBER_CLUSTER","Copy Number Cluster","Copy number cluster.","STRING","PATIENT"],["COUNTRY","Country ","Country of procurement.","STRING","PATIENT"],["COUNTRY_OF_PROCUREMENT","Country of Procurement","Country of procurement.","STRING","PATIENT"],["COVERAGE_GREATER_THAN_100X","Coverage Greater than 100X","Coverage greater than 100X.","STRING","SAMPLE"],["COVERAGE_TUMOR","Tumor Sample Coverage(fold)","Tumor Sample Coverage(fold)","NUMBER","SAMPLE"],["COVERAGE_NORMAL","Normal Sample Coverage(fold)","Normal Sample Coverage(fold)","NUMBER","SAMPLE"],["COVERED_BASES","Covered Bases","Covered Bases","STRING","SAMPLE"],["CQCF_DAYS_TO_SAMPLE_PROCUREMENT","CQCF Days to Sample Procurement","CQCF days to sample procurement.","STRING","PATIENT"],["CQCF_METHOD_OF_SAMPLE_PROCUREMEN","CQCF Method of Sample Procurement","CQCF method of sample procurement.","STRING","PATIENT"],["CR_STATUS_AT_END_OF_COURSE_1","CR Status at End of Course 1","CR status at end of course 1.","STRING","PATIENT"],["CR_STATUS_AT_END_OF_COURSE_2","CR Status at End of Course 2","CR status at end of course 2.","STRING","PATIENT"],["CT_CAP","CT Cap","CT Cap","STRING","PATIENT"],["CTNNB1_MUTATION","CTNNB1 Mutation","CTNNB1 Mutation is present","STRING","SAMPLE"],["CYTOGENETIC_CODE_OTHER","Cytogenetic Code (Other)","Cytogenetic code (other).","STRING","PATIENT"],["CYTOGENETICS","Cytogenetics","Cytogenetics.","NUMBER","PATIENT"],["CYTOLOGY","Cytology","Cytology","STRING","SAMPLE"],["DAILY_ALCOHOL","Daily Alcohol","Daily alcohol","STRING","PATIENT"],["DARK_ZONE_STAT","DZ Stat","Dark zone stat at transplant.","STRING","PATIENT"],["DATA_CORE_SAMPLE","Data Core Sample","Data core sample.","STRING","SAMPLE"],["DATA_SOURCE","Data Source","Data Source","STRING","PATIENT"],["DATE_OF_DIAGNOSIS","Date Of Diagnosis","Date of Diagnosis","STRING","PATIENT"],["DAYS_LAST_FOLLOWUP","Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER","PATIENT"],["DAYS_METASTATIC","Metastasis Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the date of metastasis discovery to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_ADDITIONAL_SURGERY_METASTATIC_PROCEDURE","Days to additional surgery metastatic procedure","Days to additional surgery metastatic procedure.","NUMBER","PATIENT"],["DAYS_TO_BIRTH","Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_BONE_SCAN_PERFORMED","Days to bone Scan performed","Days to bone Scan performed","NUMBER","PATIENT"],["DAYS_TO_DEATH","Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_DIAGNOSIS","Days to Diagnosis","Days to diagnosis.","NUMBER","PATIENT"],["DAYS_TO_FIRST_BIOCHEMICAL_RECURRENCE","Days to First Biochemical Recurrence","Days to biochemical recurrence.","NUMBER","PATIENT"],["DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_INITIAL_SCORE_PERFOR","Days to Initial Score Performance","Days to initial score performance.","NUMBER","PATIENT"],["DAYS_TO_LAST_FOLLOWUP","Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_LAST_KNOWN_ALIVE","Last Known Alive Status Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the date of last known alive status to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_NEW_TUMOR_EVENT","New Tumor Event Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the date of new tumor event including progression, recurrence and new primary malignacies to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER","PATIENT"],["DAYS_TO_PSA","Days to PSA","Days to Prostate-Specific Antigen (PSA) Test","NUMBER","PATIENT"],["DAYS_TO_COLLECTION","Days to Sample Collection.","Days to sample collection.","NUMBER","SAMPLE"],["DAYS_TO_SPECIMEN_COLLECTION","Days to Sample Procurement","Days to sample procurement.","STRING","SAMPLE"],["DE_NOVO_START_OUTOFFRAME","de novo start outofframe","de novo start outofframe","STRING","SAMPLE"],["DEATH_FROM_DISEASE","Death due to disease","Death due to disease","STRING","PATIENT"],["DEFINITIVE_SURGERY","Definitive Surgery","Definitive surgery.","STRING","PATIENT"],["DEFINITIVE_TX_TYPE","Definitive TX Type","Definitive TX type.","STRING","PATIENT"],["DEL_5Q","5Q Deletion","5Q deletion.","STRING","SAMPLE"],["DEL_7Q","7Q Deletion","7Q deletion.","STRING","SAMPLE"],["DEL_9Q","9Q Deletion","9Q deletion.","STRING","SAMPLE"],["DFS_MONTHS","Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER","PATIENT"],["DFS_STATUS","Disease Free Status","Disease free status since initial treatment.","STRING","PATIENT"],["DIABETES_STATUS","Diabetes Status","Diabetes Status","STRING","PATIENT"],["DIAGNOSIS","Diagnosis","Diagnosis.","STRING","PATIENT"],["DIAGNOSTIC_CT_ABD_PELVIS_RESULT","Diagnostic CT Abdomin-Pelvis Result","Diagonostic CT abdomin-pelvis result.","STRING","PATIENT"],["DIAGNOSTIC_MRI_RESULT","Diagonstic MRI Result","Diagonostic MRI result.","STRING","PATIENT"],["DISEASE_STAGE","disease stage","disease stage","STRING","SAMPLE"],["DISTANT_METASTASIS_PATHOLOGIC_SPREAD","Distant Metastasis Pathologic Spread","Distant metastasis pathologic spread.","STRING","SAMPLE"],["DISTANT_RECURRENCE","Distant Recurrence","Distant recurrence.","STRING","PATIENT"],["DISTANT_RECURRENCE_NUM","Number of Distant Recurrence","Number of Distant Recurrence","NUMBER","PATIENT"],["DNA_INDEX","DNA Index","DNA index.","STRING","SAMPLE"],["DOCE","DOCE","DOCE.","STRING","SAMPLE"],["DOUBLING_TIME","Doubling Time","Doubling time.","NUMBER","SAMPLE"],["DRINKER","Drinker","Drinker.","STRING","PATIENT"],["DSS_MONTHS","Months of disease-specific survival","The time period (months) usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.","NUMBER","PATIENT"],["DSS_STATUS","Disease-specific Survival status","The time period usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.","STRING","PATIENT"],["DUPLICATION_NUM","Duplication Number","Duplication Number","NUMBER","SAMPLE"],["DURATION_OF_THERAPY_WEEKS","duration of therapy weeks","duration of therapy weeks","STRING","PATIENT"],["DURATION_OF_THERAPY_DAYS","duration of therapy days","duration of therapy days","STRING","PATIENT"],["DYSPLASIA","Dysplasia","Dysplasia.","STRING","SAMPLE"],["E2A_STATUS","E2A Status","E2A status.","STRING","SAMPLE"],["EASTERN_CANCER_ONCOLOGY_GROUP","Eastern Cancer Onocology Group","Eastern Cancer Oncology Group.","STRING","PATIENT"],["EBV_POSITIVE_MALIGNANT_CELLS_PERCENT","EBV Positive Malignant Cells Percent","EBV Positive Malignant Cells Percent","NUMBER","SAMPLE"],["EBV_PRESENT","EBV Present","EBV present.","STRING","PATIENT"],["EBV_POSITIVE","EBV Positive","EBV Positive","NUMBER","PATIENT"],["EBV_STATUS","EBV Status","Epstein-Barr Virus (EBV) Status","STRING","PATIENT"],["EBV_STATUS_MALIGNANT_CELLS_METHOD","EBV Status Malignant Cells Method","EBV Status Malignant Cells Method","STRING","PATIENT"],["ECE","ECE","ECE ","STRING","SAMPLE"],["ECE_BINARY","ECE Binary","ECE Binary","STRING","SAMPLE"],["ECOG_SCORE","Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER","PATIENT"],["ECOG_STATUS","ECOG status","ECOG status","STRING","PATIENT"],["ECZEMA_HISTORY","Eczema History","History of eczema.","STRING","PATIENT"],["EFS_EVENT_TYPE_ID","EFS Event Type ID","EFS event type id.","STRING","PATIENT"],["EFS_TIME","EFS Time","EFS time.","STRING","PATIENT"],["EFS_MONTHS","Event Free Survival (Months)","In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or events that the treatment was intended to prevent or delay. These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.","NUMBER","PATIENT"],["EFSCENS","EFS-CENS","EFS-CENS.","STRING","PATIENT"],["EGD","Esophagogastroduodenoscopy","Esophagogastroduodenoscopy","STRING","PATIENT"],["ENCAPSULATION","ENCAPSULATION","ENCAPSULATION","STRING","SAMPLE"],["EPITHELIAL","Epithelial","Epithelial.","STRING","SAMPLE"],["ER_STATUS","ER Status","ER Status","STRING","SAMPLE"],["ERBB_PATHWAY_MUTATION","ErbB Pathway Mutation","ErbB Pathway Mutation","STRING","SAMPLE"],["ERG_FISH_RESULT","ERG FISH Result","ERG Fish result.","STRING","SAMPLE"],["ERG_FUSION_ACGH","ERG Fusion ACGH","ERG fusion acgh.","STRING","SAMPLE"],["ERG_FUSION_GEX","ERG Fusion GEX","ERG fusion gex.","STRING","SAMPLE"],["ERG_FUSION_STATUS","ERG Fusion Status","ERG fusion status.","STRING","SAMPLE"],["ERROR_PERCENT","Error Percent","Error percent.","STRING","SAMPLE"],["EST_TUMOR_CELLULARITY","Estimated Tumor Cellularity","Estimated tumor cellularity.","STRING","SAMPLE"],["ESTIMATED_LEUKOCYTE_PERCENTAGE","Estimated Leukocyte Percentage","Estimated leukocyte percentage.","NUMBER","SAMPLE"],["ETE ","ETE","ETE","STRING","PATIENT"],["ETE_STATUS","ETE STATUS","Yes or No inidcator for extrathyroid extension","STRING","PATIENT"],["ETHNICITY","Ethnicity Category","The text for reporting information about ethnicity.","STRING","PATIENT"],["ETS_FUSION_SEQ","ETS Fusion SEQ","ETS fusion seq","STRING","SAMPLE"],["ETS_RAF_SPINK1_STATUS","ETS RAF-SPINK1 Status","ETS RAF-SPINK1 status.","STRING","SAMPLE"],["ETV1_EXPRESSION","ETV1 Expression","ETV1 Expression","NUMBER","SAMPLE"],["ETV1_FUSION","ETV1 Fusion","ETV1 Fusion","STRING","SAMPLE"],["ETV1_STATUS","ETV1 Status","ETV1 Status","STRING","SAMPLE"],["ETV4_EXPRESSION","ETV4 Expression","ETV4 Expression","NUMBER","SAMPLE"],["ETV4_FUSION","ETV4 Fusion","ETV4 Fusion","STRING","SAMPLE"],["ETV4_STATUS","ETV4 Status","ETV4 Status","STRING","SAMPLE"],["EVENT_TYPE","Event Type","Event Type","STRING","PATIENT"],["EXOME_SEQUENCED_IN_BARBIERI_ET_AL_2012","Exome Sequenced in Barbieri et al.","Exome sequenced in Barbieri et al.","STRING","SAMPLE"],["EXPOSURE","Exposure","Exposure","STRING","SAMPLE"],["EXPRESSION_SUBTYPE","Expression Subtype","Expression subtype.","STRING","SAMPLE"],["EXTENSION","Extension","Extension","STRING","SAMPLE"],["EXTRACAPSULAR_SPREAD","extracapsular spread ","extracapsular spread (ECS), can be yes or no","STRING","SAMPLE"],["EXTRANODAL_INVOLVEMENT","Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING","PATIENT"],["EXTRATHYROIDAL_EXTENSION","Extrathyroidal Extension","Extrathyroidal Extension","STRING","SAMPLE"],["FAB","FAB","FAB.","STRING","PATIENT"],["FAMILY_HISTORY","Family History ","Family History ","STRING","PATIENT"],["FAMILY_HISTORY_CANCER_TYPE","Family History Cancer Type","Family history cancer type.","STRING","PATIENT"],["FAMILY_HISTORY_OF_CANCER","Family History of Cancer","Family history of cancer.","STRING","PATIENT"],["FAMILY_HISTORY_OF_PRIMARY_BRAIN_TUMOR","Family History of Primary Brain Tumor","Family history of primary brain tumor.","STRING","PATIENT"],["FAMILY_HISTORY_OF_STOMACH_CANCER","Family History of Stomach Cancer","Family history of stomach cancer.","STRING","PATIENT"],["FAMILY_HISTORY_OF_THYROID_CANCER","Family History of Thyroid Cancer","Family History of Thyroid Cancer","STRING","PATIENT"],["FGFR1_FISH","FGFR1 FISH","FGFR1 FISH","STRING","PATIENT"],["FIRST_DIAGNOSIS_AGE_ASTH_ECZ","Age at First Diagnosis of ASTH-ECZ ","Age at first diagnosis of ASTH-ECZ.","STRING","PATIENT"],["FIRST_DIAGNOSIS_AGE_OF_ANIMA","Age at First Diagnosis of Anima","Age at first diagnosis of Anima.","STRING","PATIENT"],["FIRST_DIAGNOSIS_AGE_OF_FOOD_ALLERGY","Age at First Diagnosis of Food Allergy","Age at first diagnosis of food allergy.","STRING","PATIENT"],["FIRST_LINE_THERAPY","First Line Therapy","First Line Therapy","STRING","PATIENT"],["FIRST_PRESENTING_SYMPTOM","First Presenting Symptom","First presenting symptom.","STRING","PATIENT"],["FIRST_PRESENTING_SYMPTOM_LON","First Presenting Symptom LON","First presenting symptom LON.","STRING","PATIENT"],["FIRST_RECURRENCE_RESECTABLE_FOR_NED","First Recurrence Resectable for NED","First Recurrence Resectable for NED","STRING","PATIENT"],["FISH_TRANSLOCATION","FISH Translocation","FISH translocation.","STRING","SAMPLE"],["FLI1_EXPRESSION","FLI1 Expression","FLI1 Expression","NUMBER","SAMPLE"],["FLI1_STATUS","FLI1 Status","FLI1 Status","STRING","SAMPLE"],["FLT3_ITD_ALLELIC_RATIO","FLT3-ITD Allelic Ratio.","FLT3-ITD allelic ratio.","STRING","SAMPLE"],["FLT3_ITD_POSITIVE","FLT3-ITD Postive","FLT3-ITD positive.","STRING","SAMPLE"],["FLT3_PM","FLT3-PM","FLT3-PM.","STRING","SAMPLE"],["FMI_CASE_ID","FMI Case Id.","Foundation medicine case id.","STRING","SAMPLE"],["FOCAL_LESIONS_AT_RELAPSE","Focal Lesions At Relapse","Focal Lesions At Relapse","STRING","SAMPLE"],["FOLLOWUP_LENGTH","Follow up length (year)","Follow up length","STRING","PATIENT"],["FOLLOWUP_TREATMENT_SUCCESS","Followup treatment success","Followup treatment success","STRING","PATIENT"],["FOOD_ALLERGY_AGE","Age of Food Allergy ","Age of Food Allergy ","NUMBER","PATIENT"],["FOOD_ALLERGY_HISTORY","Food Allergy History","Food allergy history.","STRING","PATIENT"],["FOOD_ALLERGY_TYPES","Food Allergy Types","Food allergy types.","STRING","PATIENT"],["FOXA1_MUTATION","FOXA1 mutation","FOXA1 mutation is present","STRING","SAMPLE"],["FRAMESHIFT_INSERTION","Frameshift Insertion","Frameshift Insertion","STRING","SAMPLE"],["FRAMESHIFT_DELETION","Frameshift Deletion","Frameshift Deletion","STRING","SAMPLE"],["FUPTIME_MONTHS","F-Uptime (months)","F-Uptime in months.","STRING","PATIENT"],["FUSION_BY_RNA_PCR","Fusion By RNA PCR ","Fusion By RNA PCR","STRING","SAMPLE"],["G_CIMP_METHYLATION","G-CIMP  Methylation","G-CIMP  Methylation","STRING","SAMPLE"],["GALLBLADDER_STONES","Gallbladder Stone","Gallbladder Stone","STRING","SAMPLE"],["GENDER","Person Gender","Patient gender.","STRING","PATIENT"],["GENE_EXPRESSION_CLUSTER","Gene Expression Cluster","Gene expression cluster.","STRING","SAMPLE"],["GENE_PANEL","Gene Panel","Gene panel.","STRING","SAMPLE"],["GERMLINE_CONTROL","Germline Control","Germline Control","STRING","SAMPLE"],["GLEASON_SCORE","Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING","SAMPLE"],["GLEASON_SCORE_1","Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING","SAMPLE"],["GLEASON_SCORE_2","Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING","SAMPLE"],["GLI2_Amplification","GLI2 Amplification","GLI2 Amplification","STRING","SAMPLE"],["GLEASON_SCORE_PERCENT_4_AND_5","Gleason Score Percent 4 & 5","Gleason score percent 4 & 5.","STRING","SAMPLE"],["GRADE","Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING","SAMPLE"],["GTF2I_MUTATION_STATUS","GTF2I Mutation Status","GTF2I Mutation Status","STRING","SAMPLE"],["H_PYLORI","H-PYLORI","H-PYLORI.","STRING","SAMPLE"],["H_PYLORI_INFECTION","H-PYLORI Infection","H-PYLORI infection.","STRING","PATIENT"],["HAS_MATCHED_NORMAL","Matched Normal","Has matched normal.","STRING","SAMPLE"],["HAS_OTHER_CANCER","Other Cancer","Has other cancer.","STRING","PATIENT"],["OTHER_CANCER_TYPE","Types of Other Cancers","Types of Other Cancers","STRING","PATIENT"],["HAS_OTHER_KIDNEY_CONDITION","Other Kidney Condition","Has other kidney condition.","STRING","PATIENT"],["HAY_FEVER_HISTORY","Fever History","Has history of fever.","STRING","PATIENT"],["HEADACHE_HISTORY","Headache History","Has history of headaches.","STRING","PATIENT"],["HEIGHT","Patient Height","Height in centimeters.","NUMBER","PATIENT"],["HER2_DETAILS","HER2 Details","HER2 Details","STRING","SAMPLE"],["HER2_FISH","HER2 FISH","HER2 FISH","STRING","SAMPLE"],["HER2_RATIO","HER2 Ratio","HER2 Ratio","STRING","SAMPLE"],["HER2_STATUS","HER2 Status","HER2 Status","STRING","SAMPLE"],["HGB_(g/dL)","hgb (g/dl)","hgb (g/dl)","STRING","SAMPLE"],["HISTOLOGICAL_DIAGNOSIS","Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING","PATIENT"],["HISTOLOGICAL_SUBTYPE","Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING","PATIENT"],["HISTOLOGICAL_TYPE","Histological Type","Histological Type","STRING","PATIENT"],["HISTOLOGY","Histology ","Histology ","STRING","PATIENT"],["HISTORY_NEOADJUVANT_MEDICATION","Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING","PATIENT"],["HISTORY_NEOADJUVANT_TRTYN","Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING","PATIENT"],["HISTORY_OTHER_MALIGNANCY","Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING","PATIENT"],["HIV_STATUS","HIV Status","HIV Status","STRING","PATIENT"],["HL_STATUS","HL status","Hl Status","STRING","PATIENT"],["HORMONE_STATUS","Hormone Status","Hormone status.","STRING","PATIENT"],["HORMONE_THERAPY_DETAILS","Homrone Therapy Details","Homrone Therapy Details","STRING","PATIENT"],["HORMONE_THERAPY_YEARS","Hormone Therapy Years","Hormone Therapy Years","STRING","PATIENT"],["HPV_ISH","Tumor HPV ISH","Tumor human papilloma virus status by in situ hybridization: Positive/Negative/Not Evaluated","STRING","SAMPLE"],["HPV_PATHSEQ","Tumor HPV PATHSEQ","Tumor human papilloma virus status by PathSeq: Positive/Negative","STRING","SAMPLE"],["HPV_PCR","Tumor HPV PCR","Tumor human papilloma virus status by HPV-16 PCR: Positive/Negative/Not Evaluated","STRING","SAMPLE"],["HPV_STATUS","HPV Status","HPV status.","STRING","PATIENT"],["HPV_DETAILS","HPV Status Details","HPV Status Details","STRING","SAMPLE"],["HRAS_EXPRESSION","HRAS expression","HRAS expression","STRING","SAMPLE"],["HRAS_HIGH","HRAS High","HRAS high","STRING","SAMPLE"],["HRAS_MUTATION","HRAS mutation","HRAS mutation is present","STRING","SAMPLE"],["HTN_STATUS","HTN Status","HTN Status","STRING","PATIENT"],["HYDRONEPHROSIS","Hydronephrosis","Hydronephrosis","STRING","SAMPLE"],["HYPERDIPLOID","Hyper-diploid","Hyper-diploid.","STRING","SAMPLE"],["HYPERMETH_CLUSTER","Hyper-meth Cluster","Hyper-meth Cluster","STRING","SAMPLE"],["HYPERMUTATED","Hyper-mutated","Hyper-mutated.","STRING","SAMPLE"],["ICD_10","ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING","PATIENT"],["ICD_O_3_HISTOLOGY","International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING","PATIENT"],["ICD_O_3_SITE","International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING","PATIENT"],["ICDO","ICDO","ICDO.","STRING","PATIENT"],["ICDO_SNOMED_DESCRIPTION","ICDO Snomed Description","ICDO snomed description.","STRING","PATIENT"],["ICLUSTER","iCluster","ICluster.","STRING","SAMPLE"],["IDH_1P19Q_SUBTYPE","IDH-1P10Q Subtype","IDH-1P10Q subtype.","STRING","SAMPLE"],["IDH1_MUTATION","IDH1 Mutation","IDH1 mutation is present","STRING","SAMPLE"],["IDH1_MUTATION_TEST_INDICATOR","IDH1 Mutation Test Indicator","IDH1 mutation test was performed.","STRING","SAMPLE"],["IHC_ARID1A","IHC-ARID1A","IHC-ARID1A.","STRING","SAMPLE"],["IHC_BASAL","IHC_BASAL","Basal carcinoma by immunohistochemistry for EGFR and CK5/6","STRING","SAMPLE"],["IHC_CDX2","IHC For CDX2","IHC For CDX2","STRING","SAMPLE"],["IHC_CK20","IHC For CK20","IHC For CK20","STRING","SAMPLE"],["IHC_CK5_6","IHC_CK5/6","IHC_CK5/6","STRING","SAMPLE"],["IHC_CK7","IHC For CK7","IHC For CK7","STRING","SAMPLE"],["IHC_EGFR","IHC_EGFR","IHC_EGFR","STRING","SAMPLE"],["IHC_ER","IHC For ER","IHC For ER","STRING","SAMPLE"],["IHC_HER2","IHC-HER2","IHC-HER2","STRING","SAMPLE"],["IHC_MSH6","IHC For MSH6","IHC For MSH6","STRING","SAMPLE"],["IHC_P16","IHC For P16","IHC For P16","STRING","SAMPLE"],["IHC_PAX8","IHC For PAX8","IHC For PAX8","STRING","SAMPLE"],["IHC_PMS2","IHC For PMS2","IHC For PMS2","STRING","SAMPLE"],["IHC_PR","IHC For PR","IHC For PR","STRING","SAMPLE"],["IHC_PTEN","IHC PTEN","IHC PTEN","STRING","SAMPLE"],["IHC_SCORE","IHC Score","IHC Score","NUMBER","SAMPLE"],["IHC_SMAD4","IHC-SMAD4","IHC-SMAD4.","STRING","SAMPLE"],["IHC_TP53","IHC For TP53","IHC For TP53","STRING","SAMPLE"],["IHC_CD10","IHC_CD10","IHC_CD10","STRING","SAMPLE"],["IHC_BCL6","IHC_BCL6","IHC_BCL6","STRING","SAMPLE"],["IHC_MUM1","IHC_MUM1","IHC_MUM1","STRING","SAMPLE"],["IHC_P4EBP1","IHC_P4EBP1","IHC_P4EBP1","STRING","SAMPLE"],["IHC_pS6_235","IHC_pS6_235","IHC_pS6_235","STRING","SAMPLE"],["PI3K_MTOR_STATUS","PI3K_MTOR_STATUS","PI3K_MTOR_STATUS","STRING","SAMPLE"],["IM","IM","IM.","STRING","PATIENT"],["IMMUNOPHENOTYPE","Immunophenotype","Immunophenotype.","STRING","PATIENT"],["IMMUNOSUPPRESSION","Immunosuppression","Suppression of the immune system.","STRING","PATIENT"],["IN_FRAME_DELETION","In frame Deletion","In frame Deletion","STRING","SAMPLE"],["IN_FRAME_INSERTION","In frame Insertion","In frame Insertion","STRING","SAMPLE"],["INDUCTION","Induction","Induction.","STRING","PATIENT"],["INDEL_SOMATIC_GENOMEWIDE","Indel Somatic Genomewide","Indel Somatic Genomewide","NUMBER","SAMPLE"],["INDEL_SOMATIC_CODING","Indel Somatic Coding","Indel Somatic Coding","NUMBER","SAMPLE"],["INFERRED_GENOMIC_REARRANGEMENT","Inferred Genomic Rearrangement","Inferred genomic rearrangement (from RNA-Seq fusion).","STRING","SAMPLE"],["INHERITED_GENETIC_SYNDROME_FOUND","Inherited Genetic Syndrome Found","Inherited genetic syndrome found.","STRING","PATIENT"],["INHERITED_GENETIC_SYNDROME_RESULT","Inherited Genetic Syndrome Result","Inherited genetic syndrome result.","STRING","PATIENT"],["INITIAL_CA-125","Initial CA-125","Initial CA-125","STRING","PATIENT"],["INITIAL_DEFINITIVE_TREATMENT_DETAILS","Initial Definitive Treatment Details","Initial definitive treatment details.","STRING","PATIENT"],["INITIAL_LN_STATUS","Initial LN Status","Initial LN Status","STRING","PATIENT"],["INITIAL_PATHOLOGIC_DX_YEAR","Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER","PATIENT"],["INITIAL_STAGE","Initial Stage","Initial Stage","STRING","PATIENT"],["INSERTION_NUM","Insertion Number","Insertion Number","NUMBER","SAMPLE"],["INSS_STAGE","INSS Stage","Staging according to the International Neuroblastoma Staging System","STRING","PATIENT"],["INSULIN_STATUS","Insulin Status","Insulin Status","STRING","PATIENT"],["INT_ID","INT-ID","INT-ID.","STRING","PATIENT"],["INTEGRATED_CLUSTERS_NO_EXP","Integrated Clusters (no exp)","Integrated Clusters (no exp)","STRING","SAMPLE"],["INTEGRATED_CLUSTERS_UNSUP_EXP","Integrated Clusters (unsup exp)","Integrated Clusters (unsup exp)","STRING","SAMPLE"],["INTEGRATED_CLUSTERS_WITH_PAM50","Integrated Clusters (with PAM50)","Integrated Clusters (with PAM50)","STRING","SAMPLE"],["INTERVAL_TO_METS","Interval to Mets","Interval to Mets","STRING","PATIENT"],["INTESTINAL_TYPE_SUBCLASS","Intestinal Type Subclass","Intestinal type subclass.","STRING","PATIENT"],["INVASION_DEPTH","Invasion Depth (mm)","Invasion depth (mm).","STRING","SAMPLE"],["IPI","IPI","International Prognostic Index (IPI) ","NUMBER","PATIENT"],["IPSS_SCORE","IPSS Score","IPSS (the International Prognostic Scoring System) Score","STRING","PATIENT"],["ISCN","ISCN","ISCN.","STRING","PATIENT"],["JAUNDICE","Jaundice","Jaundice","STRING","PATIENT"],["KARYOTYPE","Karyotype","Karyotype.","STRING","PATIENT"],["KATABI_PATH","Katabi Path","Katabi path.","STRING","PATIENT"],["KDM6A_MUTATION","KDM6A mutation","KDM6A mutation is present","STRING","SAMPLE"],["Ki-67","Ki-67","Ki-67","STRING","PATIENT"],["KMT2A_MUTATION","KMT2A mutation","KMT2A mutation is present","STRING","SAMPLE"],["KMT2D_MUTATION","KMT2D Mutation","KMT2D Mutation","STRING","SAMPLE"],["KNOWN_MOLECULAR_CLASSIFIER","Known Molecular Classifier","Known Molecular Classifier","STRING","PATIENT"],["KRAS_MUTATION","KRAS Mutation","KRAS mutation is present.","STRING","SAMPLE"],["LARGE_DELETION_NUM","Large Deletion Number","Large Deletion Number","NUMBER","SAMPLE"],["LARGEST_SIZE","Largest Size","Largest Size","STRING","PATIENT"],["LAST_CONTACT_DAYS_TO","Last Communication Contact","Time interval from a person's date of death to the date of initial pathologic diagnosis.","NUMBER","PATIENT"],["LAST_STATUS","Last Status","Last Status.","STRING","PATIENT"],["LATERALITY","Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING","PATIENT"],["LAUREN_CLASS","Lauren Class","Lauren class.","STRING","PATIENT"],["LDH_(U/L)","ldh (u/l)","ldh (u/l)","STRING","SAMPLE"],["LDH_LEVEL","Laboratory Procedure Lactate Dehydrogenase Result","Information related to the result of the medical procedure that involves testing a sample of blood for lactic dehydrogenase, a family of homotetrameric cytoplasmic enzymes involved in the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis.","STRING","SAMPLE"],["LIGHT_CHAIN","Light Chain","Light chain.","STRING","SAMPLE"],["LINES_OF_TX","Lines of treatment","Lines of treatment","STRING","PATIENT"],["LN_METASTASIS_2CAT","LN Metastasis 2CAT","LT metastasis 2CAT.","STRING","SAMPLE"],["LN_METS","LN Mets","LN mets.","STRING","PATIENT"],["LNI","LNI","Lymph Node Invovlement","STRING","SAMPLE"],["LOCAL_RECURRENCE","Local Recurrence","Local recurrence.","STRING","PATIENT"],["LOCAL_RECURRENCE_MONTHS","Local Recurrence (months)","Local recurrence (months).","NUMBER","PATIENT"],["LOCAL_RECURRENCE_NUM","Number of Local Recurrence","Number of Local Recurrence","NUMBER","PATIENT"],["LOCALIZED_VS_METS_AT_DX","Localized or Metastaic at Diagnosis","Localized or Metastaic at Diagnosis","STRING","PATIENT"],["LOW_GRADE_HISTORY","Low Grade History","Low grade history.","STRING","PATIENT"],["LYMPH_NODE_EXAMINED_COUNT","Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER","PATIENT"],["LYMPH_NODE_METASTASIS","Lymph Nodes Metastasis","Lymph nodes metastasis.","STRING","SAMPLE"],["LYMPH_NODES","Lymph Nodes ","Lymph Nodes ","STRING","PATIENT"],["LYMPH_NODES_EXAMINED","Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING","PATIENT"],["LYMPH_NODES_EXAMINED_HE_COUNT","Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER","PATIENT"],["LYMPH_NODES_EXAMINED_IHC_COUNT","Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER","PATIENT"],["M_STAGE","M Stage","M Stage","STRING","PATIENT"],["MAF_DATA","MAF Data","MAF Data.","STRING","SAMPLE"],["MARGIN_STATUS","Margin Status","Margin Status","STRING","SAMPLE"],["MATCH_STATUS","Match Status","Match Status","STRING","PATIENT"],["MATCHED_GE_ACGH","Matched GE ACGH","Matched GE acgh.","STRING","SAMPLE"],["MDR","MDR","MDR.","NUMBER","SAMPLE"],["MEAN_PLODY","mean plody","mean plody","STRING","SAMPLE"],["MEAN_TARGET_COVERAGE_NORMAL","mean target coverage normal","mean target coverage normal","STRING","SAMPLE"],["MEAN_TARGET_COVERAGE_TUMOR","mean target coverage tumor","mean target coverage tumor","STRING","SAMPLE"],["MED12_MUTATION","MED12 Mutation","MED12 Mutation is present","STRING","SAMPLE"],["MEDIAN_COVERAGE","Median Coverage","Median coverage.","STRING","SAMPLE"],["MEDICATION","medication","medication","STRING","PATIENT"],["MENOPAUSE_STATUS","Menopause Status","Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.","STRING","PATIENT"],["MENTAL_STATUS_CHANGES","Mental Status Changes","Mental status changes.","STRING","PATIENT"],["MET_SKIPPED_EXON_2","MET Skipped Exon 2","MET skipped exon 2.","STRING","SAMPLE"],["MET_SKIPPED_EXONS_18_AND_19","MET Skipped Exons 18 & 19","MET skipped exons 18 and 19.","STRING","SAMPLE"],["METASTASIS","Metastasis","Metastasis.","STRING","PATIENT"],["METASTASIS_CODED","Metastasis-Coded","Metastasis-Coded","STRING","SAMPLE"],["METASTATIC_SITE","Metastatic Site","The anatomic location to which the cancer has spread.","STRING","SAMPLE"],["METASTATIC_SITE_OTHER","Metastatic Site Other","Metastatic Site Other","STRING","SAMPLE"],["METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING","PATIENT"],["METHOD_OF_SAMPLE_PROCUREMENT","First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING","PATIENT"],["METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING","PATIENT"],["METHOD_OF_SAMPLE_PROCUREMENT_OTHER","First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING","PATIENT"],["METHYLATION_CLASS","Methylation Class","Methylation Class","STRING","SAMPLE"],["METHYLATION_CLUSTER","Methylation Cluster","Methylation cluster.","STRING","SAMPLE"],["METHYLATION_DATA","Methylation Data","Methylation data.","STRING","SAMPLE"],["METHYLATION_SUBTYPE","Methylation Subtype","Methylation subtype.","STRING","SAMPLE"],["METS_FREE_TIME_MONTHS","MetsFreeTime_Months","MetsFreeTime_Months","NUMBER","PATIENT"],["MGMT_STATUS","MGMT Status","MGMT Status","STRING","SAMPLE"],["MICRO_RNA_CLUSTER","MicroRNA Cluster","MicroRNA cluster.","STRING","SAMPLE"],["MICRO_RNA_SCORE","MicroRNA Score","MicroRNA score.","NUMBER","SAMPLE"],["MICRORNA_EXPRESSION_CLUSTER","MicroRNA Expression Cluster","MicroRNA expression cluster.","STRING","SAMPLE"],["MINUS_X","Minus-X","Minus-X.","STRING","SAMPLE"],["MINUS_Y","Minus-Y","Minus-Y.","STRING","SAMPLE"],["MIRNA_CLUSTER","MIRNA Cluster","MICRNA cluster","STRING","SAMPLE"],["MITO","MITO","MITO.","STRING","SAMPLE"],["MITOTIC_ACTIVITY","Mitotic Activity","Mitotic Activity","STRING","SAMPLE"],["MITOTIC_COUNT","Mitotic Count","Mitotic Count","NUMBER","SAMPLE"],["MITOTIC_SCORE","Mitotic Score","Mitotic Score","NUMBER","SAMPLE"],["MKI","MKI","MKI.","STRING","SAMPLE"],["MLH1_METHYLATION","MLH1 Methylation","MLH1 methylation.","STRING","SAMPLE"],["MLH1_SILENCING","MLH1 Silencing","Epigenetic silencing status of MLH1.","STRING","SAMPLE"],["MLL","MLL","MLL.","STRING","SAMPLE"],["MLL_STATUS","MLL Status","MLL status.","STRING","SAMPLE"],["MLL_FUSION","MLL Fusion","MLL Fusion","STRING","SAMPLE"],["MODIFIED_CAPRA-S_SCORE_WITHOUT_INCLUDING_SURGICAL_MARGINS","Modified CAPRA-S Score wOut Margins","Modified CAPRA-S score without including margins.","STRING","PATIENT"],["MOLD_OR_DUST_ALLERGY_HISTORY","Mold or Dust Allergy History","History of mold or dust allergy.","STRING","PATIENT"],["MOLECULAR_SUBTYPE","Molecular Subtype","Molecular subtype.","STRING","SAMPLE"],["MONOSOMY_5","Monosomy 5","Monosomy 5.","STRING","SAMPLE"],["MONOSOMY_7","Monosomy 7","Monosomy 7.","STRING","SAMPLE"],["MONTHS_ON_STUDY","months on study","months on study","NUMBER","PATIENT"],["RECURRENCE_AT_DIAGNOSIS","Recurrence at Diagnosis","Recurrence at Diagnosis","STRING","PATIENT"],["MONTHS_TO_DISTANT_RECURRENCE","Months to Distant Recurrence","Months to distant recurrence.","STRING","PATIENT"],["MONTHS_TO_LOCAL_RECURRENCE","Months to Local Recurrence.","Months to local recurrence.","STRING","PATIENT"],["MOTOR_MOVEMENT_CHANGES","Motor Movement Changes.","Motor movement changes.","STRING","PATIENT"],["MRD_AT_END_OF_COURSE_1","MRD at end of Course 1","MRD at end of course 1.","STRING","PATIENT"],["MRD_AT_END_OF_COURSE_2","MRD at end of Course 2","MRD at end of course 2.","STRING","PATIENT"],["MRD_PERCENT_DAY_29","MRD Percentage Day 29","MRD percentage at day 29.","STRING","PATIENT"],["MRD_PERCENTAGE_AT_END_OF_COURSE_1","MRD Percentage at end of Course 1","MRD percentage at end of course 1.","STRING","PATIENT"],["MRD_PERCENTAGE_AT_END_OF_COURSE_2","MRD Percentage at end of Course 2","MRD percentage at end of course 2.","STRING","PATIENT"],["MRNA_DATA","MRNA Data","MRNA data.","STRING","SAMPLE"],["MRNA_EXPRESSION_CLUSTER","MRNA Expression Cluster","MRNA expression cluster.","STRING","SAMPLE"],["MSI_MMR","MSI MMR","MSI MMR","STRING","SAMPLE"],["MSI_STATUS","MSI Status","MSI status.","STRING","SAMPLE"],["MSI_STATUS_5_MARKER_CALL","MSI Status 5 Marker Call","MSI status 5 marker call.","STRING","SAMPLE"],["MSI_STATUS_7_MARKER_CALL","MSI Status 7 Marker Call","MSI status 7 marker call.","STRING","SAMPLE"],["MSI_PREDICTION_SCORE","MSI Prediction Score","MSI Prediction Score","NUMBER","SAMPLE"],["MULTICENTRICITY","Multicentricity","Multicentricity","STRING","SAMPLE"],["MUTATION_RATE","Mutation Rate","Mutation Rate","NUMBER","SAMPLE"],["MUTATION_RATE_CLUSTER","Mutation Rate Cluster","Mutation rate cluster","STRING","SAMPLE"],["MUTATION_STATUS","Mutation Status","Mutation Status","STRING","SAMPLE"],["MUTATION_TYPE","Mutation Type","Mutation Type","STRING","SAMPLE"],["MUTSIG_RATENON_PERMB","Mutsig Rate NON-PERMB","Mutsig rate non-permb.","NUMBER","SAMPLE"],["MUTSIG_RATESIL_PERMB","Mutsig Rate SIL-PERMB","Mutsig rate sil-perbm.","NUMBER","SAMPLE"],["MUTSIG_RATETOT_PERMB","Mutsig Rate TOT-PERMB","Mutsig rate tot-perbm","NUMBER","SAMPLE"],["MYB-NFIB_FISH","MYB-NFIB FISH","MYB-NFIB FISH.","STRING","SAMPLE"],["MYCN","MYCN","MYCN.","STRING","SAMPLE"],["N_STAGE","N Stage","N Stage","STRING","PATIENT"],["N+_N-","N+,N-","N+, N-","STRING","SAMPLE"],["NECK_DISSECTION_TYPE","Neck Dissection type","Neck Dissection type","STRING","SAMPLE"],["NECROSIS","Necrosis","Necrosis","STRING","SAMPLE"],["NEOADJ_CHEMO","Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING","PATIENT"],["NEOADJUVANT_CHEMO","Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING","PATIENT"],["NEOADJUVANT_SYSTEMIC_CHEMO","Neoadjuvant   Systemic Chemotherapy","Neoadjuvant   Systemic Chemotherapy","STRING","PATIENT"],["NEW_NEOPLASM_EVENT_OCCURRENCE_ANATOMIC_SITE","New Neoplasm Event Occurence Anatomic Site","New neoplasm event occurence anatomic site","STRING","SAMPLE"],["NEW_NEOPLASM_EVENT_TYPE","New Neoplasm Event Type","New neoplasm event type.","STRING","SAMPLE"],["NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING","PATIENT"],["NODES","Node","Node","STRING","SAMPLE"],["NODES_DETAILS","Nodes Details","Nodes details.","STRING","PATIENT"],["NON_SILENT_MUTATION","Non Silent Mutations","Non Silent Mutations","STRING","SAMPLE"],["NON_SILENT_SNV","Non-Slient SNVs","Non-Slient Single-Nucleotide Variants","NUMBER","SAMPLE"],["NONSENSE_MUTATION","Nonsense Mutations","Nonsense Mutations","STRING","SAMPLE"],["NONSILENT_PER_MB","Non Silent per Mb","Non Silent per Mb","STRING","SAMPLE"],["NONSTOP_MUTATION","Nonstop Mutations","Nonstop Mutations","STRING","SAMPLE"],["NORMAL_GENOME_COVERAGE","Normal Genome Coverage","Normal Genome Coverage","NUMBER","SAMPLE"],["NORMAL_GENOME_LIBRARY","Normal Genome Library","Normal Genome Library","STRING","SAMPLE"],["NORMAL_SITE","Normal location","Tissue where normal was derived.","STRING","SAMPLE"],["NOTE","Note","Note.","STRING","SAMPLE"],["NPM_MUTATION","NPM Mutation","NPM mutation.","STRING","SAMPLE"],["NRAS_STATUS","nras status","nras status","STRING","SAMPLE"],["NUMBER_OF_LYMPHNODES_POSITIVE","Positive Finding Lymph Node","Positive Finding Lymph Node","STRING","SAMPLE"],["NUMBER_OF_LYMPHNODES_POSITIVE_BY_HE","Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER","PATIENT"],["NUMBER_OF_RELATIVES_WITH_STOMACH_CANCER","Number of Relatives w/Stomach Cancer","Number of relatives with stomach cancer.","STRING","PATIENT"],["OFFICIAL_PATH","Official Pathology","Official pathology.","STRING","PATIENT"],["ONCOSIGN_CLUSTER","Oncosign Cluster","Oncosign cluster.","STRING","SAMPLE"],["OR_PERCENT","OR percent","OR Percent","STRING","SAMPLE"],["OS_MONTHS","Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER","PATIENT"],["OS_STATUS","Overall Survival Status","Overall patient survival status.","STRING","PATIENT"],["OTHER_CHEMO","Other Chemotherapy","Other Chemotherapy.","STRING","PATIENT"],["OTHER_METHOD_OF_SAMPLE_PROCUREMENT","Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING","PATIENT"],["OTHER_MLL","Other MLL","Other MLL.","STRING","PATIENT"],["OTHER_PATIENT_ID","Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING","PATIENT"],["OTHER_SAMPLE_ID","Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING","SAMPLE"],["P53","P53","P53.","STRING","SAMPLE"],["P53_MUTATION","P53 Mutation","P53 Mutation","STRING","SAMPLE"],["P53_GERMLINE","P53 Germline","P53 Germline","STRING","SAMPLE"],["PAM50_SUBTYPE","PAM50 subtype","PAM50 subtype","STRING","SAMPLE"],["PATH_CANCER_MAX_DIM_CM","Pathology Cancer Maximum Dimension (cm)","Pathology cancer maximum dimension (cm).","STRING","PATIENT"],["PATH_GLEASON_SCORE","PATH GLEASON SCORE ","PATH GLEASON SCORE ","STRING","SAMPLE"],["PATH_GLEASON_SCORE_1","PATH GLEASON SCORE 1","PATH GLEASON SCORE 1","STRING","SAMPLE"],["PATH_GLEASON_SCORE_2","PATH GLEASON SCORE 2","PATH GLEASON SCORE 2","STRING","SAMPLE"],["PATH_M_STAGE","American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING","PATIENT"],["PATH_MARGIN","Disease Surgical Margin Status","Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.","STRING","PATIENT"],["PATH_N_STAGE","Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING","PATIENT"],["PATH_T_STAGE","American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING","PATIENT"],["PATHOLOGIC_PRIMARY_TUMOR_STAGE","pathologic primary tumor stage","pathologic primary tumor stage","STRING","SAMPLE"],["PATHOLOGICAL_DIAGNOSIS","Pathological Diagnosis","Pathological Diagnosis","STRING","PATIENT"],["PATHOLOGY_LAUREN","Pathology Lauren","Pathology Lauren.","STRING","PATIENT"],["PATIENT_DEATH_REASON","Patient Death Reason","Text term to identify the cause of death for a patient.","STRING","PATIENT"],["PATIENT_ID","Patient Identifier","Identifier to uniquely specify a patient.","STRING","PATIENT"],["PATIENT_ID_LEGACY","Legacy Patient Identifier","Deprecated patient identifier","STRING","PATIENT"],["PATIENT_STUDY_ID","patient study id","patient study id","STRING","PATIENT"],["PAX8","PAX8","PAX8","STRING","PATIENT"],["PAX_FUSION","PAX Fusion","PAX Fusion","STRING","SAMPLE"],["PB_BLAST_PERCENTAGE","PB Blast Percentage","PB blast percentage","NUMBER","PATIENT"],["PERCENT_GLEASON_PATTERN_4_OR_5","Gleason Score Percent 4 & 5","Gleason Score Percent 4 & 5.","NUMBER","PATIENT"],["PERCENT_LYMPHOCYTE_INFILTRATION","Percent Lymphocyte Infiltration","Numeric value to represent the percentage of infiltration by lymphocytes in a tumor sample or specimen.","NUMBER","PATIENT"],["PERCENT_TUMOR_CELLS","Percent Tumor Cells","Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen.","NUMBER","PATIENT"],["PERCENT_TUMOR_NUCLEI","Percent Tumor Nuclei","Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen.","NUMBER","PATIENT"],["PERCENTAGE_NECROSIS","Percent Necrosis","Percent necrosis.","NUMBER","PATIENT"],["PERCENTAGE_TUMOR_PURITY","Percent Tumor Purity","Percent tumor purity.","NUMBER","PATIENT"],["PERFORMANCE_STATUS_SCALE_TIMING","Performance Status Scale Timing","Performance status scale timing.","STRING","PATIENT"],["PERFORMANCE_STATUS_TIMING","Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING","PATIENT"],["PERI_OP_CHEMO","peri op chemo","peri op chemo","STRING","PATIENT"],["PERINEURAL_INVASION","Perineural Invasion","Perineural invasion.","STRING","SAMPLE"],["PERIPHERAL_BLASTS_PERCENTAGE","Peripheral Blasts Percentage","Peripheral blasts percentage.","NUMBER","PATIENT"],["PERSON_NEOPLASM_CANCER_STATUS","Person Neoplasm Cancer Status ","Person neoplasm cancer status.","STRING","PATIENT"],["PEG10_MUTATION","PEG10 Mutation","PEG10 Mutation","STRING","SAMPLE"],["PET_SCAN","PET Scan","PET Scan","STRING","PATIENT"],["PFS_MONTHS","Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER","PATIENT"],["PHARMACEUTICAL_TX_ADJUVANT","Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING","PATIENT"],["PHENOTYPE","Phenotype","Phenotype","STRING","SAMPLE"],["PHYSICIAN","Physician","Physician.","STRING","PATIENT"],["PI3K_MUTATION","PI3K Mutation","PI3K Mutation","STRING","SAMPLE"],["PIK3CA_MUTATION","PIK3CA Mutation","PIK3CA mutation is present.","STRING","SAMPLE"],["PIPELINE_VERSION","Pipeline Version","Analysis pipeline version.","STRING","SAMPLE"],["PLATFORM","Platform","Platform.","STRING","SAMPLE"],["PLATINUM_DOUBLET","Platinum Doublet","Platinum Doublet","STRING","PATIENT"],["PLATINUM_STATUS","Platinum Status","Platinum status.","STRING","PATIENT"],["PLEOMORPHISM_SCORE","Pleomorphism Score","Pleomorphism Score","STRING","SAMPLE"],["PLOIDY","Ploidy","Ploidy.","NUMBER","SAMPLE"],["PNI","PNI","PNI.","STRING","PATIENT"],["POOL","pool","Pool","STRING","SAMPLE"],["POSTTREATMENT_STAGE","Post-treatment Stage","Post-treatment stage.","STRING","PATIENT"],["PR_STATUS","PR Status","PR Status","STRING","SAMPLE"],["PREOPERATIVE_ANTISEIZURE_MED","Preoperative Anti-Seizure Medication ","Pre-operative anti-seizure medication.","STRING","PATIENT"],["PREOPERATIVE_CORTICOSTEROIDS","Preoperative Corticosteroids","Pre-operative corticosteriods.","STRING","PATIENT"],["PREOPERATIVE_PSA","Preop PSA","Preop PSA","NUMBER","PATIENT"],["PRETREATMENT_HISTORY","Pre-treatment History","Pre-treatment history.","STRING","PATIENT"],["PRETREATMENT_IMAGING","Pre-treatment Imaging","Pre-treatment imaging.","STRING","PATIENT"],["PRETREATMENT_STAGE","Pre-treatment Stage","Pre-treatment stage.","STRING","PATIENT"],["PREVIOUS_TREATMENT","Previous Treatment","Previous treatment.","STRING","PATIENT"],["PRIMARY_CYTOGENETIC_CODE","Primary Cytogenetic Code","Primary cytogenetic code.","STRING","PATIENT"],["PRIMARY_DIAGNOSIS","Primary Diagosis","Primary Diagnosis","STRING","PATIENT"],["PRIMARY_HISTOLOGY","Primary histology","Primary Histology","STRING","PATIENT"],["PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING","PATIENT"],["PRIMARY_PHARMA_THERAPY","Primary Pharmacologic Therapy","Primary pharmacologic therapy.","STRING","PATIENT"],["PRIMARY_RADIATION_THERAPY","Primary Radiation Therapy","Primary radiation therapy.","STRING","PATIENT"],["PRIMARY_SITE","Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING","SAMPLE"],["PRIMARY_SITE_OTHER","Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING","SAMPLE"],["PRIMARY_SITE_PROGRESSION","Primary Site Progression","Primary site progression.","STRING","PATIENT"],["PRIMARY_THERAPY_OUTCOME_SUCCESS","Primary Therapy Outcome Success","Primary therapy outhcome success.","STRING","PATIENT"],["PRIMARY_TUMOR_LOCALIZATION_TYPE","Primary Tumor Localization Type","Primary Tumor Localization Type","STRING","PATIENT"],["PRIMARY_TUMOR_PATHOLOGIC_SPREAD","Primary Tumor Pathologic Spread","Primary tumor pathologic spread.","STRING","PATIENT"],["PRIMARY_TUMOR_SIZE","Primary Tumor Size","Primary Tumor Size","STRING","SAMPLE"],["PRIOR_AI","Prior AI","Prior AI.","STRING","PATIENT"],["PRIOR_DIAGNOSIS","Prior Diagnosis","Prior diagnosis.","STRING","PATIENT"],["PRIOR_DX","Prior Diagnosis","Prior diagnosis.","STRING","PATIENT"],["PRIOR_DXYN","Prior Diagnosis","Prior diagnosis.","STRING","PATIENT"],["PRIOR_FULVESTRANT","Prior Fulvestrant","Prior fulvestrant.","STRING","PATIENT"],["PRIOR_GLIOMA","Prior Glioma","Prior glioma.","STRING","PATIENT"],["PRIOR_HERCEPTIN","Prior Herceptin","Prior herceptin.","STRING","PATIENT"],["PRIOR_LAPATINIB","Prior Lapatinib","Prior lapatinib.","STRING","PATIENT"],["PRIOR_MGUS","Prior MGUS","Prior MGUS.","STRING","PATIENT"],["PRIOR_PERTUZUMAB","Prior Pertuzumab","Prior pertuzumab.","STRING","PATIENT"],["PRIOR_RT","Prior RT.","Prior RT.","STRING","PATIENT"],["PRIOR_TAMOXIFEN","Prior Tamoxifen","Prior tamoxifen.","STRING","PATIENT"],["PRIOR_TDM1","Prior TDM1","Prior TDM1.","STRING","PATIENT"],["PRIOR_THYROID_CANCER","Prior Thyroid Cancer","Prior Thyroid Cancer","STRING","PATIENT"],["PRIOR_TREATMENT","Prior Treatment","Prior treatment.","STRING","PATIENT"],["PROGRESSION_DETERMINED_BY","Progression Determined By","Method by which disease progression was determined.","STRING","PATIENT"],["PROSPECTIVE_COLLECTION","Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING","PATIENT"],["PROTOCOL","Protocol","Protocol.","STRING","PATIENT"],["PTCH1_Mutation","PTCH1 Mutation","PTCH1 Mutation","STRING","SAMPLE"],["PTEN_DELETION","PTEN Deletion","PTEN deletion is present","STRING","SAMPLE"],["PTEN_MUTATION","PTEN Mutation","PTEN Mutation is present","STRING","SAMPLE"],["PURITY_ABSOLUTE","Absolute Purity","Absolute purity.","NUMBER","SAMPLE"],["RACE","Race Category","The text for reporting information about race.","STRING","PATIENT"],["RADIATION_HISTORY","Radiation History","History of radiation","STRING","PATIENT"],["RADIATION_OR_CHEMOTHERAPY","Patient received Radiation or Chemotherapy","Patient received Radiation or Chemotherapy","STRING","PATIENT"],["RADIATION_THERAPY","Radiation Therapy","Radiation Therapy.","STRING","PATIENT"],["RADIATION_TREATMENT_ADJUVANT","Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING","PATIENT"],["RADIATION_TREATMENT_NEOADJUVANT","Did patient start neoadjuvant preoperative radiotherapy?","A yes/no indicator that asks whether the patient startedneoadjuvant preoperative radiotherapy?","STRING","PATIENT"],["RADICALITY","Radicality Of Surgery ","Radicality of Surgery: GTR = Gross Total Resection, STR = Sub-Total Resection","STRING","SAMPLE"],["RC_GRADE","RC Grade","RC Grade","STRING","SAMPLE"],["RC_YEAR","RC Year","RC Year","STRING","PATIENT"],["RESPONSE_TO_SMO_INHIBITION","Response To SMO Inhibition","Response To SMO Inhibition","STRING","PATIENT"],["REASON_FOR_TX_DISCONTINUATION","reason for tx discontinuation","reason for tx discontinuation","STRING","PATIENT"],["REFLUX_HISTORY","Reflux History","History of reflux.","STRING","PATIENT"],["REGIONAL_LYMPH_NODE","Regional Lymph Node","Regional Lymph Node","STRING","SAMPLE"],["RELAPSE","Relapse","Relapse.","STRING","PATIENT"],["RELAPSE_YEAR","Relapse Year","Relapse year.","NUMBER","PATIENT"],["RESECTION_TIMING","Resection timing","Resection timing","STRING","SAMPLE"],["RESIDUAL_TUMOR","Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING","PATIENT"],["RESPONSE_TO_FRONT_LINE_THERAPY","response to front line therapy","response to front line therapy","STRING","SAMPLE"],["RETROSPECTIVE_COLLECTION","Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING","PATIENT"],["REVIEWED_GLEASON","Reviewed gleason","Reviewed gleason","STRING","SAMPLE"],["REVIEWED_GLEASON_CATEGORY","Reviewed Gleason Category","Reviewed Gleason category","STRING","SAMPLE"],["REVIEWED_GLEASON_SUM","Reviewed Gleason Sum","Reviewed Gleason Sum","NUMBER","SAMPLE"],["RHOA_MUTATION","RHOA Mutation","RHOA mutation is present.","STRING","SAMPLE"],["RISK_CYTO","Risk (Cyto)","Risk (Cyto).","STRING","PATIENT"],["RISK_GROUP","Risk Group","Risk group.","STRING","PATIENT"],["RISK_MOLECULAR","Risk (Molecular)","Risk (Molecular).","STRING","PATIENT"],["RNASEQ_CLUSTER","RNA-SEQ Cluster","RNA-SEQ cluster.","STRING","SAMPLE"],["RNASEQ_DATA","RNA-SEQ Data","RNA-SEQ data.","STRING","SAMPLE"],["RPPA_CLUSTER","RPPA Cluster","RPPA Cluster.","STRING","SAMPLE"],["RT_MAX_DOSE_CGY","RT Max dose cgy","RT Max dose cgy","STRING","PATIENT"],["RUN","Run","Run-IMPACT","NUMBER","SAMPLE"],["SALVAGE_CHEMO","Salvage Chemo","Salvage Chemo","STRING","PATIENT"],["SALVAGE_CYSTECTOMY","Salvage Cystectomy","Salvage Cystectomy","STRING","PATIENT"],["SAMPLE_CLASS","Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING","SAMPLE"],["SAMPLE_COLLECTION_SOURCE","SAMPLE_COLLECTION_SOURCE","Sample Collection Source","STRING","SAMPLE"],["SAMPLE_ID","Sample Identifier","A unique sample identifier.","STRING","SAMPLE"],["SAMPLE_ID_LEGACY","Former Sample Identifier","Deprecated sample identifier","STRING","SAMPLE"],["SAMPLE_ORIGIN","Sample origin","Sample origin","STRING","SAMPLE"],["SAMPLE_TYPE","Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING","SAMPLE"],["SCENS","SCENS","SCENS.","STRING","PATIENT"],["SCT_IN_FIRST_CR","SCT in First CR","SCT in first CR.","STRING","PATIENT"],["SECONDARY_HISTOLOGY","Histology Secondary","Histology Secondary","STRING","SAMPLE"],["SEIZURE_HISTORY","Seizure History","Seizure history.","STRING","PATIENT"],["SENSORY_CHANGES","Sensory Changes","Sensory changes.","STRING","PATIENT"],["SEQUENCED","Sequenced","Sequenced.","STRING","SAMPLE"],["SEQUENOM","Sequenom","Sequenom","STRING","SAMPLE"],["SEQUENOME_MUTATIONS_FUSIONS","Sequenome of mutations of fusions","Sequenome of mutations of fusions","STRING","SAMPLE"],["SERUM_PSA","Serum PSA","Serum PSA.","NUMBER","PATIENT"],["SIGCLUST_INTRINSIC_MRNA","SigClust Intrinsic mRNA","SigClust Intrinsic mRNA","STRING","SAMPLE"],["SIGCLUST_UNSUPERVISED_MRNA","SigClust Unsupervised mRNA","SigClust Unsupervised mRNA","STRING","SAMPLE"],["SIGNET_RING","Signet Ring","Signet ring.","STRING","PATIENT"],["SILENT_MUTATION","Silent Mutations","Silent Mutations","STRING","SAMPLE"],["SILENT_PER_MB","Silent per Mb","Silent per Mb","STRING","SAMPLE"],["SILENT_SNV","Silent Single-Nucleotide Variants","Silent Single-Nucleotide Variants","NUMBER","SAMPLE"],["SITE_OF_INITIAL_RELAPSE","Site of Initial Relapse","Site of initial relapse.","STRING","SAMPLE"],["SITE_OF_RECURRENCE","Site of Recurrence","Site of Recurrence","STRING","SAMPLE"],["SHH_AMPLIFICATION","SHH Amplification","SHH(Sonic-hedgehog) Amplification","STRING","SAMPLE"],["SMALL_EXONIC_SOMATIC_INDELS","Small Exonic Somatic Indels","Small Exonic Somatic Indels","NUMBER","SAMPLE"],["SMO_Mutation","SMO Mutation","SMO Mutation","STRING","SAMPLE"],["SMOKER","Smoker","Indicates if person is a smoker.","STRING","PATIENT"],["SMOKING_HISTORY","Smoking History","Indicates if person has a history of smoking.","STRING","PATIENT"],["SMOKING_PACK_YEARS","Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER","PATIENT"],["SMOKING_QUESTIONNAIRE","smoking questionnaire","smoking questionnaire","STRING","PATIENT"],["SMOKING_YEAR_STARTED","Started Smoking Year","The year in which the participant began smoking.","NUMBER","PATIENT"],["SMOKING_YEAR_STOPPED","Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER","PATIENT"],["SMS","sms","sms","STRING","SAMPLE"],["SNAPSHOT_MUTATIONS","snapshot mutations","snapshot mutations","STRING","SAMPLE"],["SNOMED","SNOMED","SNOMED","STRING","PATIENT"],["SPECIMEN_COLLECTION_PRE_OR_POST_CHEMO","Specimen Collection Pre or Post Chemo","Specimen Collection Pre or Post Chemo","STRING","SAMPLE"],["SPECIMEN_CURRENT_WEIGHT","Specimen Current Weight","The weight of the specimen.","STRING","SAMPLE"],["SPECIMEN_FREEZING_METHOD","Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING","SAMPLE"],["SPECIMEN_PRESERVATION_TYPE","Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING","SAMPLE"],["SPECIMEN_REFERENCE_NUMBER","Specimen Reference Number","Specimen Reference Number","STRING","SAMPLE"],["SPECIMEN_SECOND_LONGEST_DIMENSION","Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER","SAMPLE"],["SPECIMEN_SITE","Specimen Site","Specimen Site","STRING","SAMPLE"],["SPECIMEN_TYPE","Specimen Type","The broad cancer phenotype and site information values for a sample to be processed.","STRING","SAMPLE"],["SPLICE_SITE","Splice Site","Splice Site","STRING","SAMPLE"],["SPLICE_SITE_INSERTION","Splice Site Insertion","Splice Site Insertion","STRING","SAMPLE"],["SPLICE_SITE_SNP","Splice Site SNP","Splice Site SNP","STRING","SAMPLE"],["SPOP_MUTATION","SPOP Mutation","SPOP Mutation","STRING","SAMPLE"],["STAGE_AT_PRESENTATION","Stage at Presentation","Stage at Presentation","STRING","SAMPLE"],["STAGE_AT_PRESENTATION_OR_RELAPSE","Stage at Presentation or Relapse","Stage at Presentation or Relapse","STRING","SAMPLE"],["STAGING_SYSTEM","Staging System","Staging System.","STRING","PATIENT"],["STAGING_SYSTEM_OTHER","Staging System","Staging System Other ","STRING","SAMPLE"],["START_DATE","Start Date","The start date of a treatment(days)","NUMBER","PATIENT"],["STATE_PROVINCE_COUNTRY_OF_PROCUREMENT","State-Province-Country of Procurement","State, province, or country of procurement.","STRING","PATIENT"],["STATUS","Status","Status.","STRING","PATIENT"],["STATUSDATE","Status Date","Status date.","STRING","PATIENT"],["STEAP","STEAP","STEAP.","STRING","SAMPLE"],["STEPHANSON_5YR_NOMOGRAM","stephanson 5yr nomogram","stephanson 5yr nomogram","STRING","SAMPLE"],["STIME","STIME","STIME.","STRING","PATIENT"],["STOP_DATE","Stop Date","The last date of the of the treatment(days)","NUMBER","PATIENT"],["STR_STATUS","STR (affected/tested)","Short Tandem Repeat Ratio","STRING","SAMPLE"],["STRUCTURAL_VARIANTS","Structural Variants","Structural variants from WGS.","STRING","SAMPLE"],["STUDY","Study","Study.","STRING","PATIENT"],["STUDY_ARM","study arm","study arm","STRING","PATIENT"],["SU2C_SAMPLE_ID","SU2C Sample Id","SU2C sample id.","STRING","SAMPLE"],["SUB_CLONES","Subclones","Subclones detected by WGS.","STRING","SAMPLE"],["SUB_SITE","Sub-site","Sub-site.","STRING","SAMPLE"],["SUBCLONAL_GENOMIC_FRACTION","Subclone Genomic Fraction","Subclone Genomic Fraction","STRING","SAMPLE"],["SUBGROUP","Subgroup","Subgroup","STRING","PATIENT"],["SUBSTITUTION","Substitution","Substitution Mutations","STRING","SAMPLE"],["SUBTYPE","Subtype","Subtype","STRING","PATIENT"],["SUPRATENTORIAL_LOCALIZATION","Supratentorial Localization","Supratentorial localization.","STRING","SAMPLE"],["SUFU_Mutation","SUFU Mutation","SUFU Mutation","STRING","SAMPLE"],["SURGERY","Surgery","Surgery.","STRING","PATIENT"],["SURGERY_AT_MSKCC","Surgery At MSKCC","Surgery At MSKCC","STRING","PATIENT"],["SURGERY_HISTORY","surgery history","surgery history","STRING","PATIENT"],["SURVIVAL_AFTER_BIOPSY_MONTHS","survival after biopsy months","survival after biopsy months","STRING","SAMPLE"],["SURVIVAL_DATA_FORM","Survival Data Form","Survival Data Form","STRING","SAMPLE"],["SURVIVAL_FROM_FIRST_CHEMOTHERAPY","Survival from First Chemotherapy","Survival from first chemotherapy.","NUMBER","PATIENT"],["SURVIVAL_FROM_FIRST_HORMONE_THERAPY","Survival from First Hormone Therapy","Survival from first hormone therapy","NUMBER","PATIENT"],["SVI","svi","svi","STRING","SAMPLE"],["SYNONYMS","Synonyms","Synonyms.","STRING","PATIENT"],["T_STAGE","T Stage","T Stage","STRING","SAMPLE"],["TARGET_ID","target id","target id","STRING","SAMPLE"],["TARGETED_MOLECULAR_THERAPY","Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING","PATIENT"],["TEL_STATUS","TEL Status","TEL status.","STRING","PATIENT"],["TERT_MUTATION","TERT Mutation","TERT Mutation","STRING","SAMPLE"],["TERTIARY_PATTERN","Tertiary Pattern","Tertiary pattern.","STRING","SAMPLE"],["TEST_ALK_FISH","test alk fish","test alk fish","STRING","SAMPLE"],["TEST_FGFR1_FISH","test fgfr1 fish","test fgfr1 fish","STRING","SAMPLE"],["TEST_MET_FISH","test met fish","test met fish","STRING","SAMPLE"],["TEST_MGMT_IHC","test mgmt ihc","test mgmt ihc","STRING","SAMPLE"],["TEST_PTEN_IHC","test pten ihc","test pten ihc","STRING","SAMPLE"],["TESTICULAR","Testicular","Testicular.","STRING","PATIENT"],["TTF1_STAIN","TTF1 Stain","TTF1 Stain","STRING","SAMPLE"],["TG_STAIN","Tg Stain","Tg Stain","STRING","SAMPLE"],["THERAPY","therapy","therapy","STRING","PATIENT"],["TIME_TO_COMPLETE_RESPONSE","Time To Complete Response (months)","Time To Complete Response (months)","NUMBER","PATIENT"],["TIME_TO_DISTANT_RECURRENCE","Time to distant recurrence","Time to distant recurrence","NUMBER","PATIENT"],["TIME_TO_LAST_FOLLOWUP","Time to Last Followup","Time to last followup.","NUMBER","PATIENT"],["TIME_TO_LOCAL_RECURRENCE","Time to local recurrence","Time to local recurrence","STRING","PATIENT"],["TIME_TO_LOCAL_RECURRENCE_STATUS","Time to local recurrence status","Time to local recurrence status","STRING","PATIENT"],["TIME_TO_MET_MONTHS","Time to Metastasis (months)","Time to metastasis (months).","NUMBER","PATIENT"],["TIME_TO_RECURRENCE_MONTHS","Time to Recurrence (months)","Time to Recurrence (months)","STRING","PATIENT"],["TIME_TO_RELAPSE","Time To Relapse (months)","Time To Relapse (months)","NUMBER","PATIENT"],["TIME_TO_UNRESECTABLE_OR_METASTATIC_DISEASE_MONTHS","Time to unresectable or metastatic disease in months","Time to unresectable or metastatic disease in months","NUMBER","PATIENT"],["TISSUE_ANALYZED","Tissue Analyzed","Tissue Analyzed","STRING","PATIENT"],["TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING","SAMPLE"],["TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING","SAMPLE"],["TISSUE_SEQUENCED","Tissue Sequenced","Tissue Sequnced","STRING","SAMPLE"],["TISSUE_SOURCE_SITE","Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING","SAMPLE"],["TISSUE_TYPE","Tissue Type","Tissue Type","STRING","SAMPLE"],["TMPRSS2_ERG_FUSION_STATUS","TMPRSS2-ERG Fusion Status","TMPRESS2-ERG fusion status.","STRING","SAMPLE"],["TNM","TNM","TNM.","STRING","SAMPLE"],["TNMSTAGE","TNM Stage","TNM stage.","STRING","SAMPLE"],["TOBACCO_SMOKING_HISTORY_INDICATOR","Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING","PATIENT"],["TOTAL","TOTAL","TOTAL","STRING","SAMPLE"],["TOTAL_CNA","Total CNA ","Total CNA","NUMBER","SAMPLE"],["TOTAL_PER_MB","TOTAL PER Mb","TOTAL PER Mb","STRING","SAMPLE"],["TOTAL_REARRANGEMENT","Total Rearrangement","Total Rearrangement","NUMBER","SAMPLE"],["TOTAL_SNV","Total SNV","Total Single-Nucleotide Variants","NUMBER","SAMPLE"],["TP53_DELETION","TP53 Deletion","TP53 Deletion is present","STRING","SAMPLE"],["TP53_MUTATION","TP53 Mutation","TP53 mutation is present.","STRING","SAMPLE"],["TRANSLOCATION_16","Translocation 16","Translocation 16.","STRING","SAMPLE"],["TRANSLOCATIONS","Translocations","Translocations","STRING","SAMPLE"],["TRANSPLANT_TYPE","Transplant Type","Type of transplant (sib Allo, MUD, Auto, etc).","STRING","PATIENT"],["TREATMENT","Treatment","Treatment","STRING","PATIENT"],["TREATMENT_BEST_RESPONSE","Treatment best response","Treatment best response","STRING","PATIENT"],["TREATMENT_CHEMOTHERAPY","Chemotherapy","Chemotherapy.","STRING","PATIENT"],["TREATMENT_EXPOSED_VS_NAIVE","Exposed vs. Naive","Exposed vs. Naive.","STRING","SAMPLE"],["TREATMENT_HORMONE_THERAPY","Hormone Therapy","Hormone therapy.","STRING","PATIENT"],["TREATMENT_OUTCOME_FIRST_COURSE","Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING","PATIENT"],["TREATMENT_PALLIATIVE_RADIATION","Palliative Radiation","Palliative radiation.","STRING","PATIENT"],["TREATMENT_PRIOR_TO_RESECTION","treatment prior to resection","treatment prior to resection","STRING","SAMPLE"],["TREATMENT_PROSTATECTOMY","Prostatectomy","Prostatectomy.","STRING","PATIENT"],["TREATMENT_RADIATION","Radiation","Radiation.","STRING","PATIENT"],["TREATMENT_TYPE","Treatment Type","Treatment Type","STRING","PATIENT"],["TRISOMY_10_11_P11_2_Q23","Trisomy 10-11_P11_2_Q23","Trisomy 10-11_P11_2_Q23.","STRING","SAMPLE"],["TRISOMY_11_19_Q23_P13_1","Trisomy 11_19_Q23_P13_1","Trisomy 11_19_Q23_P13_1.","STRING","SAMPLE"],["TRISOMY_21","Trisomy 21","Trisomy 21.","STRING","SAMPLE"],["TRISOMY_3_5_Q25_Q34","Trisomy 3_5_Q25_Q34","Trisomy 3_5_Q25_Q34.","STRING","SAMPLE"],["TRISOMY_4_10","Trisomy 4_10","Trisomy 4_10.","STRING","SAMPLE"],["TRISOMY_4_10_17","Trisomy 4_10_17","Trisomy 4_10_17.","STRING","SAMPLE"],["TRISOMY_6_11_Q27_Q23","Trisomy 6_11_Q27_Q23","Trisomy 6_11_Q27_Q23.","STRING","SAMPLE"],["TRISOMY_6_9","Trisomy 6_9","Trisomy 6_9.","STRING","SAMPLE"],["TRISOMY_8","Trisomy 8","Trisomy 8.","STRING","SAMPLE"],["TRISOMY_8_21","Trisomy 8_21","Trisomy 8_21.","STRING","SAMPLE"],["TRISOMY_9_11_P22_Q23","Trisomy 9_11_P22_Q23","Trisomy 9_11_P22_Q23.","STRING","SAMPLE"],["TUBE_ID","Tube Id","Tube id.","STRING","SAMPLE"],["TUBULE_SCORE","Tubule Score","Tubule Score","STRING","SAMPLE"],["TUMOR ","Tumor","Tumor","STRING","SAMPLE"],["TUMOR_CELLULARITY_DOMINANT_CLONE_VAF","Tumor cellularity dominant clone vaf","Tumor cellularity dominant clone vaf","STRING","SAMPLE"],["TUMOR_CELLULARITY_PATHOLOGY_REVIEW","Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING","SAMPLE"],["TUMOR_CONTENT","tumor content","tumor content","NUMBER","SAMPLE"],["TUMOR_DIFFERENTIATION","Tumor Differentiation ","Tumor Differentiation ","STRING","SAMPLE"],["TUMOR_GENOME_COVERAGE","Tumor Genome Coverage","Tumor Genome Coverage","NUMBER","SAMPLE"],["TUMOR_GENOME_LIBRARY","Tumor Genome Library","Tumor Genome Library","STRING","SAMPLE"],["TUMOR_LEVEL","Tumor Level","Tumor level.","STRING","SAMPLE"],["TUMOR_PURITY","tumor purity","tumor purity","STRING","SAMPLE"],["TUMOR_REGION","Tumor Region","Tumor region.","STRING","SAMPLE"],["TUMOR_RESIDUAL_DISEASE","Tumor Residual Disease","Tumor residual disease.","STRING","SAMPLE"],["TUMOR_SAMPLE_HISTOLOGY","Tumor Sample Histology","Tumor Sample Histology","STRING","SAMPLE"],["TUMOR_SIDE","Tumor Side","Tumor side.","STRING","SAMPLE"],["TUMOR_SITE","Tumor Site","Tumor Site","STRING","PATIENT"],["TUMOR_SIZE","Tumor Size","Tumor size.","STRING","SAMPLE"],["TUMOR_STAGE","Tumor Stage","Tumor stage.","STRING","SAMPLE"],["TUMOR_STAGE_2009","Tumor Stage 2009","Tumor stage 2009.","STRING","SAMPLE"],["TUMOR_STATUS","Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING","PATIENT"],["TUMOR_T1_CODED","Tumor--T1 Coded","Tumor--T1 Coded","STRING","SAMPLE"],["TUMOR_TISSUE_SITE","Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING","SAMPLE"],["TUMOR_TREATED","Tumor treated","Tumor treated","STRING","SAMPLE"],["TUMOR_TYPE","Tumor Type","Tumor Type","STRING","SAMPLE"],["TX_90DAYS_POST_RESECTION","Treatment (90 Days Post Resection)","Treatment (90 Days Post Resection)","STRING","PATIENT"],["TX_COMPLETE_RESPONSE","Treatment (Complete Response)","Treatment (Complete Response)","STRING","PATIENT"],["TX_INDUCTION_COURSES_INDICATOR","Treatment (Induction Courses Indicator)","Treatment (Induction Courses Indicator)","STRING","PATIENT"],["TX_MAINTENANCE_COURSES_INDICATOR","Treatment (Maintenance Courses Indicator)","Treatment (Maintenance Courses Indicator)","STRING","PATIENT"],["TYPE","Type","Type","STRING","SAMPLE"],["TYPE_OF_SURGERY","Type of Surgery","Type of Surgery.","STRING","SAMPLE"],["UICC_TUMOR_STAGE","UICC Tumor Stage","UICC Tumor Stage","STRING","PATIENT"],["UROTHELIAL_PRIMARY","Urothelial Primary","Urothelial primary.","STRING","PATIENT"],["VALIDATION_STATUS","Validation status","Sample validation status (unknown or valid)","STRING","SAMPLE"],["VARIANT_HISTOLOGY","Variant Histology","Variant Histology","STRING","PATIENT"],["VARIANT_HISTOLOGY_SUBTYPE","Variant Histology Subtype","Variant Histology Subtype","STRING","PATIENT"],["VASCULAR_INVASION","Vascular Invasion","Vascular invasion.","STRING","SAMPLE"],["VISUAL_CHANGES","Visual Changes","Visual changes.","STRING","PATIENT"],["VITAL_STATUS","Patient's Vital Status","The survival state of the person.","STRING","PATIENT"],["WBC","WBC","White bloodcell count.","NUMBER","PATIENT"],["WBC_X_10^3_PER_MICROLITER","WBC (10^3/microliter)","White bloodcell count (10^3 per microliter).","NUMBER","PATIENT"],["INITIAL_WEIGHT","Initial Patient Weight","Weight measured in kilograms.","NUMBER","PATIENT"],["WEIGHT","Patient Weight","Weight measured in kilograms.","NUMBER","PATIENT"],["WGS_BASED_PURITY_ESTIMATION","WGS Based Purity Estimation","WGS based purity estimation","STRING","SAMPLE"],["WHO_CLASS","WHO Class","WHO class.","STRING","PATIENT"],["WT1_MUTATION","WT1 Mutation","WT1 mutation.","STRING","SAMPLE"],["X_SOURCEINFO","X Source Infomation","X source information.","STRING","PATIENT"],["XTANDI","XTANDI","XTANDI.","STRING","SAMPLE"],["XTANDI_EXPOSED_BEFORE_BX","XTANDI Exposed Before BX","XTANDI exposed before BX.","STRING","SAMPLE"],["YEAR_OF_DIAGNOSIS","Year of Diagnosis","Year of Diagnosis","NUMBER","PATIENT"],["YEAR_OF_INITIAL_PATHOLOGIC_DIAGNOSIS","Year of initial pathologic diagnosis","Year of initial pathologic diagnosis.","NUMBER","PATIENT"],["YEAR_OF_SPECIMEN","Year of Specimen","Year of specimen.","NUMBER","SAMPLE"],["YEAR_OF_SURGERY","Year of Surgery","Year of surgery.","NUMBER","SAMPLE"],["ZYTIGA","Zytiga","Zytiga.","STRING","SAMPLE"],["ZYTIGA_EXPOSED_BEFORE_BX","Zytiga Exposed Before BX","Zytiga exposed before BX.","STRING","SAMPLE"],["BILATERAL_DIAGNOSIS_TIMING_TYPE","Bilateral Diagnosis Timing Type","Bilateral Diagnosis Timing Type","STRING","SAMPLE"],["BILIRUBIN_TOTAL","Bilirubin Total","Bilirubin Total","STRING","SAMPLE"],["BILIRUBIN_TOTAL_NORM_RANGE_LOWER","Bilirubin Total Norm Range Lower","Bilirubin Total Norm Range Lower","NUMBER","SAMPLE"],["BILIRUBIN_TOTAL_NORM_RANGE_UPPER","Bilirubin Total Norm Range Upper","Bilirubin Total Norm Range Upper","NUMBER","SAMPLE"],["BRACHYTHERAPY_TYPE","Brachytherapy Type","Brachytherapy Type","STRING","SAMPLE"],["BRACHYTHERAPY_TYPE_OTHER","Brachytherapy Type Other","Brachytherapy Type Other","STRING","SAMPLE"],["BRAF_GENE_ANALYSIS_INDICATOR","BRAF Gene Analysis Indicator","BRAF Gene Analysis Indicator","STRING","SAMPLE"],["BRAF_GENE_ANALYSIS_RESULT","BRAF Gene Analysis Result","BRAF Gene Analysis Result","STRING","SAMPLE"],["BRAFV600E_RAF_CLASS","BRAFV600E RAF Class","BRAFV600E RAF Class","NUMBER","SAMPLE"],["BRAFV600E_RAF_SCORE","BRAFV600E RAF Score","BRAFV600E RAF Score","NUMBER","SAMPLE"],["TUMOR_EXOME_DEPTH","Tumor Exome Depth","Tumor Exome Depth","NUMBER","SAMPLE"],["NORMAL_EXOME_DEPTH","Normal Exome Depth","Normal Exome Depth","NUMBER","SAMPLE"],["PURITY","Purity","Purity","NUMBER","SAMPLE"],["IF_EXTRACAPSULAR_SPREAD_PRESENT","If Extracapsular Spread Present ","If Extracapsular Spread Present ","STRING","SAMPLE"],["INCIDENTAL_PROSTATE_CANCER","Incidental Prostate Cancer Indicator","Incidental Prostate Cancer Indicator","STRING","SAMPLE"],["AJCC_INCIDENTAL_PROSTATE_CANCER","AJCC Incidental Prostate Cancer","American Joint Committee on Cancer Code Incidental Prostate Cancer","STRING","SAMPLE"],["INITIAL_SX_YEAR","Initial Symptom (Years)","The disease initial symptom date.","NUMBER","PATIENT"],["QS_DATE","QS Date","The date the survey was filled out.","STRING","PATIENT"],["NOSYSTXT","What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?","What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?","STRING","PATIENT"],["TREATMENT_ARM","Treatment Arm","Treatment Arm","STRING","PATIENT"],["IHC_PS6","IHC For PS6","IHC For PS6","STRING","SAMPLE"],["IHC_B_TUBULIN","IHC For B Tubulin","IHC For B Tubulin","STRING","SAMPLE"],["TARGETED_SEQ","Targeted Sequence","Targeted Sequence","STRING","SAMPLE"],["SYSTEMIC_THERAPY","Systemic Therapy ","Systemic Therapy ","STRING","PATIENT"],["STAGE_AT_DIAGNOSIS","Stage At Diagnosis ","Stage At Diagnosis","STRING","SAMPLE"],["SNP","SNP","Single Nucleotide Polymorphism ","STRING","SAMPLE"],["TREATMENT_DETAILS","Treatment Details","Treatment Details","STRING","PATIENT"],["SOCIAL_HISTORY","Social History","Social History ","STRING","PATIENT"],["TUMOR_INFILTRATING_LYMPHOCYTES","Tumor Infiltrating Lymphocytes","Tumor infiltrating lymphocytes (TILs) are a type of white blood cell found in tumors. TILs are implicated in killing tumor cells, and the presence of lymphocytes in tumors is often associated with better clinical outcomes.","STRING","SAMPLE"],["TUMOR_THICKNESS_MEASUREMENT","Tumor Thickness Measurement","Tumor Thickness Measurement","STRING","SAMPLE"],["TUMOR_INFILTRATING_MACROPHAGES","Tumor Infiltrating Macrophages","Tumor Infiltrating Macrophages","STRING","SAMPLE"],["TUMOR_BASAL_DIAMETER","Tumor Basal Diameter","Tumor Basal Diameter","NUMBER","SAMPLE"],["TUMOR_MORPHOLOGY_PERCENTAGE","Tumor Morphology Percentage","Tumor Morphology Percentage","STRING","SAMPLE"],["TUMOR_SHAPE_PATHOLOGIC_CLINICAL","Tumor Shape Pathologic Clinical","Tumor Shape Pathologic Clinical","STRING","SAMPLE"],["PET_CT_STANDARDIZED_VALUES","Pet Ct Standardized Values","Pet Ct Standardized Values","STRING","SAMPLE"],["TUMOR_BASAL_DIAMETER_MX","Tumor Basal Diameter Mx","Tumor Basal Diameter Mx","STRING","SAMPLE"],["TUMOR_THICKNESS","Tumor Thickness","Tumor Thickness","NUMBER","SAMPLE"],["MICROVASCULAR_DENSITY_MVD","Microvascular Density Mvd","Microvascular Density Mvd","STRING","SAMPLE"],["EXTRANOCULAR_NODULE_SIZE","Extranocular Nodule Size","Extranocular Nodule Size","STRING","SAMPLE"],["EYE_COLOR","Eye Color","Eye Color","STRING","SAMPLE"],["GENE_EXPRESSION_PROFILE","Gene Expression Profile","Gene Expression Profile","STRING","SAMPLE"],["EXTRASCLERAL_EXTENSION","Extrascleral Extension","Extrascleral Extension","STRING","SAMPLE"],["EXTRAVASCULAR_MATRIX_PATTERNS","Extravascular Matrix Patterns","Extravascular Matrix Patterns","STRING","SAMPLE"],["PATHOLOGY_REPORT_FILE_NAME","Pathology Report File Name","Pathology Report File Name","STRING","SAMPLE"],["KMT2C_MUT","KMT2C Mutation","KMT2C Mutation","NUMBER","SAMPLE"],["AR_V7_READS","AR V7 Reads","AR V7 Reads","NUMBER","SAMPLE"],["SPOPL_CNA","SPOPL CNA","SPOPL CNA","STRING","SAMPLE"],["AR_PROTEIN","AR Protein","AR Protein","NUMBER","SAMPLE"],["CDK12_MUT","CDK12 Mutation","CDK12 Mutation","NUMBER","SAMPLE"],["FANCD2_MUT","FANCD2 Mutation","FANCD2 Mutation","NUMBER","SAMPLE"],["BRCA1_GERMLINE_MUT","BRCA1 Germline Mutation","BRCA1 Germline Mutation","NUMBER","SAMPLE"],["ATM_MUT","ATM Mutation","ATM Mutation","NUMBER","SAMPLE"],["FRACTION_GENOME_ALTERED","Fraction Genome Altered","Fraction Genome Altered","NUMBER","SAMPLE"],["CDK12_CNA","CDK12 CNA","CDK12 CNA","STRING","SAMPLE"],["AR_V7_PRESENCE","AR V7 Presence","AR V7 Presence","NUMBER","SAMPLE"],["CLONET_PURITY","CLONET Purity","CLONET Purity","NUMBER","SAMPLE"],["AR_MRNA","AR mRNA","AR mRNA","NUMBER","SAMPLE"],["MUTATIONS","Mutations","Mutations","NUMBER","SAMPLE"],["AR_V7_RATIO","AR V7 Ratio","AR V7 Ratio","NUMBER","SAMPLE"],["BRCA2_GERMLINE_MUT","BRCA2 Germline Mutation","BRCA2 Germline Mutation","NUMBER","SAMPLE"],["FANCC_MUT","FANCC Mutation","FANCC Mutation","NUMBER","SAMPLE"],["TP53_CNA","TP53 CNA","TP53 CNA","STRING","SAMPLE"],["CHD1_CNA","CHD1 CNA","CHD1 CNA","STRING","SAMPLE"],["CDKN1B_CNA","CDKN1B CNA","CDKN1B CNA","STRING","SAMPLE"],["PTEN_CNA","PTEN CNA","PTEN CNA","STRING","SAMPLE"],["BRCA2_CNA","BRCA2 CNA","BRCA2 CNA","STRING","SAMPLE"],["RB1_CNA","RB1 CNA","RB1 CNA","STRING","SAMPLE"],["CHEMO_CONCURRENT_COURSE","Dose Frequency Text","The text that represents the planned dosage frequency for a agent.","STRING","PATIENT"],["CHEMO_CONCURRENT_DOSE","Concurrent Chemotherapy Dose","Occurring or operating at the same time. The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","STRING","PATIENT"],["CHEMO_CONCURRENT_FRACTIONS_TOTAL","Agent Total Dose Count","A total number of doses of a drug, vaccine or other agent administered to a patient.","NUMBER","PATIENT"],["CHEMO_CONCURRENT_REASON_NOT_GIVEN","Chemo Concurrent Reason Not Given","Text term to capture the explanation for a chemotherapy not being given concurrent to radiation therapy.","STRING","PATIENT"],["CHEMO_CONCURRENT_REASON_NOT_OTHER","Chemo Concurrent Reason Not Other","Another reason that is not already specified or mentioned for why concurrent chemotherapy was not given.","STRING","PATIENT"],["CHEMO_CONCURRENT_TYPE","Chemotherapy Regimen Type","The chemotherapy regimen or schedule and agent in the therapy of patient","STRING","PATIENT"],["CHEMO_CONCURRENT_TYPE_OTHER","Other Chemotherapy Agent Administration Specify","Specify the other chemotherapy agent administered.","STRING","PATIENT"],["ATYPICAL_MITOTIC_FIGURES","Atypical Mitotic Figures","Atypical Mitotic Figures","STRING","PATIENT"],["CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT","Cytoplasm Presence Less Than Equal 25 Percent","Cytoplasm Presence Less Than Equal 25 Percent","STRING","PATIENT"],["DIFFUSE_ARCHITECTURE","Diffuse Architecture","Diffuse Architecture","STRING","PATIENT"],["HISTORY_ADRENAL_HORMONE_EXCESS","Excess Adrenal Hormone History Type","Excess Adrenal Hormone History Type","STRING","PATIENT"],["HISTORY_BASIS_ADRENAL_HORMONE_DX","Excess Adrenal Hormone Diagnosis Method Type","Excess Adrenal Hormone Diagnosis Method Type","STRING","PATIENT"],["MITOSES_PER_50_HPF","Mitoses Count","Mitoses Count","NUMBER","PATIENT"],["MITOTIC_RATE","Mitotic Rate","Mitotic Rate","STRING","PATIENT"],["NUCLEAR_GRADE_III_IV","Nuclear Grade III IV","Nuclear Grade III IV","STRING","PATIENT"],["PHARM_TX_MITOTANE_ADJUVANT","Mitotane Therapy adjuvant setting","Mitotane Therapy Adjuvant Setting","STRING","PATIENT"],["PHARM_TX_MITOTANE_FOR_MACRO_DISEASE","Mitotane Therapy for macroscopic residual disease","Mitotane Therapy For Macroscopic Residual Disease","STRING","PATIENT"],["PHARM_TX_MITOTANE_INDICATOR","Mitotane Therapy","Mitotane Therapy","STRING","PATIENT"],["PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG","Therapeutic Mitotane lvl progression","Therapeutic Mitotane Lvl Progression","STRING","PATIENT"],["PHARM_TX_MITOTANE_THERAPUTIC_AT_REC","Therapeutic Mitotane lvl recurrence","Therapeutic Mitotane Lvl Recurrence","STRING","PATIENT"],["PHARM_TX_MITOTANE_THERAPUTIC_LEVELS","Therapeutic Mitotane levels achieved","Therapeutic Mitotane Levels Achieved","STRING","PATIENT"],["PHARM_TX_MITOTANE_THERAPUTIC_MACRO","Therapeutic Mitotane lvl macroscopic residual","Therapeutic Mitotane Lvl Macroscopic Residual","STRING","PATIENT"],["RET","RET","RET","STRING","SAMPLE"],["SDHA","SDHA","SDHA","STRING","SAMPLE"],["SDHAF2_SDH5","SDHAF2 SDH5","SDHAF2 SDH5","STRING","SAMPLE"],["SDHB","SDHB","SDHB","STRING","SAMPLE"],["SDHC","SDHC","SDHC","STRING","SAMPLE"],["SDHD","SDHD","SDHD","STRING","SAMPLE"],["SINUSOID_INVASION","Sinusoid Invasion","Sinusoid Invasion","STRING","SAMPLE"],["TMEM127","Tmem127","Tmem127","STRING","SAMPLE"],["VHL","Von Hippel-Lindau","Von Hippel-Lindau syndrome (VHL) is a hereditary condition associated with hemangioblastomas, which are blood vessel tumors of the brain, spinal cord, and eye.","STRING","SAMPLE"],["WEISS_SCORE_OVERALL","Weiss Score Overall","Weiss Score Overall","NUMBER","SAMPLE"],["WEISS_VENOUS_INVASION","Weiss Venous Invasion","Weiss Venous Invasion","STRING","SAMPLE"],["MOLECULAR_STUDIES_OTHERS_PERFORMED","Molecular Analysis Performed Indicator","Molecular Analysis Performed Indicator","STRING","SAMPLE"],["CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY","Clinical Status Within 3 Mths Surgery","Clinical Status Within 3 Mths Surgery","STRING","SAMPLE"],["METASTATIC_DX_CONFIRMED_BY","Metastatic Neoplasm Confirmed Diagnosis Method Name","Metastatic Neoplasm Confirmed Diagnosis Method Name","STRING","SAMPLE"],["METASTATIC_DX","Metastatic at Diagnosis","Metastatic at Diagnosis","STRING","PATIENT"],["METASTATIC_DX_CONFIRMED_BY_OTHER","Metastatic Neoplasm Confirmed Diagnosis Method Text","Metastatic Neoplasm Confirmed Diagnosis Method Text","STRING","SAMPLE"],["EXTRACAPSULAR_EXTENSION","Extracapsular Extension","The yes/no/unknown indicator that asks whether or not there is extracapsular extension.","STRING","SAMPLE"],["EXTRACAPSULAR_EXTENSION_PRESENT","Extracapsular Extension present","Text term to describe the extent of extracapsular extension present in a case of bladder carcinoma.","STRING","SAMPLE"],["OCCUPATION_CURRENT","Occupation Current","The text that describes the type of business or industry associated with a person's job.","STRING","PATIENT"],["OCCUPATION_PRIMARY","Occupation Primary","The primary occupation of the participant for most of their adult employment.","STRING","PATIENT"],["OCCUPATION_PRIMARY_CHEMICAL_EXPOSURE","Occupation Primary Chemical Exposure","To specify an exposure to a substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties at work.","STRING","PATIENT"],["OCCUPATION_PRIMARY_INDUSTRY","Occupation Primary Industry","Text to describe the industry in which a person's primary occupation time was spent.","STRING","PATIENT"],["OCCUPATION_PRIMARY_YEARS_WORKED","Occupation Primary Years Worked","The number that describes the duration of time expressed in number of years that a person has worked in a job.","NUMBER","PATIENT"],["KARNOFSKY_PERFORMANCE_SCORE","Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER","PATIENT"],["FAMILY_HISTORY_CANCER_RELATIONSHIP","Family History Cancer Relationship","Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individuals genes is shared (i.e., parent, sibling, offspring).","STRING","PATIENT"],["BRACHYTHERAPY_TOTAL_DOSE_POINT_A","Brachytherapy first reference point administered total dose","Brachytherapy first reference point administered total dose","STRING","PATIENT"],["CERVIX_SUV_RESULTS","Standardized uptake value cervix uteri assessment measurement","Standardized uptake value cervix uteri assessment measurement","NUMBER","PATIENT"],["CORPUS_INVOLVEMENT","Cervical carcinoma corpus uteri involvement indicator","Cervical carcinoma corpus uteri involvement indicator","STRING","PATIENT"],["DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED","Days to diagnostic computed tomography performed","Days to diagnostic computed tomography performed","NUMBER","PATIENT"],["DAYS_TO_DIAGNOSTIC_MRI_PERFORMED","Days to diagnostic mri performed","Days to diagnostic mri performed","NUMBER","PATIENT"],["DAYS_TO_FDG_OR_CT_PET_PERFORMED","Days to fdg or ct pet performed","Days to fdg or ct pet performed","NUMBER","PATIENT"],["DAYS_TO_LABORATORY_PROCEDURE_TUMOR_MARKER_SQUAMOUS_CELL_CARCINOMA_ANTIGEN_RESULT","Days to laboratory procedure tumor marker squamous cell carcinoma antigen result","Days to laboratory procedure tumor marker squamous cell carcinoma antigen result","NUMBER","PATIENT"],["DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT","Days to performance status assessment","Days to performance status assessment","NUMBER","PATIENT"],["FEDPET_OR_CT_RESULTS","Fdg or ct pet performed outcome","Fdg or ct pet performed outcome","STRING","PATIENT"],["HISTORY_IMMUNOSUPPRESSIVE_DISEASE","Patient history immune system and related disorders name","Patient history immune system and related disorders name","STRING","PATIENT"],["HPV_TYPES_OTHER","Human papillomavirus other type text","Human papillomavirus other type text","STRING","PATIENT"],["HPV_TYPES_POSITIVE","Human papillomavirus type","Human papillomavirus type","STRING","PATIENT"],["HPV_TYPING_METHOD","Human papillomavirus laboratory procedure performed name","Human papillomavirus laboratory procedure performed name","STRING","PATIENT"],["HPV_TYPING_METHOD_OTHER","Human papillomavirus laboratory procedure performed text","Human papillomavirus laboratory procedure performed text","STRING","PATIENT"],["HYSTERECTOMY_TYPE","Hysterectomy performed type","Hysterectomy performed type","STRING","PATIENT"],["KERATINIZATION_SQUAMOUS_CELL","Keratinizing squamous cell carcinoma present indicator","Keratinizing squamous cell carcinoma present indicator","STRING","PATIENT"],["LYMPH_NODES_SUPRACLAVICULAR","Diagnostic mri result outcome","Diagnostic mri result outcome","STRING","PATIENT"],["MARGINS_INVOLVED_HYSTERECTOMY","Cervical neoplasm pathologic margin involved type","Cervical neoplasm pathologic margin involved type","STRING","PATIENT"],["OTHER_HYSTERECTOMY_TYPE","Hysterectomy performed text","Hysterectomy performed text","STRING","PATIENT"],["OTHER_IMMUNOSUPPRESSIVE_DISEASE","Patient history immune system and related disorders text","Patient history immune system and related disorders text","STRING","PATIENT"],["OTHER_INVOLVED_MARGINS","Cervical neoplasm pathologic margin involved text","Cervical neoplasm pathologic margin involved text","STRING","PATIENT"],["OTHER_POS_NODE_LOCATION","Lymph node location positive pathology text","Lymph node location positive pathology text","STRING","PATIENT"],["PCR_PRIMER_PAIRS","Oligonucleotide primer pair laboratory procedure performed name","Oligonucleotide primer pair laboratory procedure performed name","STRING","PATIENT"],["PCR_PRIMER_PAIRS_OTHER","Oligonucleotide primer pair laboratory procedure performed text","Oligonucleotide primer pair laboratory procedure performed text","STRING","PATIENT"],["PELVIC_EXTENSION_COMMENT","Cervical carcinoma pelvic extension text","Cervical carcinoma pelvic extension text","STRING","PATIENT"],["POS_LYMPH_NODE_LOCATION","Lymph node location positive pathology name","Lymph node location positive pathology name","STRING","PATIENT"],["PREGNANCIES_COUNT_ECTOPIC","Ectopic pregnancy count","Ectopic pregnancy count","NUMBER","PATIENT"],["PREGNANCIES_COUNT_INDUCED_ABORTION","Patient pregnancy therapeutic abortion count","Patient pregnancy therapeutic abortion count","NUMBER","PATIENT"],["PREGNANCIES_COUNT_LIVE_BIRTH","Number of successful pregnancies which resulted in at least 1 live birth","Number of successful pregnancies which resulted in at least 1 live birth","NUMBER","PATIENT"],["PREGNANCIES_COUNT_MISCARRIAGE","Patient pregnancy spontaneous abortion count","Patient pregnancy spontaneous abortion count","NUMBER","PATIENT"],["PREGNANCIES_COUNT_STILLBIRTH","Pregnancy stillbirth count","Pregnancy stillbirth count","NUMBER","PATIENT"],["PREGNANCIES_COUNT_TOTAL","Total number of pregnancies","Total number of pregnancies","NUMBER","PATIENT"],["PREGNANT_AT_DIAGNOSIS","Pregnant at diagnosis","Pregnant at diagnosis","STRING","PATIENT"],["RADIATION_THERAPY_DOSE_PARAAORTIC_NODES","External beam radiation therapy administered paraaortic region lymph node dose","External beam radiation therapy administered paraaortic region lymph node dose","STRING","PATIENT"],["RADIATION_THERAPY_XRT_TYPE","Rt administered type","Rt administered type","STRING","PATIENT"],["RADIATION_TYPE_OTHER","Radiation type notes","Radiation type notes","STRING","PATIENT"],["RT_TX_REASON_NOT_COMPLETED","Radiation therapy not administered reason","Radiation therapy not administered reason","STRING","PATIENT"],["RT_TX_REASON_NOT_COMPLETED_OTHER","Radiation therapy not administered specify","Radiation therapy not administered specify","STRING","PATIENT"],["RT_TX_TOTAL_DOSE_TO_PELVIS","Rt pelvis administered total dose","Rt pelvis administered total dose","STRING","PATIENT"],["SCCA_TUMOR_MARKER","Laboratory procedure tumor marker squamous cell carcinoma antigen result value","Laboratory procedure tumor marker squamous cell carcinoma antigen result value","STRING","PATIENT"],["TUMOR_RESPONSE","Tumor response cdus type","Tumor response cdus type","STRING","PATIENT"],["EXTRANODAL_INVOLVEMENT_SITE","Extranodal disease involvement site","Extranodal disease involvement site","STRING","SAMPLE"],["EXTRANODAL_INVOLVMENT_OTHER","Extranodal disease involvement site","Extranodal disease involvement site","STRING","SAMPLE"],["EXTRANODAL_LYMPHOMATOUS_INVOLVEMENT","Extranodal involvement","Extranodal involvement","STRING","SAMPLE"],["FOLLICULAR_COMPONENT_PERCENT","Percentage of follicular component","Percentage of follicular component","STRING","SAMPLE"],["GENETIC_ABNORMALITY_METHOD_OTHER","Abnormality tested methodology","Abnormality tested methodology","STRING","SAMPLE"],["GENETIC_ABNORMALITY_RESULTS","Abnormality tested results","Abnormality tested results","STRING","SAMPLE"],["GENETIC_ABNORMALITY_TESTED","Genetic abnormality tested","Genetic abnormality tested","STRING","SAMPLE"],["GENETIC_ABNORMALITY_TESTED_OTHER","Other genetic abnormality tested","Other genetic abnormality tested","STRING","SAMPLE"],["HISTORY_IMMUNOLOGICAL_DISEASE","Prior immunologic disease type","Prior immunologic disease type","STRING","SAMPLE"],["HISTORY_IMMUNOLOGICAL_DISEASE_OTHER","Prior immunologic disease other","Prior immunologic disease other","STRING","SAMPLE"],["HISTORY_IMMUNOSUPPRESIVE_DX","Prior immunosuppressive therapy type","Prior immunosuppressive therapy type","STRING","SAMPLE"],["HISTORY_IMMUNOSUPPRESIVE_DX_OTHER","Prior immunosuppressive therapy other","Prior immunosuppressive therapy other","STRING","SAMPLE"],["HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER","Prior infectious disease other","Prior infectious disease other","STRING","SAMPLE"],["HISTORY_RELEVANT_INFECTIOUS_DX","Prior infectious disease","Prior infectious disease","STRING","SAMPLE"],["IGH_GENOTYPE_RESULT","Igh genotype results","Igh genotype results","STRING","SAMPLE"],["IGK_GENOTYPE_RESULT","Igk genotype results","Igk genotype results","STRING","SAMPLE"],["IMMUNOPHENOTYPIC_ANALYSIS_METHOD","Immunophenotypic analysis methodology","Immunophenotypic analysis methodology","STRING","SAMPLE"],["IMMUNOPHENOTYPIC_ANALYSIS_RESULTS","Result of immunophenotypic analysis","Result of immunophenotypic analysis","STRING","SAMPLE"],["IMMUNOPHENOTYPIC_ANALYSIS_TESTED","Immunophenotypic analysis test","Immunophenotypic analysis test","STRING","SAMPLE"],["LDH_NORM_RANGE_UPPER","Ldh upper limit","Ldh upper limit","STRING","SAMPLE"],["LYMPH_NODE_INVOLVEMENT_SITE","Nodal anatomic site","Nodal anatomic site","STRING","SAMPLE"],["MAXIMUM_TUMOR_BULK_ANATOMIC_SITE","Maximum tumor bulk anatomic location","Maximum tumor bulk anatomic location","STRING","SAMPLE"],["MIB_1_POSITIVE_PERCENT_RANGE","Mib1 positive percentage range","Mib1 positive percentage range","STRING","SAMPLE"],["COLUMNAR_METAPLASIA_GOBLET_CELL_INDICATOR","Columnar mucosa goblet cell present","Columnar mucosa goblet cell present","STRING","SAMPLE"],["ESOPH_COLUMNAR_METAPLASIA_INDICATOR","Columnar metaplasia present","Columnar metaplasia present","STRING","SAMPLE"],["ESOPH_NON_CA_DEGREE_OF_DYSPLASIA","Columnar mucosa dysplasia","Columnar mucosa dysplasia","STRING","SAMPLE"],["ESOPHAGEAL_TUMOR_LOCATION_CENTERED","Esophageal tumor cental location","Esophageal tumor cental location","STRING","SAMPLE"],["ESOPHAGEAL_TUMOR_LOCATION_INVOLVED","Esophageal tumor involvement site","Esophageal tumor involvement site","STRING","SAMPLE"],["FAMILY_HISTORY_ESOPH_GASTIC_CANCER","History of esophageal cancer","History of esophageal cancer","STRING","PATIENT"],["HISTORY_BARRETTS_ESOPHAGEAL_INDICATOR","Barretts esophagus","Barretts esophagus","STRING","PATIENT"],["HISTORY_IF_BARRETTS_GOBLET_CELL_INDICATOR","Goblet cells present","Goblet cells present","STRING","SAMPLE"],["HISTORY_REFLUX_DISEASE_TREATMENT","Antireflux treatment type","Antireflux treatment type","STRING","SAMPLE"],["INITIAL_DIAGNOSIS_ESOPHAGEAL_CA_TYPE","Initial diagnosis by","Initial diagnosis by","STRING","PATIENT"],["LYMPH_NODE_SPRD_RADIOGRAPH_EVIDENCE","Lymph node metastasis radiographic evidence","Lymph node metastasis radiographic evidence","STRING","SAMPLE"],["NUMBER_OF_RELATIVES_DIAGNOSED","Number of relatives diagnosed","Number of relatives diagnosed","NUMBER","SAMPLE"],["PATIENT_TO_UNDERGO_SURGERY","Planned surgery status","Planned surgery status","STRING","PATIENT"],["TREATMENT_PRIOR_TO_SURGERY_INDICATOR","Treatment prior to surgery","Treatment prior to surgery","STRING","PATIENT"],["FIRST_SYMPTOM_LONGEST_DURATION","First symptom longest duration","First symptom longest duration","STRING","PATIENT"],["HISTORY_IONIZING_RT_TO_HEAD","History ionizing rt to head","History ionizing rt to head","STRING","PATIENT"],["HISTORY_NEOADJUVANT_STEROID_TX","Preoperative corticosteroids","Preoperative corticosteroids","STRING","PATIENT"],["IDH1_MUTATION_TEST_METHOD","Ldh1 mutation test method","Ldh1 mutation test method","STRING","SAMPLE"],["INHERITED_GENETIC_SYNDROME_INDICATOR","Inherited genetic syndrome found","Inherited genetic syndrome found","STRING","PATIENT"],["INHERITED_GENETIC_SYNDROME_SPECIFIED","Inherited genetic syndrome result","Inherited genetic syndrome result","STRING","PATIENT"],["PERFORMANCE_STATUS_DAYS_TO","Days to initial score performance status scale","Days to initial score performance status scale","NUMBER","PATIENT"],["RELATED_SYMPTOM_FIRST_PRESENT","Related symptom first present","Related symptom first present","STRING","PATIENT"],["SYMP_CHANGES_MENTAL_STATUS","Symp changes mental status","Symp changes mental status","STRING","PATIENT"],["SYMP_CHANGES_MOTOR_MOVEMENT","Symp changes motor movement","Symp changes motor movement","STRING","PATIENT"],["SYMP_CHANGES_SENSORY","Symp changes sensory","Symp changes sensory","STRING","PATIENT"],["SYMP_CHANGES_VISUAL","Symp changes visual","Symp changes visual","STRING","PATIENT"],["ABLATION_EMBOLIZATION_TX_ADJUVANT","Ablation embolization tx adjuvant","Ablation embolization tx adjuvant","STRING","PATIENT"],["CHILD_PUGH_CLASSIFICATION","Child pugh classification grade","Child pugh classification grade","STRING","PATIENT"],["CREATININE_LEVEL_PRERESECTION","Hematology serum creatinine laboratory result value in mg dl","Hematology serum creatinine laboratory result value in mg dl","NUMBER","SAMPLE"],["CREATININE_NORM_RANGE_LOWER","Laboratory procedure creatinine result lower limit of normal value","Laboratory procedure creatinine result lower limit of normal value","NUMBER","SAMPLE"],["CREATININE_NORM_RANGE_UPPER","Laboratory procedure creatinine result upper limit of normal value","Laboratory procedure creatinine result upper limit of normal value","NUMBER","SAMPLE"],["DAYS_TO_DEFINITIVE_SURGICAL_PROCEDURE_PERFORMED","Days to definitive surgical procedure performed","Days to definitive surgical procedure performed","NUMBER","PATIENT"],["DEFINITIVE_SURGICAL_PROCEDURE","Specimen collection method name","Specimen collection method name","STRING","SAMPLE"],["FAMILY_HISTORY_CANCER_NUMBER_RELATIVES","Cancer diagnosis first degree relative number","Cancer diagnosis first degree relative number","STRING","PATIENT"],["HEPATIC_INFLAMMATION_ADJ_TISSUE","Adjacent hepatic tissue inflammation extent type","Adjacent hepatic tissue inflammation extent type","STRING","SAMPLE"],["HISTORY_HEPATO_CARCINOMA_RISK_FACTORS","History hepato carcinoma risk factor","History hepato carcinoma risk factor","STRING","PATIENT"],["ISHAK_FIBROSIS_SCORE","Liver fibrosis ishak score category","Liver fibrosis ishak score category","STRING","PATIENT"],["OTHER_HEPATO_CARCINOMA_RISK_FACTORS","History hepato carcinoma risk factor other","History hepato carcinoma risk factor other","STRING","PATIENT"],["PLATELET_NORM_RANGE_LOWER","Laboratory prcoedure platelet result lower limit of normal value","Laboratory prcoedure platelet result lower limit of normal value","NUMBER","SAMPLE"],["PLATELET_NORM_RANGE_UPPER","Laboratory prcoedure platelet result upper limit of normal value","Laboratory prcoedure platelet result upper limit of normal value","NUMBER","SAMPLE"],["PROTHROM_TIME_INR_NORM_RANGE_LOWER","Laboratory procedure international normalization ratio result lower limit of normal value","Laboratory procedure international normalization ratio result lower limit of normal value","NUMBER","SAMPLE"],["PROTHROMBIN_TIME_INR_AT_PROCUREMENT","Laboratory procedure prothrombin time result value","Laboratory procedure prothrombin time result value","NUMBER","SAMPLE"],["PROTHROMBIN_TIME_NORM_RANGE_UPPER","Laboratory procedure international normalization ratio result upper limit of normal value","Laboratory procedure international normalization ratio result upper limit of normal value","NUMBER","SAMPLE"],["SERUM_ALBUMIN_NORM_RANGE_LOWER","Laboratory procedure albumin result lower limit of normal value","Laboratory procedure albumin result lower limit of normal value","NUMBER","SAMPLE"],["SERUM_ALBUMIN_NORM_RANGE_UPPER","Laboratory procedure albumin result upper limit of normal value","Laboratory procedure albumin result upper limit of normal value","NUMBER","SAMPLE"],["SERUM_ALBUMIN_PRERESECTION","Laboratory procedure albumin result specified value","Laboratory procedure albumin result specified value","NUMBER","SAMPLE"],["EXON_IMBALANCE_SCORE","Exon Imbalance Score","Exon Imbalance Score","NUMBER","SAMPLE"],["ERG_EXPRESSION","ERG Expression","ERG Expression","NUMBER","SAMPLE"],["DEMIX_PURITY","DeMix Purity","DeMix Purity","NUMBER","SAMPLE"],["ISOPURE_PURITY","ISOpure Purity","ISOpure Purity","NUMBER","SAMPLE"],["NODES_EX","Nodes Ex","Nodes Ex","NUMBER","SAMPLE"],["ERK_SCORE","ERK Score","ERK Score ","NUMBER","SAMPLE"],["MACIS_SCORE","MACIS Score","MACIS Score","NUMBER","PATIENT"],["MB_COV","MB Cov","MB Cov","NUMBER","PATIENT"],["ARMDRIVER_CN","ArmDriver CN","ArmDriver CN","STRING","SAMPLE"],["DIFFERENTIATION_SCORE","Differentiation Score","Differentiation Score","NUMBER","SAMPLE"],["MUT_CANCER_GENE_CENSUS_PROTEIN_CHANGE","Mutation Cancer Gene Census Protein Change","Mutation Cancer Gene Census Protein Change","STRING","SAMPLE"],["NUM_NONSILENT_MUTATION","Total Number of Nonsilent Mutation","Total Number of Nonsilent Mutation","NUMBER","SAMPLE"],["NUM_MUT_APOBEC","APOBEC Mutation Number","APOBEC Mutation Number","NUMBER","SAMPLE"],["NUM_MUT_CPGT","CpGT Mutation Number","CpGT Mutation Number","NUMBER","SAMPLE"],["NONSILENT_MUTATION_DENSITY","Nonsilent Mutation Density","Nonsilent Mutation Density","NUMBER","SAMPLE"],["NUM_SILENT_MUTATION","Total Number of Silent Mutation","Total Number of Silent Mutation","NUMBER","SAMPLE"],["MRD_PERCENT_DAY_8","MRD Percentage Day 8","MRD percentage at day 8","STRING","PATIENT"],["MRD_PERCENT_DAY_43","MRD Percentage Day 43","MRD percentage at day 43","STRING","PATIENT"],["MRD_END_CONSOLIDATION","MRD Percentage at end of Consolidation","MRD percentage at end of consolidation","STRING","PATIENT"],["BCR_ABL1_STATUS","BCR ABL1 Status","BCR ABL1 status","STRING","PATIENT"],["DAYS_TO_EVENT","Time To Event (days)","Time To Event (days)","NUMBER","PATIENT"],["BONE_MARROW_SITE_OF_RELAPSE","Bone Marrow Site of Relapse","Bone Marrow Site of Relapse","STRING","SAMPLE"],["CNS_SITE_OF_RELAPSE","CNS Site of Relapse","CNS Site of Relapse","STRING","SAMPLE"],["TESTES_SITE_OF_RELAPSE","Testes Site of Relapse","Testes Site of Relapse","STRING","SAMPLE"],["OTHER_SITE_OF_RELAPSE","Other Site of Relapse","Other Site of Relapse","STRING","SAMPLE"],["AGE_IN_DAYS","Diagnosis Age (days)","Age at which a condition or disease was first diagnosed.","NUMBER","PATIENT"],["NUP98_NSD1","NUP98-NSD1","NUP98 NSD1 gene fusion","STRING","SAMPLE"],["CBFT2A3_GLIS","CBFT2A3-GLIS","CBFT2A3 GLIS gene fusion","STRING","SAMPLE"],["OS_DAYS","Overall Survival Days","Overall patient survival days","NUMBER","PATIENT"],["t(6;9)","t(6;9)","t(6;9) gene fusion status","STRING","SAMPLE"],["t(8;21)","t(8;21)","t(8;21) gene fusion status","STRING","SAMPLE"],["t(3;5)(q25;q34)","t(3;5)(q25;q34)","t(3;5)(q25;q34) gene fusion status","STRING","SAMPLE"],["t(6;11)(q27;q23)","t(6;11)(q27;q23)","t(6;11)(q27;q23) gene fusion status","STRING","SAMPLE"],["t(9;11)(p22;q23)","t(9;11)(p22;q23)","t(9;11)(p22;q23) gene fusion status","STRING","SAMPLE"],["t(10;11)(p11.2;q23)","t(10;11)(p11.2;q23)","t(10;11)(p11.2;q23) gene fusion status","STRING","SAMPLE"],["t(11:19)(q23:p13.1)","t(11:19)(q23:p13.1)","t(11:19)(q23:p13.1) gene fusion status","STRING","SAMPLE"],["inv(16)","inv(16)","inv(16) gene fusion status","STRING","SAMPLE"],["inv(3)","inv(3)","inv(3)","STRING","SAMPLE"],["t(1;22)","t(1;22)","t(1;22)","STRING","SAMPLE"],["t(9;11)","t(9;11)","t(9;11)","STRING","SAMPLE"],["t(6;9)","t(6;9)","t(6;9)","STRING","SAMPLE"],["t(15;17)","t(15;17)","t(15;17)","STRING","SAMPLE"],["t(11;17)","t(11;17)","t(11;17)","STRING","SAMPLE"],["t(11q23)","t(11q23)","t(11q23)","STRING","SAMPLE"],["ICD_0_3_T","ICD-0-3-T","ICD-0-3-T","STRING","SAMPLE"],["DAYS_TO_FIRST_SMN","Time to first SMN (days)","Time to first SMN (days)","NUMBER","PATIENT"],["TIME_TO_FIRST_EVENT_OR_EVENT_FREE_SURVIAL","Time to First Event/Event Free Survival","Time to first event or event-free survival","NUMBER","PATIENT"],["FIRST_EVENT","First Event","First Event","STRING","PATIENT"],["DISEASE_AT_DIAGNOSIS","Disease at Diagnosis","Disease at diagnosis","STRING","PATIENT"],["HISTOLOGY_CLASSIFICATION_IN_PRIMARY_TUMOR","Histology Classification in Primary Tumor","Histology classification in primary tumor","STRING","SAMPLE"],["NONINVASIVE_BLADDER_CA_TX_TYPE","Noninvasive Bladder Cancer Treatment Type","Noninvasive Bladder Cancer Treatment Type","STRING","PATIENT"],["NONINVASIVE_BLADDER_HISTORY","History of Noninvasive Bladder Cancer","History of Noninvasive Bladder Cancer","STRING","PATIENT"],["CLINICAL_ASSESSMENT","Clinical Assessment","Clinical Assessment","STRING","PATIENT"],["METHOD_OF_INITIAL_PATH_DIAGNOSIS","Method Of Initial Pathologic Diagnosis","Method Of Initial Pathologic Diagnosis","STRING","PATIENT"],["METHOD_OF_INITIAL_PATH_DIAGNOSIS_OTHER","Other Method Of Initial Pathological Diagnosis","Other Method Of Initial Pathological Diagnosis","STRING","PATIENT"],["NEW_TUMOR_EVENT_OTHER_SITE","Other Site of New Tumor Event ","Other Site of New Tumor Event ","STRING","PATIENT"],["PATHOLOGIC_DISTANT_SPREAD","Pathologic Distant Spread","Pathologic Distant Spread","STRING","PATIENT"],["REGIONAL_NODES_PATHOLOGIC_SPREAD","Regional Nodes Pathologic Spread","Regional Nodes Pathologic Spread","STRING","SAMPLE"],["PRIOR_TUMOR","Prior Tumor","Prior Tumor","STRING","SAMPLE"],["NEW_TUMOR_EVENT_SITE","New Tumor Event Site","New Tumor Event Site","STRING","SAMPLE"],["NEW_TUMOR_EVENT_TYPE","New Tumor Event Type","New Tumor Event Type","STRING","SAMPLE"],["SEQUENCING_TYPE","Sequencing Type","Sequencing Type","STRING","SAMPLE"],["HER2_AMPLIFICATION_STATUS","HER2 Amplification Status","HER2 Amplification Status","STRING","SAMPLE"],["NONSILENT_RATE","Nonsilent Mutation Rate","Nonsilent Mutation Rate","NUMBER","SAMPLE"],["SILENT_RATE","Silent Mutation Rate","Silent Mutation Rate","NUMBER","SAMPLE"],["CENT17_COPY_NUMBER","Cent17 Copy Number","Fluorescence in situ hybridization diagnostic procedure chromosome 17 signal result range","NUMBER","SAMPLE"],["ER_POSITIVITY_METHOD","ER positivity method","ER detection method text","STRING","SAMPLE"],["ER_POSITIVITY_SCALE_OTHER","ER positivity scale other","Positive finding estrogen receptor other measurement scale text","STRING","SAMPLE"],["ER_POSITIVITY_SCALE_USED","ER positivity scale used","Breast carcinoma immunohistochemistry er pos finding scale","STRING","SAMPLE"],["ER_STATUS_BY_IHC","ER Status By IHC","breast carcinoma progesterone receptor status","STRING","SAMPLE"],["ER_STATUS_IHC_PERCENT_POSITIVE","ER Status IHC Percent Positive","progesterone receptor level cell percent category","STRING","SAMPLE"],["FIRST_SURGICAL_PROCEDURE_OTHER","First surgical procedure other","Surgical procedure purpose other text","STRING","SAMPLE"],["HER2_AND_CENT17_CELLS_COUNT","HER2 and cent17 cells count","HER2 neu and centromere 17 copy number analysis input total number count","NUMBER","SAMPLE"],["HER2_AND_CENT17_SCALE_OTHER","HER2 and cent17 scale other","HER2 and centromere 17 positive finding other measurement scale text","STRING","SAMPLE"],["HER2_CENT17_COUNTED_CELLS_COUNT","HER2 cent17 counted cells count","HER2 neu and centromere 17 copy number metastatic breast carcinoma analysis input total number count","NUMBER","SAMPLE"],["HER2_CENT17_RATIO","HER2 cent17 ratio","HER2 neu chromosone 17 signal ratio value","NUMBER","SAMPLE"],["HER2_COPY_NUMBER","HER2 copy number","HER2 neu breast carcinoma copy analysis input total number","NUMBER","SAMPLE"],["HER2_FISH_METHOD","HER2 fish method","HER2 erbb pos finding fluorescence in situ hybridization calculation method text","STRING","SAMPLE"],["HER2_FISH_STATUS","HER2 fish status","Lab procedure HER2 neu in situ hybrid outcome type","STRING","SAMPLE"],["HER2_IHC_PERCENT_POSITIVE","HER2 ihc percent positive","HER2 erbb pos finding cell percent category","STRING","SAMPLE"],["HER2_IHC_SCORE","HER2 ihc score","HER2 immunohistochemistry level result","NUMBER","SAMPLE"],["HER2_POSITIVITY_METHOD_TEXT","HER2 positivity method text","HER2 erbb method calculation method text","STRING","SAMPLE"],["HER2_POSITIVITY_SCALE_OTHER","HER2 positivity scale other","Pos finding HER2 erbb2 other measurement scale text","STRING","SAMPLE"],["MARGIN_STATUS_REEXCISION","Margin status reexcision","Breast cancer surgery margin status","STRING","SAMPLE"],["METASTATIC_TUMOR_INDICATOR","Metastatic tumor indicator","Distant metastasis present ind2","STRING","SAMPLE"],["MICROMET_DETECTION_BY_IHC","Micromet detection by ihc","Cytokeratin immunohistochemistry staining method micrometastasis indicator","STRING","SAMPLE"],["NTE_CENT_17_HER2_RATIO","Nte cent 17 HER2 ratio","Metastatic breast carcinoma HER2 neu chromosone 17 signal ratio value","NUMBER","SAMPLE"],["NTE_CENT_17_SIGNAL_NUMBER","Nte cent 17 signal number","Metastatic breast carcinoma fluorescence in situ hybridization diagnostic proc centromere 17 signal result range","STRING","SAMPLE"],["NTE_CENT17_HER2_OTHER_SCALE","Nte cent17 HER2 other scale","Metastatic breast carcinoma pos finding other scale measurement text","STRING","SAMPLE"],["NTE_ER_IHC_INTENSITY_SCORE","Nte er ihc intensity score","Metastatic breast carcinoma immunohistochemistry er pos cell score","STRING","SAMPLE"],["NTE_ER_POSITIVITY_DEFINE_METHOD","Nte er positivity define method","Metastatic breast carcinoma estrogen receptor detection method text","STRING","SAMPLE"],["NTE_ER_POSITIVITY_OTHER_SCALE","Nte er positivity other scale","Pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text","STRING","SAMPLE"],["NTE_ER_STATUS","Nte er status","Metastatic breast carcinoma estrogen receptor status","STRING","SAMPLE"],["NTE_ER_STATUS_IHC__POSITIVE","Nte er status ihc positive","Metastatic breast carcinoma estrogen receptor level cell percent category","STRING","SAMPLE"],["NTE_HER2_FISH_DEFINE_METHOD","Nte HER2 fish define method","Metastatic breast carcinoma HER2 erbb pos finding fluorescence in situ hybridization calculation method text","STRING","SAMPLE"],["NTE_HER2_FISH_STATUS","Nte HER2 fish status","Metastatic breast carcinoma lab proc HER2 neu in situ hybridization outcome type","STRING","SAMPLE"],["NTE_HER2_POSITIVITY_IHC_SCORE","Nte HER2 positivity ihc score","Metastatic breast carcinoma erbb2 immunohistochemistry level result","STRING","SAMPLE"],["NTE_HER2_POSITIVITY_METHOD","Nte HER2 positivity method","Metastatic breast carcinoma HER2 erbb method calculation method text","STRING","SAMPLE"],["NTE_HER2_POSITIVITY_OTHER_SCALE","Nte HER2 positivity other scale","Metastatic breast carcinoma pos finding HER2 erbb2 other measure scale text","STRING","SAMPLE"],["NTE_HER2_SIGNAL_NUMBER","Nte HER2 signal number","HER2 neu metastatic breast carcinoma copy analysis input total number","STRING","SAMPLE"],["NTE_HER2_STATUS","Nte HER2 status","Metastatic breast carcinoma lab proc HER2 neu immunohistochemistry receptor status","STRING","SAMPLE"],["NTE_HER2_STATUS_IHC__POSITIVE","Nte HER2 status ihc positive","Metastatic breast carcinoma HER2 erbb pos finding cell percent category","STRING","SAMPLE"],["NTE_PR_IHC_INTENSITY_SCORE","Nte pr ihc intensity score","Metastatic breast carcinoma immunohistochemistry pr pos cell score","NUMBER","SAMPLE"],["NTE_PR_POSITIVITY_DEFINE_METHOD","Nte pr positivity define method","Metastatic breast carcinoma progesterone receptor detection method text","STRING","SAMPLE"],["NTE_PR_POSITIVITY_OTHER_SCALE","Nte pr positivity other scale","Metastatic breast carcinoma pos finding progesterone receptor other measure scale text","STRING","SAMPLE"],["NTE_PR_STATUS_BY_IHC","Nte pr status by ihc","Metastatic breast carcinoma progesterone receptor status","STRING","SAMPLE"],["NTE_PR_STATUS_IHC__POSITIVE","Nte pr status ihc positive","Metastatic breast carcinoma progesterone receptor level cell percent category","STRING","SAMPLE"],["PR_POSITIVITY_DEFINE_METHOD","PR positivity define method","Pgr detection method text","STRING","SAMPLE"],["PR_POSITIVITY_IHC_INTENSITY_SCORE","PR positivity ihc intensity score","Breast carcinoma immunohistochemistry pos cell score","STRING","SAMPLE"],["PR_POSITIVITY_SCALE_OTHER","PR positivity scale other","Pos finding progesterone receptor other measurement scale text","STRING","SAMPLE"],["PR_POSITIVITY_SCALE_USED","PR positivity scale used","Breast carcinoma immunohistochemistry progesterone receptor pos finding scale","STRING","SAMPLE"],["PR_STATUS_BY_IHC","PR status by ihc","Breast carcinoma progesterone receptor status","STRING","SAMPLE"],["PR_STATUS_IHC_PERCENT_POSITIVE","PR status ihc percent positive","Progesterone receptor level cell percent category","STRING","SAMPLE"],["SURGERY_FOR_POSITIVE_MARGINS","Surgery for positive margins","Breast carcinoma primary surgical procedure name","STRING","SAMPLE"],["SURGERY_FOR_POSITIVE_MARGINS_OTHER","Surgery for positive margins other","Breast neoplasm other surgical procedure descriptive text","STRING","SAMPLE"],["SURGICAL_PROCEDURE_FIRST","Surgical procedure first","Breast carcinoma surgical procedure name","STRING","SAMPLE"],["DAYS_TO_BILATERAL_TUMOR_DX","Days to bilateral tumor dx","Days to bilateral tumor dx","NUMBER","PATIENT"],["DAYS_TO_POST_ORCHI_SERUM_TEST","Days to post orchi serum test","Days to post orchi serum test","NUMBER","PATIENT"],["DAYS_TO_PRE_ORCHI_SERUM_TEST","Days to pre orchi serum test","Days to pre orchi serum test","NUMBER","PATIENT"],["FAMILY_HISTORY_OTHER_CANCER","Family history other cancer","Family history other cancer","STRING","PATIENT"],["FAMILY_HISTORY_TESTICULAR_CANCER","Family history testicular cancer","Family history testicular cancer","STRING","PATIENT"],["FIRST_TREATMENT_SUCCESS","First treatment success","First treatment success","STRING","PATIENT"],["HISTOLOGIC_DIAGNOSIS_PERCENT","Histologic diagnosis percent","Histological percentage","STRING","PATIENT"],["HISTORY_FERTILITY","History fertility","History fertility","STRING","PATIENT"],["HISTORY_HYPOSPADIAS","History hypospadias","History hypospadias","STRING","PATIENT"],["HISTORY_OF_UNDESCENDED_TESTIS","History of undescended testis","History of undescended testis","STRING","PATIENT"],["INTRATUBULAR_GERM_CELL_NEOPLASM","Intratubular germ cell neoplasm","Intratubular germ cell neoplasm","STRING","PATIENT"],["LEVEL_OF_NON_DESCENT","Level of non descent","Level of non descent","STRING","PATIENT"],["LYMPHOVASCULAR_INVASION_PRESENT","Lymphovascular invasion present","Lymphovascular invasion present","STRING","SAMPLE"],["MOLECULAR_TEST_RESULT","Molecular test result","Molecular test result","STRING","SAMPLE"],["POST_ORCHI_AFP","Post orchi afp","Post orchi afp","NUMBER","SAMPLE"],["POST_ORCHI_HCG","Post orchi hcg","Post orchi hcg","NUMBER","SAMPLE"],["POST_ORCHI_LDH","Post orchi ldh","Post orchi ldh","NUMBER","SAMPLE"],["POST_ORCHI_LH","Post orchi lh","Post orchi lh","NUMBER","SAMPLE"],["POST_ORCHI_LYMPH_NODE_DISSECTION","Post orchi lymph node dissection","Post orchi lymph node dissection","STRING","SAMPLE"],["POST_ORCHI_TESTOSTERONE","Post orchi testosterone","Post orchi testosterone","STRING","SAMPLE"],["POSTOPERATIVE_TX","Postoperative tx","Postoperative tx","STRING","SAMPLE"],["PRE_ORCHI_AFP","Pre orchi afp","Pre orchi afp","NUMBER","SAMPLE"],["PRE_ORCHI_HCG","Pre orchi hcg","Pre orchi hcg","NUMBER","SAMPLE"],["PRE_ORCHI_LDH","Pre orchi ldh","Pre orchi ldh","NUMBER","SAMPLE"],["PRE_ORCHI_LH","Pre orchi lh","Pre orchi lh","NUMBER","SAMPLE"],["PRE_ORCHI_TESTOSTERONE","Pre orchi testosterone","Pre orchi testosterone","STRING","SAMPLE"],["RELATION_TESTICULAR_CANCER","Relation testicular cancer","Relation testicular cancer","STRING","SAMPLE"],["RELATIVE_FAMILY_CANCER_HX_TEXT","Relative family cancer hx text","Relative family cancer hx text","STRING","SAMPLE"],["SYNCHRONOUS_TUMOR_HISTOLOGY_PCT","Synchronous tumor histology pct","Synchronous tumor histology pct","STRING","SAMPLE"],["TESTIS_TUMOR_MACROEXTENT","Testis tumor macroextent","Testis tumor macroextent","STRING","SAMPLE"],["TESTIS_TUMOR_MACROEXTENT_OTHER","Testis tumor macroextent other","Testis tumor macroextent other","STRING","SAMPLE"],["TESTIS_TUMOR_MICROEXTENT","Testis tumor microextent","Testis tumor microextent","STRING","SAMPLE"],["UNDESCENDED_TESTIS_CORRECTED","Undescended testis corrected","Undescended testis corrected","STRING","PATIENT"],["UNDESCENDED_TESTIS_CORRECTED_AGE","Undescended testis corrected age","Undescended testis corrected age","STRING","PATIENT"],["UNDESCENDED_TESTIS_METHOD_LEFT","Undescended testis method left","Undescended testis method left","STRING","PATIENT"],["UNDESCENDED_TESTIS_METHOD_RIGHT","Undescended testis method right","Undescended testis method right","STRING","PATIENT"],["IS_FFPE","Is FFPE","If the sample is from FFPE","STRING","SAMPLE"],["BCR_PATIENT_UUID","BCR patient uuid","BCR patient uuid","STRING","PATIENT"],["BCR_SAMPLE_UUID","BCR sample uuid","BCR sample uuid","STRING","SAMPLE"],["OCT_EMBEDDED","Oct embedded","Oct embedded","STRING","SAMPLE"],["PATHOLOGY_REPORT_UUID","Pathology report uuid","Pathology report uuid","STRING","PATIENT"],["STUDY_ID","Study ID","Study Identifier ","STRING","PATIENT"],["FORM_COMPLETION_DATE","Form completion date","Form completion date","STRING","PATIENT"],["INFORMED_CONSENT_VERIFIED","Informed consent verified","Informed consent verified","STRING","PATIENT"],["HISTORY_HORMONAL_CONTRACEPTIVES_USE","History hormonal contraceptives use","History hormonal contraceptives use","STRING","PATIENT"],["HISTORY_LGG_DX_OF_BRAIN_TISSUE","History lgg dx of brain tissue","History lgg dx of brain tissue","STRING","PATIENT"],["PLATELET_COUNT_PRERESECTION","Platelet count preresection","Platelet count preresection","NUMBER","PATIENT"],["SURGICAL_PROCEDURE_OTHER","Surgical procedure other","Surgical procedure other","STRING","PATIENT"],["CARBON_MONOXIDE_DIFFUSION_DLCO","Carbon monoxide diffusion dlco","Carbon monoxide diffusion dlco","NUMBER","PATIENT"],["FEV1_FVC_RATIO_POSTBRONCHOLIATOR","Fev1 fvc ratio postbroncholiator","Fev1 fvc ratio postbroncholiator","NUMBER","PATIENT"],["FEV1_FVC_RATIO_PREBRONCHOLIATOR","Fev1 fvc ratio prebroncholiator","Fev1 fvc ratio prebroncholiator","NUMBER","PATIENT"],["FEV1_PERCENT_REF_POSTBRONCHOLIATOR","Fev1 percent ref postbroncholiator","Fev1 percent ref postbroncholiator","NUMBER","PATIENT"],["FEV1_PERCENT_REF_PREBRONCHOLIATOR","Fev1 percent ref prebroncholiator","Fev1 percent ref prebroncholiator","NUMBER","PATIENT"],["KRAS_MUTATION_IDENTIFIED_TYPE","Kras mutation identified type","Kras mutation identified type","STRING","PATIENT"],["LOCATION_LUNG_PARENCHYMA","Location lung parenchyma","Location lung parenchyma","STRING","PATIENT"],["PULMONARY_FUNCTION_TEST_INDICATOR","Pulmonary function test indicator","Pulmonary function test indicator","STRING","PATIENT"],["CT_SCAN_PREOP_RESULTS","Ct scan preop results","Diagnostic ct result outcome","STRING","PATIENT"],["PERFORMANCE_STATUS_OTHER_TIMING","Performance status other timing","Performance status assessment timepoint category other text","STRING","PATIENT"],["CAUSE_OF_DEATH_OTHER","Cause of death other","Death cause text","STRING","PATIENT"],["EXTRACAPSULAR_SPREAD_PATHOLOGIC","Extracapsular spread pathologic","Presence of pathological nodal extracapsular spread","STRING","PATIENT"],["HPV_STATUS_ISH","Hpv status ish","Hpv status by ish testing","STRING","PATIENT"],["HPV_STATUS_P16","Hpv status p16","Hpv status by p16 testing","STRING","PATIENT"],["LYMPH_NODE_DISSECTION_METHOD","Lymph node dissection method","Lymphnode dissection method left","STRING","PATIENT"],["LYMPH_NODE_NECK_DISSECTION_INDICATOR","Lymph node neck dissection indicator","Lymphnode neck dissection","STRING","PATIENT"],["P53_GENE_ANALYSIS","P53 gene analysis","P53 gene analysis","STRING","SAMPLE"],["SARCOMATOID_FEATURES","Sarcomatoid features","Presence of sarcomatoid features","STRING","PATIENT"],["SARCOMATOID_PERCENT_OF_TUMOR","Sarcomatoid percent of tumor","Percent tumor sarcomatoid","STRING","PATIENT"],["ERYTHROCYTE_SEDIMENTATION_RATE","Erythrocyte sedimentation rate","Erythrocyte sedimentation rate result","STRING","PATIENT"],["HEMOGLOBIN_LEVEL","Hemoglobin level","Hemoglobin result","STRING","PATIENT"],["LYMPH_NODES_EXAMINED_POSITIVE","Lymph nodes examined positive","Number of lymphnodes positive","STRING","PATIENT"],["LYMPH_NODES_EXAMINED_NEGATIVE","Lymph nodes examined negative","Number of lymphnodes negative","STRING","PATIENT"],["PLATELET_COUNT","Platelet count","Platelet qualitative result","STRING","PATIENT"],["SERUM_CALCIUM_LEVEL","Serum calcium level","Serum calcium result","STRING","PATIENT"],["LYMPHOVASCULAR_INVOLVEMENT","Lymphovascular involvement","Lymphovascular invasion indicator","STRING","PATIENT"],["CAUSE_OF_DEATH_SOURCE","Cause of death source","Source of patient death reason","STRING","PATIENT"],["CT_SCAN_AB_PELVIS_INDICATOR","Ct scan ab pelvis indicator","Diagnostic ct abd pelvis performed","STRING","PATIENT"],["CT_SCAN_AB_PELVIS_RESULTS","Ct scan ab pelvis results","Diagnostic ct abd pelvis result","STRING","PATIENT"],["DAYS_TO_BIOCHEMICAL_RECURRENCE_FIRST","Days to biochemical recurrence first","Days to first biochemical recurrence","NUMBER","PATIENT"],["DAYS_TO_CT_SCAN_AB_PELVIS","Days to ct scan ab pelvis","Days to diagnostic computed tomography performed","NUMBER","PATIENT"],["DAYS_TO_MRI","Days to mri","Days to diagnostic mri performed","NUMBER","PATIENT"],["GLEASON_PATTERN_PRIMARY","Gleason pattern primary","Gleason pattern primary","NUMBER","PATIENT"],["GLEASON_PATTERN_SECONDARY","Gleason pattern secondary","Gleason pattern secondary","NUMBER","PATIENT"],["GLEASON_PATTERN_TERTIARY","Gleason pattern tertiary","Gleason pattern tertiary","NUMBER","PATIENT"],["INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD","Initial pathologic diagnosis method","Initial pathologic diagnosis method","STRING","PATIENT"],["MRI_RESULTS","Mri results","Diagnostic mri result","STRING","PATIENT"],["PSA_MOST_RECENT_RESULTS","Psa most recent results","Psa most recent results","NUMBER","PATIENT"],["CONTIGUOUS_ORGAN_INVADED","Contiguous organ invaded","Contiguous organ invaded","STRING","PATIENT"],["CONTIGUOUS_ORGAN_RESECTION","Contiguous organ resection","Contiguous organ resection site","STRING","PATIENT"],["CONTIGUOUS_ORGAN_RESECTION_OTHER","Contiguous organ resection other","Other contiguous organ resection site","STRING","PATIENT"],["DISCONTINUOUS_LESIONS_COUNT","Discontinuous lesions count","Discontiguous lesion count","NUMBER","PATIENT"],["DISEASE_MULTIFOCAL_INDICATOR","Disease multifocal indicator","Disease multifocal indicator","STRING","PATIENT"],["LEIOMYO_MAJOR_VESSEL_INVOLVEMENT","Leiomyo major vessel involvement","Leiomyosarcoma major vessel involvement","STRING","PATIENT"],["LEIOMYOSARCOMA_UTERINE_INVOLVEMENT","Leiomyosarcoma uterine involvement","Primary tumor lower uterus segment","STRING","PATIENT"],["LOCOREGIONAL_RECURRENCE_INDICATOR","Locoregional recurrence indicator","Local disease recurrence","STRING","PATIENT"],["METASTATIC_DISEASE_CONFIRMED","Metastatic disease confirmed","Metastatic neoplasm confirmed","STRING","PATIENT"],["MPNST_NF_FAMILIAL_OR_SPORADIC","Mpnst nf familial or sporadic","Mpnst neurofibromatosis heredity","STRING","PATIENT"],["MPNST_NF_INDICATOR","Mpnst nf indicator","Mpnst neurofibromatosis","STRING","PATIENT"],["MPNST_NF1_GENETIC_TESTING_INDICATOR","Mpnst nf1 genetic testing indicator","Mpnst nf1 genetic testing","STRING","PATIENT"],["MPNST_NF1_MUTATIONS_IDENTIFIED","Mpnst nf1 mutations identified","Mpnst specific mutations","STRING","SAMPLE"],["MPNST_PLEXIFORM_NEUROFIBROMA_SITE","Mpnst plexiform neurofibroma site","Mpnst exisiting plexiform neurofibroma","STRING","SAMPLE"],["NTE_LESION_PATHOLOGIC_DEPTH","Nte lesion pathologic depth","Nte lesion pathologic depth","NUMBER","SAMPLE"],["NTE_LESION_PATHOLOGIC_LENGTH","Nte lesion pathologic length","Nte lesion pathologic length","NUMBER","SAMPLE"],["NTE_LESION_PATHOLOGIC_WIDTH","Nte lesion pathologic width","Nte lesion pathologic width","NUMBER","SAMPLE"],["NTE_LESION_RADIOLOGIC_DEPTH","Nte lesion radiologic depth","Nte lesion radiologic depth","NUMBER","SAMPLE"],["NTE_LESION_RADIOLOGIC_LENGTH","Nte lesion radiologic length","Nte lesion radiologic length","NUMBER","SAMPLE"],["NTE_LESION_RADIOLOGIC_WIDTH","Nte lesion radiologic width","Nte lesion radiologic width","NUMBER","SAMPLE"],["SYNOVIAL_SS18SSX_FUSION_STATUS","Synovial ss18ssx fusion status","Synovial ss18ssx fusion status","STRING","SAMPLE"],["SYNOVIAL_SS18SSX_TESTING_METHOD","Synovial ss18ssx testing method","Synovial ss18ssx testing method","STRING","SAMPLE"],["TUMOR_BURDEN_PATHOLOGIC","Tumor burden pathologic","Tumor burden pathologic","STRING","SAMPLE"],["TUMOR_BURDEN_RADIOLOGIC","Tumor burden radiologic","Tumor burden radiologic","STRING","SAMPLE"],["TUMOR_TOTAL_DEPTH","Tumor total depth","Tumor total depth","STRING","SAMPLE"],["TUMOR_TOTAL_NECROSIS","Tumor total necrosis","Tumor total necrosis","STRING","SAMPLE"],["WELL_DIFF_LIPOSARC_PRIOR_DX_DAYS_TO","Well diff liposarc prior dx days to","Days to well differentiated liposarcoma primary dx","NUMBER","PATIENT"],["WELL_DIFF_LIPOSARC_PRIOR_DX_INDICATOR","Well diff liposarc prior dx indicator","Well differentiated liposarcoma primary dx","NUMBER","PATIENT"],["WELL_DIFF_LIPOSARC_RESECTION_DAYS_TO","Well diff liposarc resection days to","Days to well differentiated liposarcoma resection","NUMBER","PATIENT"],["CLARK_LEVEL_AT_DIAGNOSIS","Clark level at diagnosis","Melanoma clark level value","STRING","PATIENT"],["HISTORY_NEOADJUVANT_TX_TYPE","History neoadjuvant tx type","Prior systemic therapy type","STRING","PATIENT"],["IFN_TX_90_DAYS_PRIOR_TO_RESECTION","Ifn tx 90 days prior to resection","Interferon 90 day prior excision admin indicator","STRING","PATIENT"],["NEW_TUMOR_EVENT_MELANOMA_COUNT","New tumor event melanoma count","Primary anatomic site count","NUMBER","PATIENT"],["NEW_TUMOR_EVENT_PRIOR_TO_BCR_TUMOR","New tumor event prior to bcr tumor","New tumor dx prior submitted specimen dx","STRING","PATIENT"],["PRIMARY_AT_DX_COUNT","Primary at dx count","Primary melanoma at diagnosis count","NUMBER","PATIENT"],["PRIMARY_MELANOMA_KNOWN_DX","Primary melanoma known dx","Primary neoplasm melanoma dx","STRING","PATIENT"],["PRIMARY_MELANOMA_MITOTIC_RATE","Primary melanoma mitotic rate","Malignant neoplasm mitotic count rate","NUMBER","PATIENT"],["PRIMARY_MELANOMA_SKIN_TYPE","Primary melanoma skin type","Melanoma origin skin anatomic site","STRING","PATIENT"],["PRIMARY_MELANOMA_TUMOR_ULCERATION","Primary melanoma tumor ulceration","Melanoma ulceration indicator","STRING","PATIENT"],["PRIMARY_MULTIPLE_AT_DX","Primary multiple at dx","Primary tumor multiple present ind","STRING","PATIENT"],["SUBMITTED_TUMOR_DX_DAYS_TO","Submitted tumor dx days to","Days to submitted specimen dx","NUMBER","PATIENT"],["TUMOR_TISSUE_SITE_OTHER","Tumor tissue site other","Tumor tissue site other","STRING","SAMPLE"],["FAMILY_HISTORY_THYROID_CANCER","Family history thyroid cancer","First degree relative history thyroid gland carcinoma diagnosis relationship type","STRING","PATIENT"],["GENOTYPIC_ANALYSIS_DETECTED","Genotypic analysis detected","Genotype analysis performed indicator","STRING","SAMPLE"],["GENOTYPIC_ANALYSIS_RESULTS_OTHER","Genotypic analysis results other","Other genotyping outcome lab results text","STRING","SAMPLE"],["GENOTYPING_RESULTS_GENE_MUTATION_NOT_REPORTED_REASON","Genotyping results gene mutation not reported reason","Genotyping results gene mutation not reported reason","STRING","SAMPLE"],["HISTORY_RADIATION_EXPOSURE","History radiation exposure","Person lifetime risk radiation exposure indicator","STRING","PATIENT"],["HISTORY_THYROID_DISEASE","History thyroid disease","Patient personal medical history thyroid gland disorder name","STRING","PATIENT"],["HISTORY_THYROID_DISEASE_OTHER","History thyroid disease other","Patient personal medical history thyroid other specify text","STRING","PATIENT"],["I_131_RADIATION_FIRST_TX_DOSE","I 131 radiation first tx dose","I 131 first administered dose","STRING","PATIENT"],["I_131_RADIATION_FIRST_TX_METHOD","I 131 radiation first tx method","I 131 total administered preparation technique","STRING","PATIENT"],["I_131_RADIATION_SUBSEQUENT_TX","I 131 radiation subsequent tx","I 131 subsequent administered dose","STRING","PATIENT"],["I_131_RADIATION_TX_CUMULATIVE_DOSE","I 131 radiation tx cumulative dose","I 131 total administered dose","NUMBER","PATIENT"],["LYMPH_NODES_PREOP_IMAGING","Lymph nodes preop imaging","Lymph node preoperative scan indicator","STRING","PATIENT"],["LYMPH_NODES_PREOP_IMAGING_TYPE","Lymph nodes preop imaging type","Lymph node preoperative assessment diagnostic imaging type","STRING","PATIENT"],["RADIATION_THERAPY_XRT_DOSE","Radiation therapy xrt dose","Radiation therapy administered dose text","NUMBER","PATIENT"],["RADIATION_THERAPY_XRT_METHOD_PREP","Radiation therapy xrt method prep","Radiation therapy administered preparation technique text","STRING","PATIENT"],["RADIATION_THERAPY_XRT_SENSITIZERS","Radiation therapy xrt sensitizers","Radiosensitizing agent administered indicator","STRING","PATIENT"],["RAS_MUTATION_RESULT","Ras mutation result","Ras family gene genotyping outcome lab results text","STRING","SAMPLE"],["RET_PTC_REARRANGEMENT_RESULT","Ret ptc rearrangement result","Ret ptc rearrangement genotyping outcome lab results text","STRING","SAMPLE"],["TUMOR_FOCALITY","Tumor focality","Primary neoplasm focus type","STRING","PATIENT"],["TUMOR_SIZE_WIDTH","Tumor size width","Tumor size width","NUMBER","SAMPLE"],["HISTORY_COLORECTAL_CANCER","History colorectal cancer","History colorectal cancer","STRING","PATIENT"],["HISTORY_MENOPAUSAL_HORMONE_THERAPY","History menopausal hormone therapy","History menopausal hormone therapy","STRING","PATIENT"],["HISTORY_TAMOXIFEN_USE","History tamoxifen use","History tamoxifen use","STRING","PATIENT"],["HYPERTENSION_DIAGNOSIS","Hypertension diagnosis","Hypertension diagnosis","STRING","PATIENT"],["LYMPH_NODES_AORTIC_EXAMINED_COUNT","Lymph nodes aortic examined count","Lymph nodes aortic examined count","NUMBER","SAMPLE"],["LYMPH_NODES_AORTIC_POS_BY_HE","Lymph nodes aortic pos by he","Lymph nodes aortic pos by he","NUMBER","SAMPLE"],["LYMPH_NODES_AORTIC_POS_BY_IHC","Lymph nodes aortic pos by ihc","Lymph nodes aortic pos by ihc","NUMBER","SAMPLE"],["LYMPH_NODES_AORTIC_POS_TOTAL","Lymph nodes aortic pos total","Lymph nodes aortic pos total","NUMBER","SAMPLE"],["LYMPH_NODES_PELVIC_EXAMINED_COUNT","Lymph nodes pelvic examined count","Lymph nodes pelvic examined count","NUMBER","SAMPLE"],["LYMPH_NODES_PELVIC_POS__BY_HE","Lymph nodes pelvic pos by he","Lymph nodes pelvic pos by he","NUMBER","SAMPLE"],["LYMPH_NODES_PELVIC_POS_BY_IHC","Lymph nodes pelvic pos by ihc","Lymph nodes pelvic pos by ihc","NUMBER","SAMPLE"],["LYMPH_NODES_PELVIC_POS_TOTAL","Lymph nodes pelvic pos total","Lymph nodes pelvic pos total","NUMBER","SAMPLE"],["LYMPH_NODE_STATUS","Lymph Node Status","Lymph Node Status","STRING","SAMPLE"],["PERITONEAL_WASHING","Peritoneal washing","Peritoneal washing","STRING","PATIENT"],["PREGNANCIES_FULL_TERM_COUNT","Pregnancies full term count","Pregnancies full term count","STRING","PATIENT"],["SURGICAL_APPROACH_AT_DIAGNOSIS","Surgical approach at diagnosis","Surgical approach at diagnosis","STRING","PATIENT"],["TUMOR_INVASION_PERCENT","Tumor invasion percent","Tumor invasion percent","NUMBER","PATIENT"],["LONGEST_DIMENSION","Longest Dimension","Longest Dimension","NUMBER","SAMPLE"],["SHORTEST_DIMENSION","Shortest Dimension","Shortest Dimension","NUMBER","SAMPLE"],["NCNNCT_OTHMETHONSP","Ncnnct othmethonsp","Ncnnct othmethonsp","STRING","PATIENT"],["SAMPLE_TYPE_ID","Sample type id","Sample type id","STRING","PATIENT"],["TIME_BETWEEN_CLAMPING_AND_FREEZING","Time between clamping and freezing","Time between clamping and freezing","STRING","PATIENT"],["TIME_BETWEEN_EXCISION_AND_FREEZING","Time between excision and freezing","Time between excision and freezing","STRING","PATIENT"],["VIAL_NUMBER","Vial number","Vial number","STRING","PATIENT"],["FOLLOW_UP_TIME_MONTHS","Follow up time months","Follow up time months","NUMBER","PATIENT"],["TUMOR_RESECTED_MAX_DIMENSION","Tumor resected max dimension","Tumor resected max dimension","NUMBER","PATIENT"],["BCL2_BA","BCL2 Break Apart","BCL2 Break Apart","STRING","PATIENT"],["BCL6_BA","BCL6 Break Apart","BCL6 Break Apart","STRING","PATIENT"],["MYC_BA","Myc ba","Myc ba","STRING","PATIENT"],["PERFORMANCE_STATUS","Performance status","Performance status","STRING","PATIENT"],["SITE","Site","Site","STRING","PATIENT"],["IDH_LEVEL","Idh level","Idh level","STRING","PATIENT"],["EXOME_SEQ","Exome seq","Exome seq","STRING","PATIENT"],["NODAL_STAGE","Nodal stage","Nodal stage","STRING","PATIENT"],["CYTOGENETIC_ABNORMALITY_TYPE","Cytogenetic abnormality type","Cytogenetic abnormality type","STRING","PATIENT"],["KRAS_GENE_ANALYSIS_INDICATOR","Kras gene analysis indicator","Kras gene analysis indicator","STRING","PATIENT"],["YEAR_OF_RC","Year of rc","Year of rc","STRING","PATIENT"],["MSK_THERAPEUTIC_CLINICAL_TRIAL","Msk therapeutic clinical trial","Msk therapeutic clinical trial","STRING","SAMPLE"],["TREATMENT_AT_MSK","Treatment at msk","Treatment at msk","STRING","PATIENT"],["MSK_DEPT","Msk dept","Msk dept","STRING","PATIENT"],["METASTASIS_LIVER","Metastasis liver","Metastasis liver","STRING","PATIENT"],["MSK_VISITS","Msk visits","Msk visits","STRING","PATIENT"],["SUSPECTED_PRIMARY","Suspected primary","Suspected primary","STRING","PATIENT"],["METASTASIS_BONE","Metastasis bone","Metastasis bone","STRING","PATIENT"],["NEUROENDOCRINE_CARCINOMA","Neuroendocrine carcinoma","Neuroendocrine carcinoma","STRING","PATIENT"],["METASTASIS_LUNG","Metastasis lung","Metastasis lung","STRING","PATIENT"],["TREATED_OR_UNTREATED_AT_TIME_OF_INITIAL_VISIT","Treated or untreated at time of initial visit","Treated or untreated at time of initial visit","STRING","PATIENT"],["BLOOD_COLLECTION","Blood collection","Blood collection","STRING","PATIENT"],["METASTASIS_PERITONEUM","Metastasis peritoneum","Metastasis peritoneum","STRING","PATIENT"],["LVI","Lvi","Lvi","STRING","PATIENT"],["PRIMARY_SURGICAL_THERAPY","Primary surgical therapy","Primary surgical therapy","STRING","PATIENT"],["PF_MONTHS","Pf months","Pf months","STRING","PATIENT"],["PF_STATUS","Pf status","Pf status","STRING","PATIENT"],["SERUM_MARKERS","Serum markers","Serum markers","STRING","PATIENT"],["IGCCCG_STAGE","Igcccg stage","Igcccg stage","STRING","PATIENT"],["LYMPHOVASCULAR_INVASION_INDICATOR","Lymphovascular invasion indicator","Lymphovascular invasion indicator","STRING","PATIENT"],["VASCULAR_INVASION_INDICATOR","Vascular invasion indicator","Vascular invasion indicator","STRING","PATIENT"],["CDKN1B_MUT","Cdkn1b mut","Cdkn1b mut","NUMBER","PATIENT"],["ERG_STATUS","Erg status","Erg status","STRING","PATIENT"],["PIPELINE_VER","Pipeline ver","Pipeline ver","STRING","PATIENT"],["RB1_MUT","Rb1 mut","Rb1 mut","NUMBER","PATIENT"],["ZMYM3_MUT","Zmym3 mut","Zmym3 mut","NUMBER","PATIENT"],["BRCA1_CNA","Brca1 cna","Brca1 cna","STRING","PATIENT"],["PRIMARY_TISSUE","Primary tissue","Primary tissue","STRING","PATIENT"],["SAMPLE_NAME","Sample name","Sample name","STRING","PATIENT"],["RESPONSE_GRADE","Response grade","Response grade","STRING","PATIENT"],["CRX","Crx","Crx","NUMBER","PATIENT"],["CURATIVE","Curative","Curative","NUMBER","PATIENT"],["DIFF","Diff","Diff","NUMBER","PATIENT"],["DURATION","Duration","Duration","NUMBER","PATIENT"],["DURLASTFU","Durlastfu","Durlastfu","NUMBER","PATIENT"],["EGF1","Egf1","Egf1","NUMBER","PATIENT"],["EGF2","Egf2","Egf2","NUMBER","PATIENT"],["FGF1","Fgf1","Fgf1","NUMBER","PATIENT"],["FGF2","Fgf2","Fgf2","NUMBER","PATIENT"],["FUPTIME","Fuptime","Fuptime","NUMBER","PATIENT"],["GCLID","Gclid","Gclid","NUMBER","PATIENT"],["HER2N","Her2n","Her2n","NUMBER","PATIENT"],["HER2NEU","Her2neu","Her2neu","STRING","PATIENT"],["HGF1","Hgf1","Hgf1","NUMBER","PATIENT"],["HGF2","Hgf2","Hgf2","NUMBER","PATIENT"],["LOCATION","Location","Location","STRING","PATIENT"],["MEGF","Megf","Megf","NUMBER","PATIENT"],["MEGF1","Megf1","Megf1","NUMBER","PATIENT"],["MEGF2","Megf2","Megf2","NUMBER","PATIENT"],["METHYL","Methyl","Methyl","NUMBER","PATIENT"],["MFGF","Mfgf","Mfgf","NUMBER","PATIENT"],["MFGF1","Mfgf1","Mfgf1","NUMBER","PATIENT"],["MFGF2","Mfgf2","Mfgf2","NUMBER","PATIENT"],["MHGF","Mhgf","Mhgf","NUMBER","PATIENT"],["MHGF2","Mhgf2","Mhgf2","NUMBER","PATIENT"],["MVEGF","Mvegf","Mvegf","NUMBER","PATIENT"],["MVEGF1","Mvegf1","Mvegf1","NUMBER","PATIENT"],["MVEGF2","Mvegf2","Mvegf2","NUMBER","PATIENT"],["NEOCRX","Neocrx","Neocrx","NUMBER","PATIENT"],["NEORX","Neorx","Neorx","NUMBER","PATIENT"],["NI","Ni","Ni","NUMBER","PATIENT"],["NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC","Number of lymphnodes positive by ihc","Number of lymphnodes positive by ihc","STRING","PATIENT"],["PATHFINDNUMNODESREMD","Pathfindnumnodesremd","Pathfindnumnodesremd","NUMBER","PATIENT"],["PATHFINDPOSNODES","Pathfindposnodes","Pathfindposnodes","NUMBER","PATIENT"],["PATHLOCATION","Pathlocation","Pathlocation","STRING","PATIENT"],["PATHMARGIN","Pathmargin","Pathmargin","STRING","PATIENT"],["PATHPERINEURALINV","Pathperineuralinv","Pathperineuralinv","STRING","PATIENT"],["PATHSTAGEDISEASE","Pathstagedisease","Pathstagedisease","STRING","PATIENT"],["PATHSTAGEGROUP","Pathstagegroup","Pathstagegroup","STRING","PATIENT"],["PATHSTAGEM","Pathstagem","Pathstagem","STRING","PATIENT"],["PATHSTAGEN","Pathstagen","Pathstagen","STRING","PATIENT"],["PATHSTAGET","Pathstaget","Pathstaget","STRING","PATIENT"],["PATHTUMORMAXDIM","Pathtumormaxdim","Pathtumormaxdim","NUMBER","PATIENT"],["PATHVASCULARINV","Pathvascularinv","Pathvascularinv","STRING","PATIENT"],["PATHOLOGIC_VASCULAR_INVASION","Pathologic Vascular Invasion","Pathologic Vascular Invasion","STRING","PATIENT"],["PCLTPS","Pcltps","Pcltps","NUMBER","PATIENT"],["PLOCATION","Plocation","Plocation","NUMBER","PATIENT"],["PM","Pm","Pm","NUMBER","PATIENT"],["PN","Pn","Pn","NUMBER","PATIENT"],["POSSIBLE HPYLORI INFECTION","Possible hpylori infection","Possible hpylori infection","NUMBER","PATIENT"],["PRENEOPLASTIC CHANGE","Preneoplastic change","Preneoplastic change","NUMBER","PATIENT"],["PRIORCHEMOFOROTHERCANCER","Priorchemoforothercancer","Priorchemoforothercancer","STRING","PATIENT"],["PRIORRADIATIONFOROTHERCANCER","Priorradiationforothercancer","Priorradiationforothercancer","STRING","PATIENT"],["PROCINTENT","Procintent","Procintent","STRING","PATIENT"],["PROCSUBSITE","Procsubsite","Procsubsite","STRING","PATIENT"],["RADADJUVANT","Radadjuvant","Radadjuvant","STRING","PATIENT"],["RADNEOADJUVANT","Radneoadjuvant","Radneoadjuvant","STRING","PATIENT"],["REC","Rec","Rec","NUMBER","PATIENT"],["RECUR","Recur","Recur","NUMBER","PATIENT"],["RECUR1","Recur1","Recur1","NUMBER","PATIENT"],["RSITE","Rsite","Rsite","NUMBER","PATIENT"],["RSITE1","Rsite1","Rsite1","NUMBER","PATIENT"],["RX","Rx","Rx","NUMBER","PATIENT"],["SIEWERT1","Siewert1","Siewert1","NUMBER","PATIENT"],["STATUS1","Status1","Status1","NUMBER","PATIENT"],["SVEGF","Svegf","Svegf","NUMBER","PATIENT"],["SVEGFMED","Svegfmed","Svegfmed","NUMBER","PATIENT"],["SVMEDBASE","Svmedbase","Svmedbase","NUMBER","PATIENT"],["TPS","Tps","Tps","NUMBER","PATIENT"],["V","V","V","NUMBER","PATIENT"],["V1","V1","V1","NUMBER","PATIENT"],["V2","V2","V2","NUMBER","PATIENT"],["V3","V3","V3","NUMBER","PATIENT"],["VEGF1","Vegf1","Vegf1","NUMBER","PATIENT"],["VEGF2","Vegf2","Vegf2","NUMBER","PATIENT"],["VI","Vi","Vi","NUMBER","PATIENT"],["TUMOR_SAMPLE_PROCUREMENT_COUNTRY","Tumor sample procurement country","Tumor sample procurement country","STRING","PATIENT"],["DISEASE_CODE","Disease code","Disease code","STRING","SAMPLE"],["PROJECT_CODE","Project code","Project code","STRING","SAMPLE"],["CBIO_PROJECT_NAME","Cbioportal Project Name","Cbioportal Project Name","STRING","SAMPLE"],["PRE_POST_CHEMO","Pre/Post Chemo","Pre/Post Chemo","STRING","PATIENT"],["SMOKING","Smoking","Smoking","STRING","PATIENT"],["INVASIVE","Invasive","Invasive or not (Y/N)","STRING","SAMPLE"],["NORMAL","Normal ","Normal","STRING","SAMPLE"],["PAPILLARY_FLAT","Papillary/Flat","Papillary/Flat","STRING","SAMPLE"],["INTRA_TUMORAL_HETEROGENEITY","Intra-tumoral Heterogeneity","Intra-tumoral Heterogeneity Y/N","STRING","SAMPLE"],["DOD","Died Of Disease","Died Of Disease","STRING","PATIENT"],["TIME_TO_DEATH_MONTHS","Time To Death (Months)","Time To Death (Months)","NUMBER","PATIENT"],["LOST_TO_FOLLOWUP","Lost To Followup","Lost To Followup","STRING","PATIENT"],["ARID1A_PROTEIN_CODING","ARID1A Protein Coding","ARID1A Protein Coding","NUMBER","SAMPLE"],["TP53_PROTEIN_CODING","TP53 Protein Coding","TP53 Protein Coding","NUMBER","SAMPLE"],["PROTEIN_EXPRESSION_CLUSTER","Protein Expression Cluster","Protein Expression Cluster","STRING","SAMPLE"],["KRAS_PROTEIN_CODING","KRAS Protein Coding","KRAS Protein Coding","NUMBER","SAMPLE"],["PIK3CA_PROTEIN_CODING","PIK3CA Protein Coding","PIK3CA Protein Coding","NUMBER","SAMPLE"],["GEJ_CATEGORY","GEJ Category","GEJ Category","STRING","PATIENT"],["SCNA_CLUSTER","SCNA Cluster","SCNA Cluster","STRING","SAMPLE"],["RHOA_PROTEIN_CODING","RHOA Protein Coding","RHOA Protein Coding","NUMBER","PATIENT"],["HYPERMUTATED_COMBINED","Hypermutated Combined","Hypermutated Combined","NUMBER","SAMPLE"],["FAM175A_CNA","FAM175A CNA","FAM175A CNA","STRING","SAMPLE"],["FANCC_CNA","FANCC CNA","FANCC CNA","STRING","SAMPLE"],["FANCD2_CNA","FANCD2 CNA","FANCD2 CNA","STRING","SAMPLE"],["RAD51C_CNA","RAD51C CNA","RAD51C CNA","STRING","SAMPLE"],["HEAVY_CHAIN","HEAVY CHAIN","HEAVY CHAIN","STRING","SAMPLE"],["PRIOR_SURGICAL_RESECTION","Prior Surgical Resection","Prior Surgical Resection","STRING","PATIENT"],["HBV","HBV","HBV","STRING","PATIENT"],["PRIOR_LOCAL_THERAPY","Prior Local Therapy","Prior Local Therapy","STRING","PATIENT"],["HCV","HCV","HCV","STRING","PATIENT"],["PDL1_EXPRESSION","PDL1 Expression","PDL1 Expression","STRING","PATIENT"],["ADMINISTRATION_OF_DRUG_WEEKS","Administration Of Drug Weeks","Administration Of Drug Weeks","NUMBER","PATIENT"],["MOLECULAR_SMOKING_SIGNATURE","Molecular Smoking Signature","Molecular Smoking Signature","STRING","PATIENT"],["TOTAL_EXONIC_MUTATION_BURDEN","Total Exonic Mutation Burden","Total Exonic Mutation Burden","NUMBER","PATIENT"],["NONSYNONYMOUS_MUTATION_BURDEN","Nonsynonymous Mutation Burden","Nonsynonymous Mutation Burden","NUMBER","PATIENT"],["DURABLE_CLINICAL_BENEFIT","Durable Clinical Benefit","Durable Clinical Benefit","STRING","PATIENT"],["PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY","Prior Treatment Of Cytotoxic Chemotherapy","Prior Treatment Of Cytotoxic Chemotherapy","NUMBER","PATIENT"],["NEOANTIGEN_BURDEN","Neoantigen Burden","Neoantigen Burden","NUMBER","PATIENT"],["XENOGRAFT_INFORMATION","Xenograft Information","Xenograft Information","STRING","PATIENT"],["CELL_LINE_INFORMATION","Cell Line Information","Cell Line Information","STRING","PATIENT"],["EXTRAHEPATIC_DISEASE","Extrahepatic Disease","Extrahepatic Disease","STRING","PATIENT"],["HISTORY_OF_ULCERATIVE_COLITIS","History of Ulcerative Colitis        ","History of Ulcerative Colitis        ","STRING","PATIENT"],["HISTORY_OF_CROHNS_DISEASE","History of Crohn Disease","History of Crohn Disease","STRING","PATIENT"],["LYNCH_SYNDROME","Lynch Syndrome","Lynch Syndrome","STRING","PATIENT"],["STAGE_AT_TESTING","Stage at Testing","Stage at Testing","STRING","PATIENT"],["PRIMARY_RESECTION","Resection of the primary","Resection of the primary","STRING","PATIENT"],["CYTOREDUCTIVE_SURGERY","Cytoreductive Surgery","Cytoreductive Surgery","STRING","PATIENT"],["MONTHS_ON_TREATMENT","Months on Treatment","Months on Treatment","NUMBER","PATIENT"],["DIFFERENTIATION","Differentiation","Differentiation","STRING","SAMPLE"],["TUMOR_LARGER_THAN_FOUR_CM","Tumor  4 cm","Tumor Larger Than 4 Cm","STRING","SAMPLE"],["INVADE_LARGER_THAN_SUBCUTANEOUS_TISSUE","Invade > Subcutaneous Tissue","Invade > Subcutaneous Tissue","STRING","SAMPLE"],["INVADE_PAROTID","Invade Parotid","Invade Parotid","STRING","PATIENT"],["PAROTID_LN","Parotid LN","Parotid Lymph Node","STRING","PATIENT"],["INVADE_BONE","Invade Bone","Invade Bone","STRING","PATIENT"],["INVADE_SKULL_BASE","Invade Skull Base","Invade Skull Base","STRING","PATIENT"],["MULTIPLE_HN_CSCC","Multiple HN cSCC","Multiple Head and Neck cSCC","STRING","PATIENT"],["DISEASE_RECURRENCE_OR_PERSISTENCE","Disease Recurrence or Persistence","Disease Recurrence or Persistence","STRING","PATIENT"],["OTHER_SKIN_TUMORS","Other Skin Tumors","Other Skin Tumors","STRING","PATIENT"],["INTERVAL_FROM_LAST_LESION_TO_STUDY","Interval From Previous Lesion to Tumor Studied (months)","Interval From Previous Lesion to Tumor Studied (months)","STRING","PATIENT"],["INTERVAL_FROM_INDEX_LESION_TO_PRESENT_LESION","Interval From Index Lesion to Present Lesion (months)","Interval From Index Lesion to Present Lesion (months)","STRING","PATIENT"],["PERSISTANT_DISEASE_TUMOR_STUDIED","Persistant Disease Tumor Studied","Persistant Disease Tumor Studied","STRING","PATIENT"],["RECURRENT_DISEASE_TUMOR_STUDIED","Recurrent Disease Tumor Studies","Recurrent Disease Tumor Studied","STRING","PATIENT"],["EVENT_STATUS_FOR_DFS","Event Status For Disease Free Survival","Event Status For Disease Free Survival ","STRING","PATIENT"],["RECURRENT_FREE_INTERVAL_MONTHS","Recurrent Free Interval (Months)","Recurrent Free Interval (Months)","STRING","PATIENT"],["SUBSEQUENT_CANCERS","Subsequent Cancers","Subsequent Cancers","STRING","PATIENT"],["TOTAL_MUTATIONS","Total Mutations","Total Mutations","NUMBER","PATIENT"],["TUMOR_SUBTYPE","Tumor Subtype","Tumor Subtype","STRING","SAMPLE"],["LEUKEMIA_TYPE","Leukemia Type","Leukemia Type","STRING","SAMPLE"],["SARCOMATOID_COMPONENT","Sarcomatoid Component","Sarcomatoid Component","STRING","SAMPLE"],["VHL_MUTATION_CODON","VHL Mutation (Codon)","VHL Mutation (Codon)","STRING","SAMPLE"],["VHL_MUTATION_AA","VHL Mutation (AA)","VHL Mutation (AA)","STRING","SAMPLE"],["IMMUNE_STATUS","Immune Status","Immune Status","STRING","SAMPLE"],["MERKEL_CELL","Merkel Cell","Merkel cells are oval receptor cells found in the skin of vertebrates that have synaptic contacts with somatosensory afferents.","STRING","SAMPLE"],["SECOND_PRIMARY_CANCER","Second Primary Cancer","Refers to a new primary cancer in a person with a history of cancer","STRING","SAMPLE"],["SEX","Sex","Sex","STRING","PATIENT"],["RAI","Radioactive Iodine","Radioactive Iodine","STRING","PATIENT"],["RAI_AVID","RAI AVID","RAI AVID","STRING","PATIENT"],["LOCAL_RFS_MONTHS","local recurrence free survival (months)","local recurrence free survival (months)","NUMBER","PATIENT"],["NECK_RECURRENCE","Neck Recurrence","Neck Recurrence","STRING","PATIENT"],["NECK_RFS_MONTHS","Neck Recurrence Free Survival (months)","Neck Recurrence Free Survival (months)","NUMBER","PATIENT"],["LOCO_REG_STATUS","Locolized Reg Status","Locolized Reg Status","STRING","PATIENT"],["LOCO_REG_MONTHS","Locolized Reg (Months)","Locolized Reg (Months)","NUMBER","PATIENT"],["DISTANT_RFS_MONTHS","Distan RFS (Months)","Distan RFS (Months)","NUMBER","PATIENT"],["PFS_STATUS","Progression Free Status","Progression Free Status","STRING","PATIENT"],["PATH_CODE","Path Code","Path Code","NUMBER","PATIENT"],["DOSAGE","Dosage","Dosage","STRING","PATIENT"],["BKM120_DOSAGE","BKM120 Dosage (mg)","BKM120 Dosage (mg)","STRING","PATIENT"],["OLAPARIB_DOSAGE","Olaparib Dosage (mg)","Olaparib Dosage (mg)","STRING","PATIENT"],["MEAN_COVERAGE","Mean Coverage (x)","Mean Coverage (x)","NUMBER","SAMPLE"],["CD10_STATUS","CD10 Status","CD10 Status","STRING","SAMPLE"],["MUM1_STATUS","MUM1 Status","MUM1 Status","STRING","SAMPLE"],["P4EBP1_STATUS","P4EBP1 Status","P4EBP1 Status","STRING","SAMPLE"],["BCL6_STATUS","BCL6 Status","BCL6 Status","STRING","SAMPLE"],["NUM_PRIOR_THERAPIES","Number of Prior Therapies","Number of Prior Therapies","NUMBER","PATIENT"],["NAACCR_ETHNICITY","NAACCR Ethnicity ","NAACCR Ethnicity ","NUMBER","PATIENT"],["NAACCR_RACE","NAACCR Race","NAACCR Race","NUMBER","PATIENT"],["YEAR","Year","Year","NUMBER","PATIENT"],["MYCN_AMP","MYCN Amplification","MYCN Amplification","STRING","SAMPLE"],["INDEL","Insertion And Deletion","Insertion And Deletion","NUMBER","SAMPLE"],["MISSENSE_MUTATIONS","Missense Mutations","Missense Mutations","NUMBER","SAMPLE"],["HISTOLOGY_FOR_CALC","Histology for Calc","Histology for Calc","STRING","PATIENT"],["GENOMIC_BIOPSY","Genomic Biopsy","Genomic Biopsy","STRING","PATIENT"],["DAYS_TO_RESULTS","Days to Results","Days to Results","NUMBER","PATIENT"],["STAGE","Stage","Stage","STRING","PATIENT"],["DRIVER_MUTATIONS","Driver Mutations","Driver Mutations","STRING","SAMPLE"],["SMOKING_PACK_PER_DAY","Smoking Pack Per Day","Smoking Pack Per Day","NUMBER","PATIENT"],["SMOKER_YEARS","Years Smoked","Years Smoked","NUMBER","PATIENT"],["CAISIS_SAMPLE_HISTOLOGY","CAISIS (Sample Histology)","Sample Histology, as supplied by CAISIS","STRING","SAMPLE"],["CAISIS_WHO_GRADE","CAISIS (WHO Grade)","WHO Grade, as aupplied by CAISIS","STRING","SAMPLE"],["CAISIS_MGMT_STATUS","CAISIS (MGMT Status)","MGMT Status, as supplied by CAISIS","STRING","SAMPLE"],["CAISIS_AGE","CAISIS (Diagnosis Age)","Age at which a condition or disease was first diagnosed, as supplied by CAISIS.","STRING","PATIENT"],["CAISIS_GENDER","CAISIS (Person Gender)","Patient gender, as supplied by CAISIS.","STRING","PATIENT"],["CAISIS_OS_STATUS","CAISIS (Overall Survival Status)","Overall patient survival status, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_OS_MONTHS","CAISIS (Overall Survival Months)","Overall survival in months since initial diagnosis, as provided by CAISIS.","NUMBER","PATIENT"],["CAISIS_DFS_STATUS","CAISIS (Disease Free Status)","Disease free status since initial diagnosis, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_DFS_MONTHS","CAISIS (Disease Free Months)","Disease free (months) since initial treatment, as provided by CAISIS.","NUMBER","PATIENT"],["CAISIS_START_DATE","CAISIS (Start date)","Start date of an event, as provided by CAISIS.","NUMBER","PATIENT"],["CAISIS_STOP_DATE","CAISIS (End date)","End date of an event , as provided by CAISIS.","NUMBER","PATIENT"],["CAISIS_EVENT_TYPE","CAISIS (Event Type)","Type of event which can be a treatment, imaging, surgery, specimen collection or status , as provided by CAISIS.","STRING","PATIENT"],["CAISIS_STATUS","CAISIS (Status)","Status of the patient, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_NOTE","CAISIS (Note)","Additional Notes , as provided by CAISIS.","STRING","PATIENT"],["CAISIS_TREATMENT_TYPE","CAISIS (Treatment type)","Type of Treatment which can be medical or radiation therapies, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_SUBTYPE","CAISIS (Subtype)","Subtype of the treatment, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_AGENT","CAISIS (Agent)","Agent used for the treatment , as provided by CAISIS.","STRING","PATIENT"],["CAISIS_DIAGNOSTIC_DATE","CAISIS (Diagnostic Date)","Diagnsotic date , as provided by CAISIS.","NUMBER","PATIENT"],["CAISIS_DIAGNOSTIC_TYPE","CAISIS (Diagnostic Type)","Type of diagnostics used , as provided by CAISIS.","STRING","PATIENT"],["CAISIS_DIAGNOSTIC_TARGET","CAISIS (Diagnostic Target)","Diagnostic target, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_RESULT","CAISIS (Result)","Results, as provided by CAISIS.","STRING","PATIENT"],["CAISIS_DIAGNOSTIC_NOTES","CAISIS (Diagnostic Notes)","Notes from the diagnostics , as provided by CAISIS.","STRING","PATIENT"],["CRDB_QS_DATE","CRDB_QS_DATE","The date the survey was filled out.","STRING","PATIENT"],["CRDB_ADJ_TXT","CRDB_ADJ_TXT","Has the patient received adjuvant systemic therapy?","STRING","PATIENT"],["CRDB_NOSYSTXT","CRDB_NOSYSTXT","What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?","STRING","PATIENT"],["CRDB_PRIOR_RX","CRDB_PRIOR_RX","Has the patient received prior radiotherapy?","STRING","PATIENT"],["CRDB_BRAINMET","CRDB_BRAINMET","Does the patient have brain metastases?","STRING","PATIENT"],["CRDB_ECOG","CRDB_ECOG","What is the patient's ECOG status?","STRING","PATIENT"],["CRDB_COMMENTS","CRDB_COMMENTS","Comments.","STRING","PATIENT"],["CRDB_CONSENT_DATE_DAYS","CRDB_CONSENT_DATE_DAYS","12-245 consent date.","NUMBER","PATIENT"],["CRDB_PRIM_DISEASE_12245","CRDB_PRIM_DISEASE_12245","The patient's primary disease entered under 12-245.","STRING","PATIENT"],["CRDB_INITIAL_SX_DAYS","CRDB_INITIAL_SX_DAYS","The disease initial symptom date.","NUMBER","PATIENT"],["CRDB_INITIAL_DX_DAYS","CRDB_INITIAL_DX_DAYS","The disease initial diagnosis date.","NUMBER","PATIENT"],["CRDB_FIRST_METASTASIS_DAYS","CRDB_FIRST_METASTASIS_DAYS","The disease first metastasis date.","NUMBER","PATIENT"],["CRDB_INIT_DX_STATUS_ID","CRDB_INIT_DX_STATUS_ID","The ID related to the disease status information at diagnosis. Used as CRDB reference.","STRING","PATIENT"],["CRDB_INIT_DX_STATUS","CRDB_INIT_DX_STATUS","The status associated with the disease initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_STATUS_DAYS","CRDB_INIT_DX_STATUS_DAYS","The status date associated with the disease initial diagnosis","STRING","PATIENT"],["CRDB_INIT_DX_STAGING_DSCRP","CRDB_INIT_DX_STAGING_DSCRP","The staging system used to determine the stage of the disease at the initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_STAGE","CRDB_INIT_DX_STAGE","The stage of the disease at the initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_STAGE_DSCRP","CRDB_INIT_DX_STAGE_DSCRP","The stage description at the initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_GRADE","CRDB_INIT_DX_GRADE","The grade of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_GRADE_DSCRP","CRDB_INIT_DX_GRADE_DSCRP","The grade description of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_T_STAGE","CRDB_INIT_DX_T_STAGE","The T Stage of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_T_STAGE_DSCRP","CRDB_INIT_DX_T_STAGE_DSCRP","The T Stage description of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_N_STAGE","CRDB_INIT_DX_N_STAGE","The N Stage of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_N_STAGE_DSCRP","CRDB_INIT_DX_N_STAGE_DSCRP","The N Stage description of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_M_STAGE","CRDB_INIT_DX_M_STAGE","The M Stage of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_M_STAGE_DSCRP","CRDB_INIT_DX_M_STAGE_DSCRP","The M Stage description of the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_HIST","CRDB_INIT_DX_HIST","Histology description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_SUB_HIST","CRDB_INIT_DX_SUB_HIST","Histology sub description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_SUB_SUB_HIST","CRDB_INIT_DX_SUB_SUB_HIST","Histology sub sub description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_SUB_SUB_SUB_HIST","CRDB_INIT_DX_SUB_SUB_SUB_HIST","Histology sub sub sub description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_SITE","CRDB_INIT_DX_SITE","Site description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_SUB_SITE","CRDB_INIT_DX_SUB_SITE","Site sub description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_INIT_DX_SUB_SUB_SITE","CRDB_INIT_DX_SUB_SUB_SITE","Site sub sub description associated with the disease at initial diagnosis.","STRING","PATIENT"],["CRDB_ENROLL_DX_STATUS_ID","CRDB_ENROLL_DX_STATUS_ID","The ID related to the disease status information at enrollment for 12-245. Used as CRDB reference.","STRING","PATIENT"],["CRDB_ENROLL_DX_STATUS","CRDB_ENROLL_DX_STATUS","The status associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_STATUS_DAYS","CRDB_ENROLL_DX_STATUS_DAYS","The status date associated with the disease at enrollment for 12-245..","NUMBER","PATIENT"],["CRDB_ENROLL_DX_STAGING_DSCRP","CRDB_ENROLL_DX_STAGING_DSCRP","The staging system used to determine the stage of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_STAGE","CRDB_ENROLL_DX_STAGE","The stage of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_STAGE_DSCRP","CRDB_ENROLL_DX_STAGE_DSCRP","The stage description at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_GRADE","CRDB_ENROLL_DX_GRADE","The grade of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_GRADE_DSCRP","CRDB_ENROLL_DX_GRADE_DSCRP","The grade description of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_T_STAGE","CRDB_ENROLL_DX_T_STAGE","The T Stage of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_T_STAGE_DSCRP","CRDB_ENROLL_DX_T_STAGE_DSCRP","The T Stage description of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_N_STAGE","CRDB_ENROLL_DX_N_STAGE","The N Stage of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_N_STAGE_DSCRP","CRDB_ENROLL_DX_N_STAGE_DSCRP","The N Stage description of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_M_STAGE","CRDB_ENROLL_DX_M_STAGE","The M Stage of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_M_STAGE_DSCRP","CRDB_ENROLL_DX_M_STAGE_DSCRP","The M Stage description of the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_HIST","CRDB_ENROLL_DX_HIST","Histology description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_SUB_HIST","CRDB_ENROLL_DX_SUB_HIST","Histology sub description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_SUB_SUB_HIST","CRDB_ENROLL_DX_SUB_SUB_HIST","Histology sub sub description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_SUB_SUB_SUB_HIST","CRDB_ENROLL_DX_SUB_SUB_SUB_HIST","Histology sub sub sub description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_SITE","CRDB_ENROLL_DX_SITE","Site description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_SUB_SITE","CRDB_ENROLL_DX_SUB_SITE","Site sub description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_ENROLL_DX_SUB_SUB_SITE","CRDB_ENROLL_DX_SUB_SUB_SITE","Site sub sub description associated with the disease at enrollment for 12-245.","STRING","PATIENT"],["CRDB_SURVIVAL_STATUS","CRDB_SURVIVAL_STATUS","The patient's survival status.","STRING","PATIENT"],["CRDB_TREATMENT_END_DAYS","CRDB_TREATMENT_END_DAYS","The patient's 12-245 treatment end date.","NUMBER","PATIENT"],["CRDB_OFF_STUDY_DAYS","CRDB_OFF_STUDY_DAYS","The patient's 12-245 off study date.","STRING","PATIENT"],["DARWIN_PATIENT_AGE","DARWIN_PATIENT_AGE","The patient age.","NUMBER","PATIENT"],["DARWIN_RACE","DARWIN_RACE","Patient race, as supplied by darwin.","STRING","PATIENT"],["DARWIN_RELIGION","DARWIN_RELIGION","Patient religion, as supplied by darwin.","STRING","PATIENT"],["DARWIN_SEX","DARWIN_SEX","Patient sex, as supplied by darwin.","STRING","PATIENT"],["DARWIN_VITAL_STATUS","DARWIN_VITAL_STATUS","Patient vital status, as supplied by darwin.","STRING","PATIENT"],["DARWIN_AGE_AT_DIAGNOSIS","DARWIN_AGE_AT_DIAGNOSIS","Patient age at time of diagnosis.","NUMBER","PATIENT"],["FUSION","Fusion","Fusion","STRING","SAMPLE"],["INITIAL_TREATMENT","Initial Treatment","Initial Treatment","STRING","PATIENT"],["PRIOR_TX_TO_IMPACT_SAMPLE","Prior Treatment to IMPACT Sample","Prior Treatment to IMPACT Sample","STRING","PATIENT"],["DISEASE_EXTENT","Disease Extent At Time IMPACT Was Sent","Disease Extent At Time IMPACT Was Sent","STRING","PATIENT"],["TABACCO_TYPE","Tabacco Type","Tabacco Type","STRING","PATIENT"],["MULTIPLE_BREAST _PRIMARIES","Multiple Breast Primaries","Multiple Breast Primaries","STRING","PATIENT"],["PRIMARY_ORDERMULTIPLE_BREAST_PRIMARIES_SEQUENCE","Multiple Breast Primaries Sequenced","Multiple Breast Primaries Sequenced","STRING","PATIENT"],["SIDE_SURGERY","Side Surgery","Side Surgery","STRING","PATIENT"],["NUCLEAR_GRADE","Nuclear Grade","Nuclear Grade","STRING","PATIENT"],["PR_STATUS_PRIMARY","PR Primary Status","PR Primary Status","STRING","PATIENT"],["HER2_STATUS_PRIMARY","HER2 Primary Status","HER2 Primary Status","STRING","PATIENT"],["ER_STATUS_PRIMARY","ER Primary Status","ER Primary Status","STRING","PATIENT"],["KNOWN_MOLECULAR_CLASSIFIER_FINAL","Known Molecular Classifier Final","Known Molecular Classifier Final","STRING","PATIENT"],["BREAST_CANCER_RECEPTOR_STATUS_FINAL","Breast Cancer Receptor Status Final","Breast Cancer Receptor Status Final","STRING","PATIENT"],["PR_STATUS_METASTASIS","PR Metastatic Status","PR Metastatic Status","STRING","PATIENT"],["HER2_STATUS_METASTASIS","HER2 Metastatic Status","HER2 Metastatic Status","STRING","PATIENT"],["ER_STATUS_METASTASIS","ER Metastatic Status","ER Metastatic Status","STRING","PATIENT"],["DX_TO_IMPACT_EXTENT_MONTHS","Time from Diagnosis to IMPACT in months","Time from Diagnosis to IMPACT in months","NUMBER","PATIENT"],["BRCA2_RESULT","BRAC2 Result","BRAC2 Result","STRING","SAMPLE"],["MENOPAUSE_STATUS_AT_DIAGNOSIS","Menopasue status at Diagnosis","Menopasue status at Diagnosis","STRING","PATIENT"],["DETAILED_PRIMARY_SITE","Detailed Primary Site","Detailed Primary Site","STRING","PATIENT"],["DETAILED_METASTATIC_SITE","Detailed Metastatic Site","Detailed Metastatic Site","STRING","SAMPLE"],["DETAILED_SAMPLE_HISTOLOGY_CATEGORY","Detailed Sample Histology Category","Detailed Sample Histology Category","STRING","SAMPLE"],["S_STAGE","S Stage","S indicates the serum (blood) levels of tumor markers that are made by some testicular cancers","STRING","SAMPLE"],["PRIMARY_RPLND","Primary RPLND","Primary RPLND","STRING","SAMPLE"],["PC_RPLND","RPLND","RPLND","STRING","SAMPLE"],["RPLND_PATH","RPLND Path","RPLND Path","STRING","SAMPLE"],["CHEMO_SETTING_METASTATIC","Chemotherapy For Metastasis ","Chemotherapy For Metastasis ","STRING","PATIENT"],["RECURRENCE_METHOD","Recurrence Method","Recurrence Method","STRING","PATIENT"],["DDR_MUTATION","DDR Gene Mutation","DDR Gene Mutation ","STRING","SAMPLE"],["SO_COMMENTS","SO comments","Sign-out comments","STRING","SAMPLE"],["SAMPLE_COVERAGE","Sample coverage","Sample coverage","STRING","SAMPLE"],["RECURRENCE_HISTOLOGY","Recurrence Histology","Recurrence Histology","STRING","PATIENT"],["BRCA1_RESULT","BRCA1 Result","BRCA1 Result","STRING","SAMPLE"],["HEAD _VS_BODY_TAIL_PRIMARY_PANCREAS","Head VS Body/Tail Primary Pancreas","Head VS Body/Tail Primary Pancreas","STRING","PATIENT"],["FIRST_ADJUVANT_TX_TYPE","Type of First Systemic Therapy ADJ","Type of First Systemic Therapy ADJ","STRING","PATIENT"],["FIRST_MET_TX_TYPE","Type of First Systemic Therapy MET","Type of First Systemic Therapy MET","STRING","PATIENT"],["VISCERAL_METS","Visceral Mets","Visceral Mets","STRING","PATIENT"],["PRIOR_PERI_OPERATIVE_CHEMO","Prior peri-operative chemo","Prior peri-operative chemo","STRING","PATIENT"],["HD_CHEMO_AUTO_SCT","High Dose Chemo + Auto Stem Cell Therapy","Did the patient receive high-dose chemotherapy and autologous stem cell reinfusion?","STRING","PATIENT"],["IMAGING","Imaging","Imaging","STRING","PATIENT"],["INITIAL_RX","Initial Rx","Initial Rx","STRING","PATIENT"],["SUBSEQUENT_RX","Subsequent Rx","Subsequent Rx","STRING","PATIENT"],["LEUKOCYTE_FRACTION","Leukocyte Fraction","leukocyte_fraction","NUMBER","SAMPLE"],["PARADIGM_CLUSTER","PARADIGM CLUSTER","PARADIGM CLUSTER","NUMBER","SAMPLE"],["FNCLCC_GRADE","FNCLCC Grade","FNCLCC Grade","NUMBER","SAMPLE"],["AMP_12q15_FRS2","AMP 12q15 FRS2","AMP 12q15 FRS2","STRING","SAMPLE"],["AMP_12q15_MDM2","AMP 12q15 MDM2","AMP 12q15 MDM2","STRING","SAMPLE"],["AVG_CN_12q13_15","avg CN 12q13~15","avg CN 12q13~15","STRING","SAMPLE"],["AMP_12q15_CDK4","AMP 12q15 CDK4","AMP 12q15 CDK4","STRING","SAMPLE"],["AMP_12q15_HMGA2","AMP 12q15 HMGA2","AMP 12q15 HMGA2","STRING","SAMPLE"],["SHORT_HISTOLOGY","Short Histology","Short Histology","STRING","PATIENT"],["DISEASE_STATE_TIME_OF_COLLECTION","Disease State at time of tissue collection","Disease State at time of tissue collection","STRING","PATIENT"],["CLINICAL_STATE_AT_IMPACT_ORDER_DATE","Clinical State at IMPACT Order Date","Clinical State at IMPACT Order Date","STRING","PATIENT"],["PRIMARY_TX_MODALITY","Primary Tx Modalit","Primary Tx Modalit","STRING","PATIENT"],["MORPHOLOGICAL_ARCHITECTURE","Morphological Architecture","Morphological Architecture","STRING","SAMPLE"],["EC","EC","EC","STRING","PATIENT"],["SCC","SCC","SCC","STRING","PATIENT"],["GEA","GEA","GEA","STRING","PATIENT"],["GEA-CIN","GEA-CIN","GEA-CIN","STRING","PATIENT"],["GEA-GEJ","GEA-GEJ","GEA-GEJ","STRING","PATIENT"],["EC-SMG","EC-SMG","EC-SMG","STRING","PATIENT"],["SCC-SMG","SCC-SMG","SCC-SMG","STRING","PATIENT"],["GEA-SMG","GEA-SMG","GEA-SMG","STRING","PATIENT"],["GEA-CIN-SMG","GEA-CIN-SMG","GEA-CIN-SMG","STRING","PATIENT"],["TUMOR_EXTENT","Tumor extent","Tumor extent","STRING","PATIENT"],["REGIONAL_LYMPH_NODES","Regional lymph nodes","Regional lymph nodes","STRING","PATIENT"],["MAJOR_ANATOMIC_SITE","Major Anatomic Site","Major Anatomic Site","STRING","SAMPLE"],["GENOME_DOUBLINGS","Genome Doublings","Genome Doublings","STRING","SAMPLE"],["ABSOLUTE_GENOME_DOUBLINGS","Absolute Genome Doublings","Absolute Genome Doublings","STRING","SAMPLE"],["DNA_METHYLATION_CLUSTER_EC","DNA Methylation Cluster - EC","DNA Methylation Cluster - EC","STRING","SAMPLE"],["COPY_NUMBER_CLUSTER_EC","Copy Number Cluster - EC","Copy Number Cluster - EC","STRING","SAMPLE"],["GENE_EXPRESSION_CLUSTER_EC","Gene Expression Cluster - EC","Gene Expression Cluster - EC","STRING","SAMPLE"],["MIRNA_EXPRESSION_CLUSTER_EC","miRNA Expression Cluster - EC","miRNA Expression Cluster - EC","STRING","SAMPLE"],["RPPA_CLUSTER_EC","RPPA Cluster - EC","RPPA Cluster - EC","STRING","SAMPLE"],["DNA_METHYLATION_CLUSTER_SCC","DNA Methylation Cluster - SCC","DNA Methylation Cluster - SCC","STRING","SAMPLE"],["COPY_NUMBER_CLUSTER_SCC","Copy Number Cluster - SCC","Copy Number Cluster - SCC","STRING","SAMPLE"],["GENE_EXPRESSION_CLUSTER_SCC","Gene Expression Cluster - SCC","Gene Expression Cluster - SCC","STRING","SAMPLE"],["MIRNA_EXPRESSION_CLUSTER_SCC","miRNA Expression Cluster - SCC","miRNA Expression Cluster - SCC","STRING","SAMPLE"],["RPPA_CLUSTER_SCC","RPPA Cluster - SCC","RPPA Cluster - SCC","STRING","SAMPLE"],["COPY_NUMBER_CLUSTER_GEA","Copy Number Cluster - GEA","Copy Number Cluster - GEA","STRING","SAMPLE"],["GENE_EXPRESSION_CLUSTER_GEA","Gene Expression Cluster - GEA","Gene Expression Cluster - GEA","STRING","SAMPLE"],["DNA_METHYLATION_CLUSTER_GEA","DNA Methylation Cluster - GEA","DNA Methylation Cluster - GEA","STRING","SAMPLE"],["MIRNA_EXPRESSION_CLUSTER_GEA","miRNA Expression Cluster - GEA","miRNA Expression Cluster - GEA","STRING","SAMPLE"],["RPPA_CLUSTER _GEA","RPPA Cluster - GEA","RPPA Cluster - GEA","STRING","SAMPLE"],["COPY_NUMBER_CLUSTER_GEA_CIN","Copy Number Cluster - GEA-CIN","Copy Number Cluster - GEA-CIN","STRING","SAMPLE"],["DNA_METHYLATION_CLUSTER_GEA_CIN","DNA Methylation Cluster - GEA-CIN","DNA Methylation Cluster - GEA-CIN","STRING","SAMPLE"],["GENE_EXPRESSION_CLUSTER_GEA_CIN","Gene Expression Cluster - GEA-CIN","Gene Expression Cluster - GEA-CIN","STRING","SAMPLE"],["MIRNA_EXPRESSION_CLUSTER_GEA_CIN","miRNA Expression Cluster - GEA-CIN","miRNA Expression Cluster - GEA-CIN","STRING","SAMPLE"],["RPPA_CLUSTER _GEA_CIN","RPPA Cluster - GEA-CIN","RPPA Cluster - GEA-CIN","STRING","SAMPLE"],["DAYS_FROM_SURGERY_TO_LAST_FOLLOWUP","Days from surgery to last followup","Days from surgery to last followup","NUMBER","PATIENT"],["GASTRIC_CLASSIFICATION","Gastric Classification","Gastric Classification","STRING","SAMPLE"],["CURRENT_CLINICAL_STATUS","Current Clinical Status","Current Clinical Status","STRING","PATIENT"],["BRCA_GERMLINE_MUTATIONS","BRCA Germline mutation","BRCA Germline mutation","STRING","SAMPLE"],["HER2_IHC_OR_FISH","HER2 IHC or FISH","HER2 IHC or FISH","STRING","SAMPLE"],["TISSUE_SITE","Tissue Site","Tissue Site","STRING","SAMPLE"],["OVERALL_PATIENT_HISTOLOGY","Overall Patient Histology","Overall Patient Histology","STRING","PATIENT"],["RESECTION_AT_MSKCC","Resection At MSKCC","Resection At MSKCC","STRING","PATIENT"],["TREATMENT_FOR_MTS_DISEASE_BEFORE_MTS_SAMPLING","Treatment for MTS Disease Before MTS Sampling","Treatment for MTS Disease Before MTS Sampling","STRING","PATIENT"],["TYPE_OF_PRIOR_LOCAL_THERAPY","Type of Prior Local Therapy","Type of Prior Local Therapy","STRING","PATIENT"],["FIRST_SITE_OF_METS","First Site of Metastasis","First Site of Metastasis","STRING","PATIENT"],["CONCURRENT_TREATMENT","Concurrent Treatment ","Concurrent Treatment ","STRING","PATIENT"],["HISTORY_OTHER","Other History","Other History","STRING","PATIENT"],["TISSUE_SITE_MET_BURDEN","Tissue Site Metastasis Burden","Tissue Site Metastasis Burden","STRING","SAMPLE"],["METASTASIS_EXAMINED","Metastasis Examined ","Metastasis Examined ","STRING","PATIENT"],["METASTASIS_TESTED","Metastasis Tested","Metastasis Tested","STRING","PATIENT"],["LARGEST_METASTATIC_BURDEN","Largest Metastatic Burden","Largest Metastatic Burden","STRING","PATIENT"],["OVERALL_METASTATIC_BURDEN","Overall Metastatic Burden","Overall Metastatic Burden","STRING","PATIENT"],["INDEX_LESION","Index Lesion","Index Lesion","STRING","PATIENT"],["HISTOPATHOLOGY","Histopathology","Histopathology","STRING","PATIENT"],["PRESENTATION","Presentation","Presentation","STRING","PATIENT"],["PRETREATED_TISSUE","Pretreated Tissue","Pretreated Tissue","STRING","SAMPLE"],["PRE_RC_SYSTEMICCHEMO","Pre RC Systemic Chemotherapy","Pre RC Systemic Chemotherapy","STRING","PATIENT"],["RECURRENCE","Recurrence","Recurrence","STRING","PATIENT"],["MSK_NOMOGRAM","MSK Nomogram","MSK Nomogram","NUMBER","PATIENT"],["CEA","CEA","The value of carcinoembryonic antigen (CEA) test","NUMBER","PATIENT"],["CA_19_9","CA 19-9 Value","CA 19-9 Value","NUMBER","PATIENT"],["TIME_TO_FIRST_RECURRENCE","TIme to first recurrence (months)","TIme to first recurrence (months)","NUMBER","PATIENT"],["CHEMOTHERAPY_PRIOR_IMPACT","Chemotherapy Prior IMPACT","Chemotherapy Prior IMPACT","STRING","PATIENT"],["CHEMOTHERAPY_DETAILS","Chemotherapy Details","Chemotherapy Details","STRING","PATIENT"],["TYPE_OF_TREATMENT_BEFORE_SAMPLING","Type of Treatment Before Sampling","Type of Treatment Before Sampling","STRING","PATIENT"],["MODIFIED_CAPRA_S_SCORE_WITHOUT_INCLUDING_SURGICAL_MARGINS","Modified Capra S Score Without Including Surgical Margins","Modified Capra S Score Without Including Surgical Margins","NUMBER","SAMPLE"],["WHO_GRADE","WHO Grade","WHO Grade","STRING","SAMPLE"],["STAGE_AT_FIRST_RECURRENCE","Stage at first Recurrence","Stage at first Recurrence","STRING","SAMPLE"],["METASTATIC STAGE","MET Stage","MET Stage","STRING","SAMPLE"],["BRAF_V600_LEVEL1","BRAF V600 Level1","BRAF V600 Level1","STRING","SAMPLE"],["RAF_INHIBITOR","RAF Inhibitor","RAF Inhibitor","STRING","PATIENT"],["RAFI_AGENT","RAF inhibitor type","RAF inhibitor type","STRING","PATIENT"],["IMPACT_PRE_RAFI","IMPACT Pre RAFi","IMPACT Pre RAFi","STRING","PATIENT"],["KIT_LEVEL_2A","KIT Level 2A","KIT Level 2A","STRING","SAMPLE"],["KIT_INHIBITOR","KIT Inhibitor","KIT Inhibitor","STRING","PATIENT"],["KITI_AGENT","KIT inhibitor type","KIT inhibitor type","STRING","PATIENT"],["IMPACT_PRE_KITI","IMPACT Pre KITi","IMPACT Pre KITi","STRING","PATIENT"],["PSAT_IMPACT_ORDER","PSAT IMPACT order","PSAT IMPACT order","STRING","PATIENT"],["IMMUNE_TREATMENT","Immunotherapy","Immunotherapy","STRING","PATIENT"],["SAMPLE_PRE_POST_IMMUNE","Sample procurred pre or post immnunotherapy","Sample procurred pre or post immnunotherapy","STRING","SAMPLE"],["CYTOTOXIC_TREATMENT","Cytotoxic Treatment","Cytotoxic Treatment","STRING","PATIENT"],["IMPACT_DIRECTED_SOC_TX","IMPACT directed SOC Treatment","IMPACT directed SOC Treatment","STRING","PATIENT"],["TUMOR_MORPHOLOGY","Tumor Morphology","Tumor Morphology","STRING","PATIENT"],["ONCOTYPE_ OR_MAMAPRINT","Oncotype or Mamaprint ","Oncotype or Mamaprint genomic assay","STRING","SAMPLE"],["AGE_AT_BMI_MEASUREMENT","Age at BMI Measurement","Age at BMI Measurement","NUMBER","PATIENT"],["BMI_CATEGORY","BMI Category","BMI Category","STRING","PATIENT"],["HYPERCHOLESTEROLEMIA","Hypercholesterolemia","Hypercholesterolemia","STRING","PATIENT"],["STATIN_USE","Statin Used","Statin Used","STRING","PATIENT"],["METFORMIN_USE","Metformin Used","Metformin Used","STRING","PATIENT"],["NSAID_USE","NSAID Used","NSAID Used","STRING","PATIENT"],["HEIGHT_M","Height (metres)","Height (metres)","NUMBER","PATIENT"],["INTERVAL_FROM_PRIMARY_TO_MBC_DX_YEARS","Interval from primary to MBC dx (years)","Interval from primary to MBC dx (years)","NUMBER","PATIENT"],["PRIOR_FLUOROPYRIMIDINE","Prior fluoropyrimidine (before sample collected for sequencing)","Prior fluoropyrimidine (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_OXALIPLATIN","Prior oxaliplatin (before sample collected for sequencing)","Prior oxaliplatin (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_IRINOTECAN","Prior irinotecan (before sample collected for sequencing)","Prior irinotecan (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_ANTI_EGFR","Prior anti-EGFR (before sample collected for sequencing)","Prior anti-EGFR (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_ANTI_VEGF","Prior anti-VEGF (before sample collected for sequencing)","Prior anti-VEGF (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_HAI","Prior HAI (before sample collected for sequencing)","Prior HAI (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_IP","Prior IP (before sample collected for sequencing)","Prior IP (before sample collected for sequencing)","STRING","PATIENT"],["PRIOR_RT_OF_SEQUENCED_SITE","Prior RT (of sequenced site)","Prior RT (of sequenced site)","STRING","PATIENT"],["METASTATIC_RESECTION","Resection of Mets","Resection of Mets","STRING","PATIENT"],["RESPONSE_DURATION_MONTHS","Response Duration (months)","Response Duration (Months)","NUMBER","PATIENT"],["BIOPSY_PRE_OR_POST_IPI","Biopsy pre or post IPI","Biopsy pre or post IPI","STRING","PATIENT"],["IPILIMUMAB_DOSE_MG_PER_KG","Ipilimumab dose (mg/kg)","Ipilimumab dose (mg/kg)","STRING","PATIENT"],["SAMPLE_PRE_CHEMO","Sample procurred pre chemotherapy","Sample procurred pre chemotherapy","STRING","PATIENT"],["TIME_TO_DIAGNOSIS_WITH_ADVANCED_DISEASE","Time to diagnosis with advanced disease","Time to diagnosis with advanced disease","STRING","PATIENT"],["OS_MONTHS_ADVANCED_DISEASE","Overall Survival from Advanced Disease","Overall Survival from Advanced Disease","NUMBER","PATIENT"],["PRIMARY_TUMOR_GRADE","Primary Tumor Grade","Primary Tumor Grade","STRING","SAMPLE"],["STAGE_M","M Stage","M Stage of tumor","STRING","SAMPLE"],["FAMILY_HISTORY_OF_RENAL_CELL_CARCINOMA","Family History of Renal cell carcinoma","Family History of Renal cell carcinoma","STRING","PATIENT"],["CREATININE","Creatinine","Creatinine","NUMBER","PATIENT"],["CKD_EPI","CKD-EPI","CKD-EPI","NUMBER","SAMPLE"],["DAYS_FROM_SURGERY_TO_RECURRENCE","Days from surgery to recurrence","Days from surgery to recurrence","NUMBER","PATIENT"],["SCNA_CLUSTER_EC","SCNA Cluster EC","SCNA Cluster EC","STRING","SAMPLE"],["SCNA_CLUSTER_SCC","SCNA Cluster SCC","SCNA Cluster SCC","STRING","SAMPLE"],["SCNA_CLUSTER_GEA","SCNA Cluster GEA","SCNA Cluster GEA","STRING","SAMPLE"],["SCNA_CLUSTER_GEA_CIN","SCNA Cluster GEA CIN","SCNA Cluster GEA CIN","STRING","SAMPLE"],["MRNA_EXPRESSION_CLUSTER_EC","MRNA Expression Cluster EC","MRNA Expression Cluster EC","STRING","SAMPLE"],["MRNA_EXPRESSION_CLUSTER_SCC","MRNA Expression Cluster SCC","MRNA Expression Cluster SCC","STRING","SAMPLE"],["MRNA_EXPRESSION_CLUSTER_GEA","MRNA Expression Cluster GEA","MRNA Expression Cluster GEA","STRING","SAMPLE"],["SCC_CLUSTER_ICLUSTER_AND_SMARCA4","SCC Cluster iCluster and SMARCA4","SCC Cluster iCluster and SMARCA4","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_COCA","GEA CIN Integrated Cluster COCA","GEA CIN Integrated Cluster COCA","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_ICLUSTER","GEA CIN Integrated Cluster iCluster","GEA CIN Integrated Cluster iCluster","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_SUPERCLUSTER","GEA CIN Integrated Cluster SuperCluster","GEA CIN Integrated Cluster SuperCluster","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_4","GEA CIN Integrated Cluster MKL KNN 4","GEA CIN Integrated Cluster MKL KNN 4","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_7","GEA CIN Integrated Cluster MKL KNN 7","GEA CIN Integrated Cluster MKL KNN 7","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_VOTING","GEA CIN Integrated Cluster Voting","GEA CIN Integrated Cluster Voting","STRING","SAMPLE"],["GEA_CIN_INTEGRATED_CLUSTER_CONSENSUS","GEA CIN Integrated Cluster Consensus","GEA CIN Integrated Cluster Consensus","STRING","SAMPLE"],["PROTEIN_CODING_RHOA","RHOA Protein Coding","RHOA Protein Coding","NUMBER","SAMPLE"],["CLINICAL_STATUS_AT_DIAGNOSIS","Clinical Status at Diagnosis","Clinical Status at Diagnosis","STRING","PATIENT"],["OVERALL_STAGE","Overall Stage","Overall Stage","STRING","SAMPLE"],["GENDER_CODE","Gender Code","Gender Code","NUMBER","PATIENT"],["NODAL_STATUS","Nodal Status","Nodal Status","STRING","SAMPLE"],["PROCEDURE_COMPLETE_RESECTION","Procedure Complete Resection","Procedure Complete Resection","STRING","SAMPLE"],["PATH_INVASION_DEPTH","Path Invasion Depth","Path Invasion Depth","STRING","SAMPLE"],["PATH_MULTIFOCAL","Path Multifocal","Path Multifocal","STRING","SAMPLE"],["PRIOR_CHEMO","Prior Chemotherapy","Prior Chemotherapy","STRING","SAMPLE"],["PRIOR_RADIATION_THERAPY","Prior Radiation Therapy","Prior Radiation Therapy","STRING","SAMPLE"],["PATH_WHO_TYPE","Path WHO Type ","Path WHO Type ","STRING","SAMPLE"],["PATH_WHO_TYPE_2","Path WHO Type 2 ","Path WHO Type 2 ","STRING","SAMPLE"],["PATH_GRADE","Path Grade","Path Grade","STRING","SAMPLE"],["ONCOSIGN_CLUSTER_2","Oncosign Cluster 2","Oncosign cluster 2","STRING","SAMPLE"],["RPA","RPA","Recursive Partitioning Analysis","STRING","PATIENT"],["ACGH_TUMOR_TYPE","aCGH Tumor Type","aCGH Tumor Type","STRING","SAMPLE"],["ONCOPANEL_TUMOR_TYPE","Oncopanel Tumor Type","Oncopanel Tumor Type","STRING","SAMPLE"],["TEMOZOLOMIDE_TREATMENT","Temozolomide Treatment","Temozolomide Treatment","STRING","PATIENT"],["FIRST_CYCLE_XRT","First Cycle XRT","First Cycle XRT","STRING","PATIENT"],["IHC_IDH1","IDH1 IHC Result","IDH1 IHC Result","STRING","SAMPLE"],["ONCOPANEL_STATUS","Oncopanel status","Oncopanel status","STRING","PATIENT"],["SURGICAL_MARGIN","Surgical Margin","Surgical Margin","STRING","PATIENT"],["PRIOR_SURGERY_YEAR","Previous Surgery Year","Previous Surgery Year","NUMBER","PATIENT"],["CANCER_DNA_FRACTION","Cancer DNA Fraction","Cancer DNA Fraction","STRING","SAMPLE"],["AMP_12Q15_DDIT3","AMP 12q15 DDIT3","AMP 12q15 DDIT3","STRING","SAMPLE"],["NEW_TUMOR_EVENT_DX_INDICATOR","New tumor event dx indicator","New tumor event dx indicator","STRING","PATIENT"],["RFS_STATUS","Relapse Free Status","Relapse Free Status","STRING","PATIENT"],["RFS_MONTHS","Relapse Free Status (Months)","Relapse Free Status (Months)","NUMBER","PATIENT"],["TREATMENT_OUTCOME_AT_TCGA_FOLLOWUP","treatment outcome at tcga followup","treatment outcome at tcga followup","STRING","PATIENT"],["DAYS_TO_NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","days to new tumor event after initial treatment ","days to new tumor event after initial treatment ","NUMBER","PATIENT"],["DAYS_TO_NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT_1","days to new tumor event after initial treatment 1","days to new tumor event after initial treatment 1","NUMBER","PATIENT"],["NEW_NEOPLASM_EVENT_TYPE_1","New Neoplasm Event Type 1","New Neoplasm Event Type 1","STRING","PATIENT"],["OVERALL_RESPONSE","Overall Response","Overall Response","STRING","PATIENT"],["FUHRMAN_GRADE","Fuhrman Grade","Fuhrman Grade","STRING","SAMPLE"],["PLEURODESIS_PERFORMED_PRIOR","Prior Pleurodesis Performed","Prior Pleurodesis Performed","STRING","PATIENT"],["IMMUNOTHERAPY_RESPONSE","Response to Immunotherapy","Response to Immunotherapy","STRING","PATIENT"],["NUM_EXTRANODAL_SITES","Number of Extranodal Sites of Disease","Number of Extranodal Sites of Disease","NUMBER","PATIENT"],["AE1_AE3_STAIN","AE1:AE3 Stain","AE1:AE3 Stain","STRING","SAMPLE"],["SAMPLE_DETAILED_SUBHISTOLOGIES","Sample Detailed Subhistologies","Sample Detailed Subhistologies","STRING","SAMPLE"],["PATIENT_DISPLAY_NAME","Patient Display Name","Patient Display Name","STRING","PATIENT"],["SAMPLE_DISPLAY_NAME","Sample Display Name","Sample Display Name","STRING","SAMPLE"],["DRIVER_MUTATIONS_DETAILED","Detailed Driver Mutations ","Detailed Driver Mutations ","STRING","SAMPLE"],["IMMUNOHISTOCHEMISTRY","Immunohistochemistry","Immunohistochemistry","STRING","SAMPLE"],["PDX_PARENT","PDX Parent","PDX Parent","STRING","SAMPLE"],["BASELINE_BIOPSY_SITE","Baseline Biopsy site","Baseline Biopsy site","STRING","SAMPLE"],["TREATMENT_STATUS","Treatment Status","Treatment status (pre or Post treatment sample)","STRING","SAMPLE"],["PRIMARY_TUMOR_LOCATION","Primary Tumor Location","Primary Tumor Location","STRING","SAMPLE"],["PROGRESSION_OF_DISEASE","Progression of Disease","Progression of Disease","STRING","PATIENT"],["HISTORY_ASBESTOS_EXPOSURE","History Asbestos Exposure","History Asbestos Exposure","STRING","PATIENT"],["ASBESTOS_EXPOSURE_TYPE","Asbestos Exposure Type","Asbestos Exposure Type","STRING","PATIENT"],["ASBESTOS_EXPOSURE_SOURCE","Asbestos Exposure Source","Asbestos Exposure Source","STRING","PATIENT"],["ASBESTOS_EXPOSURE_AGE","Asbestos Exposure Age","Asbestos Exposure Age","STRING","PATIENT"],["ASBESTOS_EXPOSURE_YEARS","Asbestos Exposure Years","Asbestos Exposure Years","STRING","PATIENT"],["ASBESTOS_EXPOSURE_AGE_LAST","Asbestos Exposure Age Last","Asbestos Exposure Age Last","STRING","PATIENT"],["FAMILY_HISTORY_CANCER_TYPE_OTHER","Family History Cancer Type Other","Family History Cancer Type Other","STRING","PATIENT"],["POSTOPERATIVE_RX_TX","Postoperative Radiation Treatment","Postoperative Radiation Treatment","STRING","PATIENT"],["S_100_STAIN","S-100 stain","S-100 Stain","STRING","SAMPLE"],["RAI_UPTAKE","RAI Uptake","RAI Uptake","STRING","PATIENT"],["MUTATION_BRUDEN","Mutation Burden","Mutation Burden","STRING","SAMPLE"],["TURIN","Turin","Turin","STRING","PATIENT"],["ACTIONABLE_ALT_LEVEL","Level of actionable alterations","Level of actionable alterations","STRING","SAMPLE"],["KNOWN_EXPOSURES","Known exposures","Known exposures","STRING","PATIENT"],["NEOADJ_TX_BEFORE_FIRST_SURGERY","Neoadj Systemic Treatment Before First Surgery","Neoadj Systemic Treatment Before First Surgery","STRING","PATIENT"],["PREOP_RT_BEFORE_FIRST_SURGERY","Preop RT before first surgery","Preop RT before first surgery","STRING","PATIENT"],["ADJ_TX_AFTER_FIRST_SURGERY","Adjuvant therapy after first surgery?","Adjuvant therapy after first surgery?","STRING","PATIENT"],["ADJ_RT_AFTER_FIRST_SURGERY","Adjuvant RT after first surgery?","Adjuvant RT after first surgery?","STRING","PATIENT"],["PROTOCOL_NUM","Protocol Number","Protocol Number","STRING","PATIENT"],["PRINCIPAL_SAMPLE","Principal Sample","Principal Sample","STRING","SAMPLE"],["WGD","WGD","WGD","STRING","SAMPLE"],["SUPERFICIAL_DX_HISTORY","Superficial Dx History","Superficial Dx History","STRING","SAMPLE"],["INITIAL_TNM_STAGE","Initial TNM Stage","Initial TNM Stage","STRING","SAMPLE"],["POST_TX_TNM_STAGE","PostTx TNM Stage","PostTx TNM Stage","STRING","SAMPLE"],["POST_TX_OVERALL_STAGE","PostTx Overall Stage","PostTx Overall Stage","STRING","SAMPLE"],["PURITY_PREDICTION_SCORE","Purity Prediction Score","Purity Prediction Score","NUMBER","SAMPLE"],["PLOIDY_PREDICTION_SCORE","Ploidy Prediction Score","Ploidy Prediction Score","NUMBER","SAMPLE"],["METASTASIS_OVARY","Ovary Metastasis","Ovary Metastasis","STRING","PATIENT"],["PLEURODESIS_PERFORMED_90_DAYS","Pleurodesis Performed in 90 Days","Pleurodesis Performed in 90 Days","STRING","PATIENT"],["OCCUPATION_PRIMARY_OTHER","Occupation Primary Other","Occupation Primary Other","STRING","PATIENT"],["SERUM_MESOTHELIN_PRIOR_TX","Laboratory procedure mesothelin prior treatment","Laboratory procedure mesothelin prior treatment","NUMBER","SAMPLE"],["SERUM_MESOTHELIN_LOWER_LIMIT","Laboratory procedure mesothelin result lower limit of normal value","Laboratory procedure mesothelin result lower limit of normal value","NUMBER","SAMPLE"],["SERUM_MESOTHELIN_UPPER_LIMIT","Laboratory procedure mesothelin result upper limit of normal value","Laboratory procedure mesothelin result upper limit of normal value","NUMBER","SAMPLE"],["CREATININE_PRIOR_TX","Laboratory procedure creatinine prior treatment","Laboratory procedure creatinine prior treatment","NUMBER","SAMPLE"],["SUV_OF_PLEURA_MAX","SUV of Pleura Max","SUV of Pleura Max","NUMBER","PATIENT"],["MESOTHELIOMA_DETECTION_METHOD","Mesothelioma Detection Method","Mesothelioma Detection Method","STRING","PATIENT"],["NTE_AFTER_INITIAL_TREATMENT","New Tumor Event After Initial Treatment","New Tumor Event After Initial Treatment","STRING","PATIENT"],["AGE_AT_INITIAL_PATHOLOGIC_DIAGNOSIS","Age At Initial Pathological Diagnosis","Age At Initial Pathological Diagnosis","NUMBER","PATIENT"],["BCR_PATIENT_BARCODE","BCR Patient Barcode","BCR Patient Barcode","STRING","PATIENT"],["IMMUNOTHERAPY_DURATION","Duration of Immunotherapy","Duration of Immunotherapy","STRING","PATIENT"],["TARGET_THERAPY","Target Therapy Recieved","Target Therapy Recieved","STRING","PATIENT"],["RESPONSE_TO_TARGET_THERAPY","Response to Target Therapy","Patient responded to target therapy","STRING","PATIENT"],["SORT_FILE_NUMBER","Sort File Number","Sort File Number","STRING","SAMPLE"],["THYROID_RELATED_DEATH","Thyroid Related Death","Thyroid Related Death","STRING","PATIENT"],["MITOSES_PER_10_HPF","Mitoses Per 10 HPF","Mitoses Per 10 HPF","NUMBER","SAMPLE"],["DISTANT_METS","Distant Metastasis","Distant Metastasis","STRING","SAMPLE"],["SITE_OF_DM","Site of DM","Site of DM","STRING","SAMPLE"],["DM_SITE_CODE","DM Site","DM Site","STRING","SAMPLE"],["M1_STATUS","M1 Status","M1 Status","STRING","SAMPLE"],["DM_AT_PRESENTATION","DM at Presentation","DM at Presentation","STRING","SAMPLE"],["INVADED_STRUCTURES","Invaded Structures","Invaded Structures","STRING","SAMPLE"],["HISTOLOGY_EPC_MULTICLASS","Histology EPC multiclass","Histology EPC multiclass","STRING","SAMPLE"],["HISTOLOGY_EPC_2CLASS","Histology EPC_2class","Histology EPC_2class","STRING","SAMPLE"],["HISTOLOGY_EPC_SEMINOMA","Histology EPC - Seminoma","Histology EPC - Seminoma","STRING","SAMPLE"],["HISTOLOGY_EPC_NON_SEMINOMA_YOLK_SAC_TUMOR","Histology EPC - Non-Seminoma; Yolk Sac Tumor","Histology EPC - Non-Seminoma; Yolk Sac Tumor","STRING","SAMPLE"],["HISTOLOGY_EPC_EMBRYONAL_CARCINOMA_NON_SEMINOMA","Histology_EPC - Embryonal carcinoma,Non-Seminoma","Histology_EPC - Embryonal carcinoma,Non-Seminoma","STRING","SAMPLE"],["HISTOLOGY_EPC_NON_SEMINOMA_CHORIOCARCINOMA","Histology_EPC - Non-Seminoma; Choriocarcinoma","Histology_EPC - Non-Seminoma; Choriocarcinoma","STRING","SAMPLE"],["HISTOLOGY_EPC_NON_SEMINOMA_TERATOMA_(IMMATURE)","Histology_EPC - Non-Seminoma; Teratoma (Immature)","Histology_EPC - Non-Seminoma; Teratoma (Immature)","STRING","SAMPLE"],["HISTOLOGY_EPC_NON_SEMINOMA_TERATOMA_(MATURE)","Histology_EPC - Non-Seminoma; Teratoma (Mature)","Histology_EPC - Non-Seminoma; Teratoma (Mature)","STRING","SAMPLE"],["LOCAL_RECCURENCE_OR_DISTANT_MET","Local reccurence or distant met","Local reccurence or distant met","STRING","PATIENT"],["NEW_PRIMARY_TESTIS_TUMOR","New Primary testis tumor","New Primary testis tumor","STRING","PATIENT"],["SECONDARY_PLATFORM","Secondary Platform","Secondary Platform","STRING","SAMPLE"],["LATERALITY_OF_UNDESCENT","Laterality of undescent","Laterality of undescent","STRING","SAMPLE"],["METHYLATION450","Methylation450","Methylation450","STRING","SAMPLE"],["SNP6","SNP6","SNP6","STRING","SAMPLE"],["MIRNASEQ","miRNAseq","miRNAseq","STRING","SAMPLE"],["RPPA","RPPA","RPPA","STRING","SAMPLE"],["EXOME","Exome","Exome","STRING","SAMPLE"],["MC2_VARIANT_CALLS","MC2 Variant Calls","MC2 Variant Calls","STRING","SAMPLE"],["POSSIBLE_DNA_CONTANMINATION","Possible DNA contanmination","Possible DNA contanmination","STRING","SAMPLE"],["INCLUDE","Include","Include","STRING","SAMPLE"],["PED_NCCN_LEVEL","PED NCCN Level","PED NCCN Level","STRING","SAMPLE"],["PED_DRIVER_MUTATION","PED Driver Mutation","PED Driver Mutation","STRING","SAMPLE"],["PED_SPECIMEN_TYPE","PED Speciment Type","PED Speciment Type","STRING","SAMPLE"],["PED_AGE","PED Age","PED Age","NUMBER","PATIENT"],["PED_SEX","PED Sex","PED Sex","STRING","PATIENT"],["PED_PRIMARY_SITE","PED Primary Site","PED Primary Site","STRING","SAMPLE"],["PED_STAGE","PED Stage","PED Stage","STRING","SAMPLE"],["PED_DISEASE_CATEGORY","PED Disease Category","PED Disease Category","STRING","SAMPLE"],["PEDS_CANCER_TYPE_DETAILED","PED Cancer Type Detailed","PED Cancer Type Detailed","STRING","SAMPLE"],["PEDIATRIC_SAMPLE","Pediatric Sample","Pediatric Sample","STRING","PATIENT"],["LATERALITY_OF_SECOND_PRIMARY_TUMOR","Laterality of Second Primary Tumor","Laterality of Second Primary Tumor","STRING","SAMPLE"],["SPINK1_HIGH","SPINK1 High","SPINK1 High","STRING","SAMPLE"],["SETD2_MUTATION","SETD2 Mutation","SETD2 Mutation","STRING","SAMPLE"],["RELIGION","Religion","Religion","STRING","PATIENT"],["CA_125","CA-125","CA-125","NUMBER","PATIENT"],["CHEMO_CYCLES","Chemotherapy Cycles","Chemotherapy Cycles","STRING","PATIENT"],["CLONAL_LABEL","Clonal Label","Clonal Label","STRING","SAMPLE"],["CDH1_STATUS","CDH1 Status","CDH1 Status","STRING","SAMPLE"],["DNA_REPAIR_STATUS","DNA Repair Status","DNA Repair Status","STRING","SAMPLE"],["PLEURA_STATUS","Pleura Status","Pleura Status","STRING","SAMPLE"],["TYPE_OF_SURGERY_2","Type of Surgery 2","Type of Surgery 2","STRING","SAMPLE"],["CHEMO_REGIMEN_CATEGORY","Chemo Regimen Category","Chemo Regimen Category","STRING","PATIENT"],["CHEMO_RESISTANT","Chemo Resistance","Chemo Resistance","STRING","PATIENT"],["TIME_TO_PROGRESSION_OF_DISEASE","Time to Progression of Disease (Months)","Time to Progression of Disease (Months)","NUMBER","PATIENT"],["TIME_TO_PROGRESSION_ON_FOLFOX_AND_REGORAFENIB","Time to progerssion on FOLFOX+ regorafenib","Time to progerssion on FOLFOX+ regorafenib","NUMBER","PATIENT"],["CENTER","Center of sequencing","Center of sequencing","STRING","PATIENT"],["BEST_ORR","Best objective response rate","Best objective response rate","STRING","PATIENT"],["ETOH","EtOH","EtOH","STRING","PATIENT"],["NASH","NASH","NASH","STRING","PATIENT"],["WHOLE_EXOME_SEQUENCING","Whole Exome Sequencing ","Whole Exome Sequencing ","STRING","SAMPLE"],["WHOLE_GENOME_SEQUENCING","Whole Genome Sequencing ","Whole Genome Sequencing ","STRING","SAMPLE"],["U133A","U133a","U133a","STRING","SAMPLE"],["HM450","HM450","HM450","STRING","SAMPLE"],["HM27","HM27","HM27","STRING","SAMPLE"],["MUTATION_COUNT","Mutation Count","Mutation Count","STRING","SAMPLE"],["PERCENT_ANEUPLOIDY","Percent aneuploidy","Percent aneuploidy","STRING","SAMPLE"],["SYSTEMIC_TREATMENT","Systemic Treatment","Systemic Treatment","STRING","PATIENT"],["IDH_STATUS","IDH status","IDH status","STRING","SAMPLE"],["IDH_CODEL_SUBTYPE","IDH/codel subtype","IDH/codel subtype","STRING","SAMPLE"],["MGMT_PROMOTER_STATUS","MGMT promoter status","MGMT promoter status","STRING","SAMPLE"],["CHR_7_GAIN_CHR_10_LOSS","Chr 7 gain/Chr 10 loss","Chr 7 gain/Chr 10 loss","STRING","SAMPLE"],["CHR_19_20_CO_GAIN","Chr 19/20 co-gain","Chr 19/20 co-gain","STRING","SAMPLE"],["TERT_PROMOTER_STATUS","TERT promoter status","TERT promoter status","STRING","SAMPLE"],["TERT_EXPRESSION_LOG2","TERT expression (log2)","TERT expression (log2)","STRING","SAMPLE"],["TERT_EXPRESSION_STATUS","TERT expression status","TERT expression status","STRING","SAMPLE"],["ATRX_STATUS","ATRX status","ATRX status","STRING","SAMPLE"],["DAXX_STATUS","DAXX status","DAXX status","STRING","SAMPLE"],["TELOMERE_MAINTENANCE","Telomere Maintenance","Telomere Maintenance","STRING","SAMPLE"],["BRAF_V600E_STATUS","BRAF V600E status","BRAF V600E status","STRING","SAMPLE"],["BRAF_KIAA1549_FUSION","BRAF-KIAA1549 fusion","BRAF-KIAA1549 fusion","STRING","SAMPLE"],["ESTIMATE_STROMAL_SCORE","ESTIMATE stromal score","ESTIMATE stromal score","STRING","SAMPLE"],["ESTIMATE_IMMUNE_SCORE","ESTIMATE immune score","ESTIMATE immune score","STRING","SAMPLE"],["ESTIMATE_COMBINED_SCORE","ESTIMATE combined score","ESTIMATE combined score","STRING","SAMPLE"],["ORIGINAL_SUBTYPE","Original Subtype","Original Subtype","STRING","SAMPLE"],["TRANSCRIPTOME_SUBTYPE","Transcriptome Subtype","Transcriptome Subtype","STRING","SAMPLE"],["PAN_GLIOMA_RNA_EXPRESSION_CLUSTER","Pan-Glioma RNA Expression Cluster","Pan-Glioma RNA Expression Cluster","STRING","SAMPLE"],["IDH_SPECIFIC_RNA_EXPRESSION_CLUSTER","IDH-specific RNA Expression Cluster","IDH-specific RNA Expression Cluster","STRING","SAMPLE"],["PAN_GLIOMA_DNA_METHYLATION_CLUSTER","Pan-Glioma DNA Methylation Cluster","Pan-Glioma DNA Methylation Cluster","STRING","SAMPLE"],["IDH_SPECIFIC_DNA_METHYLATION_CLUSTER","IDH-specific DNA Methylation Cluster","IDH-specific DNA Methylation Cluster","STRING","SAMPLE"],["SUPERVISED_DNA_METHYLATION_CLUSTER","Supervised DNA Methylation Cluster","Supervised DNA Methylation Cluster","STRING","SAMPLE"],["RANDOM_FOREST_STURM_CLUSTER","Random Forest Sturm Cluster","Random Forest Sturm Cluster","STRING","SAMPLE"],["TELOMERE_LENGTH_ESTIMATE_IN_BLOOD_NORMAL_KB","Telomere length estimate in blood normal (Kb)","Telomere length estimate in blood normal (Kb)","STRING","SAMPLE"],["TELOMERE_LENGTH_ESTIMATE_IN_TUMOR_KB","Telomere length estimate in tumor (Kb)","Telomere length estimate in tumor (Kb)","STRING","SAMPLE"],["POST_OP_RADIATION","Post-op Radiation","Post-operative Radiation Therapy","STRING","PATIENT"],["DISTANT_RECURRENCE_SITE","Distant Recurrence Site","Distant Recurrence Site","STRING","PATIENT"],["CLIN_T_STAGE_CODE","Clinical T Stage Code","Clinical T Stage Code","STRING","PATIENT"],["CLIN_N_STAGE_CODE","Clinical N Stage Code","Clinical N Stage Code","STRING","PATIENT"],["PATH_N_STATUS","Pathological N Status","Pathological N Status","STRING","PATIENT"],["MARGIN_CODE","Margin Code","Margin Code","STRING","PATIENT"],["CELL_TYPE","Cell Type","Cell Type","STRING","SAMPLE"],["DISEASE_STATUS","Disease Status","Disease Status","STRING","PATIENT"],["TOTAL_CELL_NUMBERS","Total Cell Numbers","Total Cell Numbers","NUMBER","SAMPLE"],["CELL_NUM_PER_VIAL","Cell Number Per Vial","Cell Number Per Vial","NUMBER","SAMPLE"],["TREATMENT_INTERVENTION","Treatment Intervention","Treatment Intervention","STRING","PATIENT"],["OTHER_SPECIFY_SECTION","Other Specify Section","Other Specify Section","STRING","PATIENT"],["CD33_PERCENTAGE","CD33%","CD33%","STRING","PATIENT"],["DAYS_TO_CELL_SURFACE_MARKER_TEST","Days To Cell Surface Marker Test","Days To Cell Surface Marker Test","NUMBER","PATIENT"],["NPM1_POSITIVE","Positive for NPM1","Positive for NPM1","STRING","SAMPLE"],["NPM1_NEGATIVE","Negative for NPM1","Negative for NPM1","STRING","SAMPLE"],["FLT3_POSITIVE","Positive for FLT3","Positive for FLT3","STRING","SAMPLE"],["FLT3_NEGATIVE","Negative for FLT3","Negative for FLT3","STRING","SAMPLE"],["KIT_POSITIVE","Positive for KIT","Positive for KIT","STRING","SAMPLE"],["KIT_NEGATIVE","Negative for KIT","Negative for KIT","STRING","SAMPLE"],["CEBPA_POSITIVE","Positive for CEBPA","Positive for CEBPA","STRING","SAMPLE"],["CEBPA_NEGATIVE","Negative for CEBPA","Negative for CEBPA","STRING","SAMPLE"],["SOURCE_TYPE","Source Type","Source type defines where the sample is coming from , ex: Blood, bone marrow . etc.","STRING","SAMPLE"],["CELL_TYPE","Cell Type","The type of specimen isolated from blood or bone marrow, ex: Plasma, PBMC, Granulocytes.","STRING","SAMPLE"],["SAMPLE_CATEGORY","Sample Category","Sample Category","STRING","SAMPLE"],["PATIENT_NOTE","Patient Note","Patient Note","STRING","PATIENT"],["CATEGORY_SAMPLE","Category of Sample","Category of Sample","STRING","SAMPLE"],["PRE_OR_POST_TX","Pre or Post Tx","Pre or Post Tx","STRING","SAMPLE"],["CYTOLOGICAL_PHENOTYPE","Cytological Phenotype","Cytological Phenotype","STRING","SAMPLE"],["GROWTH_PATTERN","Growth Pattern","Growth Pattern","STRING","SAMPLE"],["PDTC_DEFINITION","PDTC Definition","PDTC Definition","STRING","PATIENT"],["NUM_SNV_WITHOUT_SNP","Number of SNVs (Without SNPs)","Number of SNVs (Without SNPs)","NUMBER","SAMPLE"],["LYNCH","Lynch","Lynch","STRING","PATIENT"],["CHEMO_PRIOR_IMPACT","Chemotherapy prior MSK-IMPACT","Chemotherapy prior MSK-IMPACT","STRING","SAMPLE"],["METHYLATION_CLUSTER_K3","Methylation cluster K3","Methylation cluster K3","STRING","SAMPLE"],["MRNA_CLUSTER_K4","MRNA CLUSTER K4","MRNA CLUSTER K4","STRING","SAMPLE"],["MIRNA_CLUSTER_K3","MIRNA CLUSTER K3","MIRNA CLUSTER K3","STRING","SAMPLE"],["RPPA_CLUSTERS_K4","RPPA CLUSTERS K4","RPPA CLUSTERS K4","STRING","SAMPLE"],["SURGERY_SITE","Site of Surgery","Site of Surgery","STRING","SAMPLE"],["DATE_ADDED","Date added to cBioPortal","Date added to cBioPortal","STRING","SAMPLE"],["GEJ_CATEGORY_DICHOTOMIZED","GEJ Category Dichotomized","GEJ Category Dichotomized","STRING","SAMPLE"],["GEJ_CATEGORY_DICHOTOMIZED_GEA_CIN_SAMPLES","GEJ Category Dichotomized GEA-CIN samples","GEJ Category Dichotomized GEA-CIN samples","STRING","SAMPLE"],["STES_UNIQUE_ANATOMIC_SITE","STES Unique Anatomic Site","STES Unique Anatomic Site","STRING","SAMPLE"],["STES_UNIQUE_ANATOMIC_SITE_NUMERIC_CODING","STES Unique Anatomic Site - Numeric coding","STES Unique Anatomic Site - Numeric coding","STRING","SAMPLE"],["STES_UNIQUE_ANATOMIC_SITE_GEACIN_SAMPLES_NUMERIC_CODING","STES Unique Anatomic Site - GEA-CIN Samples - Numeric coding","STES Unique Anatomic Site - GEA-CIN Samples - Numeric coding","STRING","SAMPLE"],["STES_CIN_GS","STES CIN GS","STES CIN GS","STRING","SAMPLE"],["HISTOLOGICAL _TYPE _ ESOPHAGUS","Histological Type - Esophagus","Histological Type - Esophagus","STRING","SAMPLE"],["ESOPHAGEAL _TUMOR _LOCATION _EPC","Esophageal tumor location epc","Esophageal tumor location epc","STRING","SAMPLE"],["TISSUE _LEVEL _ANATOMIC _SITE","Tissue-level Anatomic Site","Tissue-level Anatomic Site","STRING","SAMPLE"],["DAYS _FROM _SURGERY _TO _DEATH","Days from surgery to death","Days from surgery to death","STRING","PATIENT"],["E _CIMP","E-CIMP","E-CIMP","STRING","SAMPLE"],["BAIT_VERSION","Bait Version","Bait Version","STRING","SAMPLE"],["NEPC_SCORE","NEPC Score","NEPC Score","NUMBER","SAMPLE"],["AR_VALUE","AR Value","AR Value","STRING","SAMPLE"],["IHC_AR","AR IHC","AR IHC","STRING","SAMPLE"],["FISH_AR","FISH AR","FISH AR","STRING","SAMPLE"],["CGA_IHC","CGA IHC","CGA IHC","STRING","SAMPLE"],["PATHOLOGY_CLASSIFICATION","Pathology Classification","Pathology Classification","STRING","SAMPLE"],["GENOMIC_BURDEN","Genomic Burden","Genomic Burden","STRING","SAMPLE"],["CLONET_STATUS","CLONET STATUS","CLONET STATUS","STRING","SAMPLE"],["ERG_IHC","ERG IHC","ERG IHC","STRING","SAMPLE"],["ERG_FUSION_RNASEQ","ERG FUSION RNASEQ","ERG FUSION RNASEQ","STRING","SAMPLE"],["ERG_NANOSTRING","ERG NANOSTRING","ERG NANOSTRING","STRING","SAMPLE"],["PTEN_FISH","PTEN FISH","PTEN FISH","STRING","SAMPLE"],["MYCN_FISH","MYCN FISH","MYCN FISH","STRING","SAMPLE"],["AURKA_FISH","AURKA FISH","AURKA FISH","STRING","SAMPLE"],["SYN_IHC","SYN IHC","SYN IHC","STRING","SAMPLE"],["SAMPLE_RNA_ID","Sample RNA ID","Sample RNA ID","STRING","SAMPLE"],["SAMPLE_METH_ID","Sample METH ID","Sample METH ID","STRING","SAMPLE"],["SAMPLE_COLLECTION_METHOD","Sample Collection Method","Sample Collection Method","STRING","SAMPLE"],["ETIOLOGY","Etiology","Etiology","STRING","PATIENT"],["BCLC_STAGE","BCLC Stage","BCLC Stage","STRING","PATIENT"],["SERUM_ALPHA_FOETO_PROTEIN","Serum Alpha Foeto Protein (ng/ml)","Serum Alpha Foeto Protein (ng/ml)","STRING","PATIENT"],["PUBMED_ID","Pubmed ID","Pubmed ID","STRING","PATIENT"],["ORAL_CONTRACEPTION","Oral Contraception ","Oral Contraception ","STRING","PATIENT"],["ASSOCIATED_GENETIC_METABOLIC_DISEASE","Associated Genetic Metabolic Diseases","Associated Genetic Metabolic Diseases","STRING","PATIENT"],["NODULE_NUMBER","Number of Nodules","Number of Nodules","STRING","PATIENT"],["NODULE_SIZE","Nodule Size (mm)","Nodule Size (mm)","NUMBER","SAMPLE"],["TUMOR_GRADE","Tumor Grade","Histologic grading criteria for adenoid cystic carcinoma (Szanto, et. al, 1984)","STRING","PATIENT"],["GENOMIC_ALTERATIONS","Genomic Alterations","Number of genomic alterations","NUMBER","PATIENT"],["ACTIONABLE_ALTERATIONS","Actionable Alterations","Number of actionable alterations","NUMBER","PATIENT"],["MYB_ACTIVATION","MYB Activation","Presence of MYB activation","STRING","PATIENT"],["MYB_VALIDATION","MYB Validation Method","Method used for validating MYB activation","STRING","PATIENT"],["FOLLOWUP_YEARS","Followup (years)","Followup in years","NUMBER","PATIENT"],["LOCAL_REGIONAL_RECURENCE","Local-regional Recurrence","Positive or negative for local-regional recurrence","STRING","PATIENT"],["SOURCE_OF_RECURRENCE_TISSUE","Source of Recurrence Tissue","Source of Recurrence Tissue","STRING","PATIENT"],["INTCLUST","Integrative Cluster","Integrative Cluster","STRING","PATIENT"],["AGE_AT_DIAGNOSIS","Age at Diagnosis","Age at Diagnosis","NUMBER","PATIENT"],["NPI","Nottingham prognostic index","Nottingham prognostic index","NUMBER","PATIENT"],["INFERRED_MENOPAUSAL_STATE","Inferred Menopausal State","Inferred Menopausal State","STRING","PATIENT"],["BREAST_SURGERY","Type of Breast Surgery","Type of Breast Surgery","STRING","PATIENT"],["CELLULARITY","Cellularity","Tumor Content","STRING","PATIENT"],["HER2_SNP6","HER2 status measured by SNP6","HER2 status measured by SNP6","STRING","PATIENT"],["THREEGENE","3-Gene classifier subtype","3-Gene classifier subtype","STRING","PATIENT"],["HER2_EXPR","HER2 status measured by expression","HER2 status measured by expression","STRING","PATIENT"],["PR_EXPR","PR status measured by expression","PR status measured by expression","STRING","PATIENT"],["CLAUDIN_SUBTYPE","Pam50 + Claudin-low subtype","Pam50 + Claudin-low subtype","STRING","PATIENT"],["HORMONE_THERAPY","Hormone Therapy","Hormone Therapy","STRING","PATIENT"],["RADIO_THERAPY","Radio Therapy","Radio Therapy","STRING","PATIENT"],["ER_IHC","ER status measured by IHC","ER status measured by IHC","STRING","PATIENT"],["ER_EXPR","ER status measured by expression","ER status measured by expression","STRING","PATIENT"],["CONTROL_SITE","Control Site","Control Site","STRING","SAMPLE"],["ABS_NEUTROPHIL_VALUE","Abs Neutrophil Value","Abs Neutrophil Value","STRING","PATIENT"],["TRANSLOCATION_DEL_CHR_11","Chr11 Deletion or Translocation","Any translocation or deletion of chromosome 11","STRING","SAMPLE"],["DEL_17q13","del(17p13) = loss of p53","del(17p13) = loss of p53","STRING","SAMPLE"],["NUMBER_OF_PRIMARY_SITES","Number of Primary Sites","Number of Primary Sites","STRING","PATIENT"],["SITES_IN_COLON","Sites In Colon","Sites In Colon","STRING","PATIENT"],["SPECIAL_HISTOLOGY","Special Histology","Special Histology","STRING","PATIENT"],["PRE_EXISTING_POLYP","Pre-existing Polyp","Pre-existing Polyp","STRING","PATIENT"],["IBD","IBD","IBD","STRING","PATIENT"],["DURATION_OF_IBD_AT_DIAGNOSIS","Duration of IBD at Diagnosis","Duration of IBD at Diagnosis","STRING","PATIENT"],["SPECIMEN","Specimen","Specimen","STRING","SAMPLE"],["EXP","EXP","EXP","STRING","SAMPLE"],["CGH","CGH","CGH","STRING","SAMPLE"],["SEQCAP_EZ_EXOME_VERSION","SEQCAP EZ EXOME VERSION","SEQCAP EZ EXOME VERSION","STRING","SAMPLE"],["NUM_SAMPLES_CAPTURE_MULTIPLEX","NUM SAMPLES CAPTURE MULTIPLEX","NUM SAMPLES CAPTURE MULTIPLEX","STRING","SAMPLE"],["CGH_SAMPLE_ID","CGH Sample ID","CGH Sample ID","STRING","SAMPLE"],["EXP_SAMPLE_ID","EXP Sample ID","EXP Sample ID","STRING","SAMPLE"],["EXOME_SAMPLE_ID","EXOME Sample ID","EXOME Sample ID","STRING","SAMPLE"],["SYSTEM_VERSION","System Version","System Version","STRING","PATIENT"],["INIT_PATHOLOGY_DX_METHOD_OTHER","Init Pathology Dx Method Other","Init Pathology Dx Method Other","STRING","SAMPLE"],["HISTOLOGY_OF_NEW_TUMOR_EVENT","Histology Of New Tumor Event","Histology Of New Tumor Event","STRING","SAMPLE"],["ADDITIONAL_SURGERY_FOR_NEW_TUMOR_EVENT","Additional Surgery For New Tumor Event","Additional Surgery For New Tumor Event","STRING","SAMPLE"],["ADDITIONAL_TREATMENT_FOR_NEW_TUMOR_EVENT_RADIATION","Additional Treatment For New Tumor Event: Radiation","Additional Treatment For New Tumor Event: Radiation","STRING","PATIENT"],["ADDITIONAL_TREATMENT_FOR_NEW_TUMOR_EVENT_PHARMACEUTICAL","Additional Treatment For New Tumor Event: Pharmaceutical","Additional Treatment For New Tumor Event: Pharmaceutical","STRING","PATIENT"],["STAGE_OTHER","Stage Other","Stage Other","STRING","PATIENT"],["NUMBER_VIAL","Vial Number","Vial Number","STRING","SAMPLE"],["ID_SAMPLE_TYPE","Sample Type ID","Sample Type ID","STRING","SAMPLE"],["11q23_REARRANGEMENT","11q23 Rearrangement = MLL rearrangement","11q23 Rearrangement = MLL rearrangement","STRING","SAMPLE"],["14Q32_REARRANGEMENT","14q32 Rearrangement = IGH ","14q32 Rearrangement = IGH ","STRING","SAMPLE"],["1P_AMPLIFICATION","1p Amplification","1p Amplification","STRING","SAMPLE"],["1Q_AMPLIFICATION","1q Amplification","1q Amplification","STRING","SAMPLE"],["2P23_REARRANGEMENT","2p23 Rearrangement = ALK","2p23 Rearrangement = ALK","STRING","SAMPLE"],["3P27_REARRANGEMENT","3p27 Rearrangement = BCL6","3p27 Rearrangement = BCL6","STRING","SAMPLE"],["BCR_ABL(P190)_NEGATIVE","Negative for BCR-ABL(p190)","Negative for BCR-ABL(p190)","STRING","SAMPLE"],["BCR_ABL(P190)_POSITIVE","Positive for BCR-ABL(p190)","Positive for BCR-ABL(p190)","STRING","SAMPLE"],["BCR_ABL(P210)_NEGATIVE","Negative for BCL-ABL(p210)","Negative for BCL-ABL(p210)","STRING","SAMPLE"],["BCR_ABL(P210)_POSITIVE","Positive for BCL-ABL(p210)","Positive for BCL-ABL(p210)","STRING","SAMPLE"],["CD19_PERCENTAGE","CD19 %","CD19 %","STRING","PATIENT"],["CD38_PERCENTAGE","CD38 %","CD38 %","STRING","PATIENT"],["CD45_NEGATIVE","CD45 Negative","CD45 Negative","STRING","PATIENT"],["CD5_PERCENTAGE","CD5 %","CD5 %","STRING","PATIENT"],["CD56_POSITIVE","CD56 Positive","CD56 Positive","STRING","PATIENT"],["DEL_11Q","del(11q), ATM","del(11q), ATM","STRING","SAMPLE"],["DEL_12p13","del(12p13)","del(12p13)","STRING","SAMPLE"],["DEL_13Q","del(13q)","del(13q)","STRING","SAMPLE"],["DEL_13Q14","del(13q14) = ETV6 gene","del(13q14) = ETV6 gene","STRING","SAMPLE"],["DEL_16Q","del(16q)","del(16q)","STRING","SAMPLE"],["DEL_1Q","del(1q)","del(1q)","STRING","SAMPLE"],["DEL_20Q","del(20q)","del(20q)","STRING","SAMPLE"],["DEL_4Q12","del(4q12)","del(4q12)","STRING","SAMPLE"],["DEL_6Q","del(6q)","del(6q)","STRING","SAMPLE"],["DEL_7","del(7)","del(7)","STRING","SAMPLE"],["HYPODIPLOID","Hypodiploid","Hypodiploid","STRING","SAMPLE"],["IGH_GENE","IgH Gene","IgH Gene","STRING","SAMPLE"],["IGH_TRANSLOCATIONS","IgH Translocations","IgH Translocations","STRING","SAMPLE"],["IGHV_MUTATED","IGHV Mutated","IGHV Mutated","STRING","SAMPLE"],["IGHV_UNMUTATED","IGHV Unmutated","IGHV Unmutated","STRING","SAMPLE"],["IGHV_IDENTITY","IGHV Identity (%)","IGHV Identity (%)","NUMBER","SAMPLE"],["IGHV_GENE","IGHV Gene","IGHV Gene","STRING","SAMPLE"],["JAK2_NEGATIVE","JAK2 Negative","JAK2 Negative","STRING","SAMPLE"],["JAK2_POSITIVE","JAK2 Positive ","JAK2 Positive","STRING","SAMPLE"],["KAPPA_OR_LAMBDA","Kappa or Lambda","Kappa or Lambda","STRING","SAMPLE"],["MLL_MULTIPLE_COPIES","MLL Multiple Copies","MLL Multiple Copies","STRING","SAMPLE"],["MPL_EVIDENCE","Evidence of or Not of MPL(W515 or S505)","Evidence of or Not of MPL(W515 or S505)","STRING","SAMPLE"],["PLASMA_SERIES_VALUE","Plasma Series Value","Plasma Series Value","STRING","PATIENT"],["t(1;19)","t(1;19)","t(1;19)","STRING","SAMPLE"],["t(10;19)","t(10;19)","t(10;19)","STRING","SAMPLE"],["t(11;14)","t(11;14)","t(11;14)","STRING","SAMPLE"],["t(11;18)","t(11;18)","t(11;18)","STRING","SAMPLE"],["t(11;23)","t(11;23)","t(11;23)","STRING","SAMPLE"],["t(12;2)","t(12;2)","t(12;2)","STRING","SAMPLE"],["t(14;16)","t(14;16)","t(14;16)","STRING","SAMPLE"],["t(14;18)","t(14;18)","t(14;18)","STRING","SAMPLE"],["t(3q27)","t(3q27)","t(3q27)","STRING","SAMPLE"],["t(4;11)","t(4;11)","t(4;11)","STRING","SAMPLE"],["t(4;14)","t(4;14)","t(4;14)","STRING","SAMPLE"],["t(5;12)","t(5;12)","t(5;12)","STRING","SAMPLE"],["t(5;14)","t(5;14)","t(5;14)","STRING","SAMPLE"],["t(6;14)","t(6;14)","t(6;14)","STRING","SAMPLE"],["t(8;14)","t(8;14)","t(8;14)","STRING","SAMPLE"],["t(9;14)","t(9;14)","t(9;14)","STRING","SAMPLE"],["t(9;22)","t(9;22) = Ph+","t(9;22) = Ph+","STRING","SAMPLE"],["TCR_GAMMA_BETA","TCR Gamma or Beta (TCRB or TCRG)","TCR Gamma or Beta (TCRB or TCRG)","STRING","SAMPLE"],["TCR_GENE_REARRANGEMENT","TCR Gene Rearrangement ","TCR Gene Rearrangement ","STRING","SAMPLE"],["TRISOMY_11","Trisomy 11","Trisomy 11","STRING","SAMPLE"],["TRISOMY_12","Trisomy 12","Trisomy 12","STRING","SAMPLE"],["TRISOMY_3","Trisomy 3","Trisomy 3","STRING","SAMPLE"],["TRISOMY_9","Trisomy 9","Trisomy 9","STRING","SAMPLE"],["ZAP70_TEST","ZAP70","ZAP70","STRING","SAMPLE"],["LAST_FOLLOWUP_STATUS","Last Followup Status","Last Followup Status","STRING","PATIENT"],["HER2_NOTES","HER2 Notes","HER2 Notes","STRING","SAMPLE"],["TIME_TO_PATH_MONTHS","Time to Path Months","Time to Path Months","STRING","PATIENT"],["IMPACT_NOTES","IMPACT Notes","IMPACT Notes","STRING","SAMPLE"],["SITE_OF_RADIATION_THERAPY","Radiation Therapy Site","Radiation Therapy Site","STRING","SAMPLE"],["SYSTEMIC_TREATMENTS_OTHER","Systemic Treatments Other","Systemic Treatments Other","STRING","PATIENT"],["POST_SURGERY_PREVENTATIVE_THERAPY","Post Surgery Preventative Therapy","Post Surgery Preventative Therapy","STRING","PATIENT"],["NON_STANDARD_ADJUVANT","Non-Standard Adjuvant","Non-Standard Adjuvant","STRING","PATIENT"],["OUTSIDE_SURGICAL_PROCEDURES","Outside Surgical Procedures","Outside Surgical Procedures","STRING","PATIENT"],["MIBC_OR_NON_MIBC","Bladder MIBC Or Non-MIBC","Bladder MIBC Or Non-MIBC","STRING","SAMPLE"],["BLADDER_MIBC_OR_NON_MIBC","Bladder MIBC Or Non-MIBC","Bladder MIBC Or Non-MIBC","STRING","SAMPLE"],["BLADDER_GROUP_GRADE","Bladder Group Grade","Bladder Group Grade","STRING","SAMPLE"],["BLADDER_GROUP_STAGE","Bladder Group Stage","Bladder Group Stage","STRING","SAMPLE"],["BLADDER_GROUP_NODE_STAGE","Bladder Group Node Stage","Bladder Group Node Stage","STRING","SAMPLE"],["BLADDER_GROUP_METASTASIS_STAGE","Bladder Group Metastasis Stage","Bladder Group Metastasis Stage","STRING","SAMPLE"],["BLADDER_MIBC_NO_CHEMO_PROGRESSIVE","Bladder MIBC No Chemo Progressive","Bladder MIBC No Chemo Progressive","STRING","SAMPLE"],["BLADDER_MIBC_PROGRESSIVE","Bladder MIBC Progressivemibc","Bladder MIBC Progressivemibc","STRING","SAMPLE"],["BLADDER_MIBC_PRIOR_INTRAVESICAL_CHEMOTHERAPY","Bladder MIBC Prior Intravesical Chemotherapy","Bladder MIBC Prior Intravesical Chemotherapy","STRING","SAMPLE"],["BLADDER_MIBC_NO_CHEMO_PROGRESSIVEPRIOR_BCG","Bladder MIBC No Chemo Progressiveprior Bcg","Bladder MIBC No Chemo Progressiveprior Bcg","STRING","SAMPLE"],["BLADDER_MIBC_SPECIMEN_CHEMOTHERAPY_STATUS","Bladder MIBC Specimen Chemotherapy Status","Bladder MIBC Specimen Chemotherapy Status","STRING","SAMPLE"],["BLADDER_MIBC_CHEMO_TYPE","Bladder MIBC Chemo Type","Bladder MIBC Chemo Type","STRING","SAMPLE"],["BLADDER_NMIBC_GROUP","Bladder NMIBC Group","Bladder NMIBC Group","STRING","SAMPLE"],["BLADDER_NMIBC_CIS","Bladder NMIBC Cis","Bladder NMIBC Cis","STRING","SAMPLE"],["BLADDER_NMIBC_TUMOR_NUMBER","Bladder NMIBC Tumor Number","Bladder NMIBC Tumor Number","STRING","SAMPLE"],["BLADDER_NMIBC_ESTIMATED_TUMOR_SIZE","Bladder NMIBC Estimated Tumor Size","Bladder NMIBC Estimated Tumor Size","STRING","SAMPLE"],["BLADDER_NMIBC_ADJUVANT_MITOMYCIN","Bladder NMIBC Adjuvant Mitomycin","Bladder NMIBC Adjuvant Mitomycin","STRING","SAMPLE"],["BLADDER_NMIBC_ADJUVANT_BCG","Bladder NMIBC Adjuvant Bcg","Bladder NMIBC Adjuvant Bcg","STRING","SAMPLE"],["BLADDER_NMIBC_RECURRENCE","Bladder NMIBC Recurrence","Bladder NMIBC Recurrence","STRING","SAMPLE"],["BLADDER_NMIBC_TIME_TO_RECURRENCE","Bladder NMIBC Time To Recurrence","Bladder NMIBC Time To Recurrence","NUMBER","SAMPLE"],["BLADDER_NMIBC_NED_AT_24_MONTHS","Bladder NMIBC Ned At 24 Months","Bladder NMIBC Ned At 24 Months","STRING","SAMPLE"],["BLADDER_NMIBC_HIGH_GRADE_RECURRENCE","Bladder NMIBC High Grade Recurrence","Bladder NMIBC High Grade Recurrence","STRING","SAMPLE"],["BLADDER_NMIBC_HIGH_GRADE_RECURR_TIME","Bladder NMIBC High Grade Recurrence Time","Bladder NMIBC High Grade Recurrence Time","NUMBER","SAMPLE"],["BLADDER_NMIBC_HIGH_GRADE_NED_AT_24_MONTHS","Bladder NMIBC High Grade Ned At 24 Months","Bladder NMIBC High Grade Ned At 24 Months","STRING","SAMPLE"],["BLADDER_NMIBC_CYSTO_FUPTIME","Bladder NMIBC Cysto Followup Time","Bladder NMIBC Cysto Followup Time","NUMBER","SAMPLE"],["BLADDER_NMIBC_TCGA_SMOKING_CATEGORY","Bladder NMIBC Tcga Smoking Category","Bladder NMIBC Tcga Smoking Category","STRING","SAMPLE"],["HIGHEST_ACTIONABLE_LEVEL","Highest actionable level","Highest actionable level","STRING","SAMPLE"],["TARGET_THERAPY_NAME","Target Therapy name","Target Therapy name","STRING","SAMPLE"],["METASTATIC_STAGE","MET Stage","MET Stage","STRING","SAMPLE"],["TIME_TO_RECURRENCE_AFTER_COMPLERE_RESECTION_OF_METS_MONTHS","Time to recurrence after complere resection of mets (months)","Time to recurrence after complere resection of mets (months)","NUMBER","SAMPLE"],["SURGERY_MET","Surgery Met","Surgery Met","STRING","SAMPLE"],["MORPHOLOGY","Morphology","Morphology","STRING","SAMPLE"],["HARVEST_DATE","Harvest Date","Harvest Date","STRING","SAMPLE"],["PASSAGE_NUMBER","Passage Number","Passage Number","STRING","SAMPLE"],["MEDIA","Media","Media","STRING","SAMPLE"],["METHOD_NUCLEIC_ACID_DELIVERY","Method Nucleic Acid Delivery","Method Nucleic Acid Delivery","STRING","SAMPLE"],["MYCOPLASMA_TESTED","Mycoplasma Tested","Mycoplasma Tested","STRING","SAMPLE"],["STR_TESTED","STR Tested","STR Tested","STRING","SAMPLE"],["SOURCE_LAB","Source Lab","Source Lab","STRING","SAMPLE"],["CELL_LINE_SOURCE","Cell Line Source","Cell Line Source","STRING","SAMPLE"],["CELL_LINE_ORIGIN","Cell Line Origin","Cell Line Origin","STRING","SAMPLE"],["PPP2R1A_MUTATION","PPP2R1A Mutation","PPP2R1A Mutation","STRING","SAMPLE"],["ONCOTREE_CODE","Oncotree Code","Oncotree Code","STRING","SAMPLE"],["CONSOLIDATION","Consolidation","Consolidation","STRING","PATIENT"],["HBV_CONSENSUS","HBV CONSENSUS","HBV CONSENSUS","STRING","SAMPLE"],["HCV_CONSENSUS","HCV CONSENSUS","HCV CONSENSUS","STRING","SAMPLE"],["HEPATITIS_B_POSITIVE_CUTOFF_RPM_+1_>_2","HEPATITIS B POSITIVE CUTOFF RPM +1 > 2","HEPATITIS B POSITIVE CUTOFF RPM +1 > 2","STRING","SAMPLE"],["HEPATITIS_C_POSITIVE_CUTOFF_RPM_+1_>_2","HEPATITIS C POSITIVE CUTOFF RPM +1 > 2","HEPATITIS C POSITIVE CUTOFF RPM +1 > 2","STRING","SAMPLE"],["TSS_NAME","TSS NAME","TSS NAME","STRING","SAMPLE"],["AA_DNA_MUTATION_SIGNATURE","AA DNA MUTATION SIGNATURE","AA DNA MUTATION SIGNATURE","STRING","SAMPLE"],["EXCESSIVE_FRAME-SHIFT_DELETIONS","EXCESSIVE FRAME-SHIFT DELETIONS","EXCESSIVE FRAME-SHIFT DELETIONS","STRING","SAMPLE"],["AFB1_SIGNATURE_NORMALIZED","AFB1 SIGNATURE NORMALIZED","AFB1 SIGNATURE NORMALIZED","STRING","SAMPLE"],["RESIDUAL_SIGNATURE_NORMALIZED","RESIDUAL SIGNATURE NORMALIZED","RESIDUAL SIGNATURE NORMALIZED","STRING","SAMPLE"],["AA_SIGNATURE_NORMALIZED","AA SIGNATURE NORMALIZED","AA SIGNATURE NORMALIZED","STRING","SAMPLE"],["AFB1_SIGNATURE_NON_NORMALIZED","AFB1 SIGNATURE NON NORMALIZED","AFB1 SIGNATURE NON NORMALIZED","STRING","SAMPLE"],["RESIDUAL_SIGNATURE_NON_NORMALIZED","RESIDUAL SIGNATURE NON NORMALIZED","RESIDUAL SIGNATURE NON NORMALIZED","STRING","SAMPLE"],["AA_SIGNATURE_NON_NORMALIZED","AA SIGNATURE NON NORMALIZED","AA SIGNATURE NON NORMALIZED","STRING","SAMPLE"],["SIGNATURE_C","SIGNATURE C","SIGNATURE C","STRING","SAMPLE"],["SIGNATURE_A","SIGNATURE A","SIGNATURE A","STRING","SAMPLE"],["SIGNATURE_B","SIGNATURE B","SIGNATURE B","STRING","SAMPLE"],["SIGNATUREA","SIGNATUREA","SIGNATUREA","STRING","SAMPLE"],["SIGNATUREC","SIGNATUREC","SIGNATUREC","STRING","SAMPLE"],["SIGNATURED","SIGNATURED","SIGNATURED","STRING","SAMPLE"],["SIGNATUREB","SIGNATUREB","SIGNATUREB","STRING","SAMPLE"],["SIGNATUREE","SIGNATUREE","SIGNATUREE","STRING","SAMPLE"],["SIGNATUREF","SIGNATUREF","SIGNATUREF","STRING","SAMPLE"],["MYB_MYBL1_REARRANGEMENT","MYB or MYBL1 Gene Rearrangement","Description of MYB or MYBL1 gene rearrangement(s) identified by RT-PCR/qPCR.","STRING","SAMPLE"],["MYB_NFIB_NONSYNONYMOUS_COUNT","MYB-NFIB Fusion Gene Non-synonymous Mutations","Count of non-synonymous mutations in MYB-NFIB Fusion Gene ","STRING","SAMPLE"],["MYB_NFIB_CNA","MYB-NFIB Fusion Gene Copy Number Alterations","MYB-NFIB Fusion Gene Copy Number Alterations","STRING","SAMPLE"],["LOSS_OF_HER2","Loss of HER2","Loss of HER2","STRING","SAMPLE"],["TIME_FROM_DX_TO_IMPACT_TESTING_MONTHS","Time from Dx to IMPACT testing (in months)","Time from Dx to IMPACT testing (in months)","STRING","SAMPLE"],["TIME_FROM_OBTAINING_SAMPLE_TO_RUNNING_IMPACT_MONTHS","Time from obtaining sample to running IMPACT (in months)","Time from obtaining sample to running IMPACT (in months)","STRING","SAMPLE"],["IMPACT_PRE_POST","IMPACT pre/post","IMPACT pre/post","STRING","SAMPLE"],["MATCHED_PRE_POST","Matched pre/post (Y/N)","Matched pre/post (Y/N)","STRING","SAMPLE"],["COLON_POLYPS_PRESENT","Colon Polyps Present","Indicator to determine whether colon polyps are present.","STRING","SAMPLE"],["HISTORY_PHEO_OR_PARA_ANATOMIC_SITE","Prior History Pheochromocytoma Or Paraganglioma Anatomic Site Text","Text field to describe the anatomic site of the prior pheochromocytoma or paraganglioma.","STRING","PATIENT"],["DIABETES_DIAGNOSIS_DAYS_TO","Diabetes Onset Less Initial Pathologic Diagnosis Date Calculated Day Value","The number of days from the date the patient was diagnosed with cancer to the date of the patient's diagnosis of diabetes.","STRING","PATIENT"],["INVASIVE_ADENOCARCINOMA_INDICATOR","Invasive Adenocarcinoma Histology Diagnosis Indicator","Text term to indicate a histologic diagnosis of invasive adenocarcinoma in a tissue specimen.","STRING","SAMPLE"],["RELATED_TUMORS_OUTSIDE_ADRENAL_GLANDS","Tumor Specimen Outside Adrenal Gland Quantity Description Type","Text term to describe any tumor related to the specimen that is outside of the adrenal glands.","STRING","SAMPLE"],["DISEASE_DETECTED_ON_SCREENING","Screening Diagnosis Disease Detection Indicator","Indicator to signify whether or not the disease was detected by screening.","STRING","PATIENT"],["CANCER_TYPE_ACRONYM","TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING","PATIENT"],["PRIMARY_THYROID_NEOPLASM_SITE","Primary Thyroid Neoplasm Site","Text field to describe the anatomic site of a primary thyroid neoplasm.","STRING","SAMPLE"],["LEIOMYOSARCOMA_HISTOLOGIC_SUBTYPE","Leiomyosarcoma Histologic Subtype","Text field to describe the subtype of leiomyosarcoma.","STRING","SAMPLE"],["HISTORY_CHRONIC_PANCREATITIS_DAYS_TO","Chronic Pancreatitis Diagnosis Less Initial Pathologic Diagnosis Date Calculated Day Value","The number of days from the date the patient was diagnosed with cancer to the date of the patient's diagnosis of clinical chronic pancreatitis.","NUMBER","PATIENT"],["CT_SCAN_PERFORMED","CT Scan Performed","Yes/No indicator to determine whether a CT scan was performed. ","STRING","PATIENT"],["HISTOLOGICAL_TYPE_OTHER","Histological Type Details","Text field to describe the tumor histological type (cancer type).","STRING","SAMPLE"],["DIABETES_DIAGNOSIS_INDICATOR","Participant Personal Medical History Diabetes Mellitus Ind-3","Participant medical history -diabetes mellitus: a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._A term that is used to indicate a question with permissible values of yes/no/unknown.","STRING","PATIENT"],["PREOP_PRETREAT_CEA_LEVEL","Pre-Operative/Pre-Treatment CEA Level","The carcinoembryonic antigen (CEA) test measures the level of CEA in the blood. CEA is a protein normally found in the tissue of a developing baby in the womb. The blood level of this protein disappears or becomes very low after birth. In adults, an abnormal level of CEA may be a sign of cancer.","NUMBER","PATIENT"],["HISTORY_CHRONIC_PANCREATITIS","Chronic Pancreatitis Personal Medical History Indicator","Indicator to signify whether or not the patient has a history of clinical chronic pancreatitis.","STRING","PATIENT"],["HISTORY_PHEO_OR_PARA_INCLUDE_BENIGN","Patient History Pheochromocytoma Or Paraganglioma Indicator","Indicator to signify whether or not a patient has a history of pheochromocytoma or paraganglioma.","STRING","PATIENT"],["MAINT_THERAPY_COURSE_COMPLETE","Maintenance Therapy Course Completion","Text field indicating for which cancer maintenance therapy was completed.","STRING","PATIENT"],["JEWISH_RELIGION_HERITAGE_INDICATOR","Patient Jewish Heritage Text Category","Text names for Jewish heritage categories for a patient/participant on a clinical trial.","STRING","PATIENT"],["SYNCHRONOUS_COLON_CANCER_PRESENT","Synchronous Colon Cancer Present","Yes/No indicator to determine presence or absence of synchronous colon cancer. ","STRING","SAMPLE"],["FEMALE_BREAST_FEEDING_OR_PREGNANCY_STATUS_INDICATOR","Female Breast Feeding or Pregnancy Status Indicator","Yes/No indicator to determine if female is breast feeding or pregnant.","STRING","PATIENT"],["GRADE_TIER_SYSTEM","Histologic Grading System Tier Category","Term to describe the number of levels or 'tiers' in the system used to describe the cellular histologic grade in a tissue specimen.","STRING","SAMPLE"],["GASTRECTOMY","Gastrectomy","Gastrectomy","STRING","PATIENT"],["days_to_patient_progression_free","days_to_patient_progression_free","days_to_patient_progression_free","STRING","PATIENT"],["days_to_tumor_progression","days_to_tumor_progression","days_to_tumor_progression","STRING","PATIENT"],["EPIGENETIC","Epigenetic","Epigenetic","STRING","PATIENT"],["EXOME_CAPTURE","Exome Capture","Exome Capture","STRING","SAMPLE"],["12_245_PARTC_CONSENTED","12-245 Part C Consented","12-245 Part C Consented","STRING","PATIENT"],["PFS_INTERVAL_GROUP","PFS Interval group","PFS Interval group","STRING","PATIENT"],["RECIST_RESPONSE","RECIST Response","RECIST Response","STRING","PATIENT"],["MITOTIC_INDEX","Mitotic Index","Mitotic Index","STRING","SAMPLE"],["SOMATOSTATIN_ANALOG_THERAPY","Somatostatin analog therapy","Somatostatin analog therapy","STRING","SAMPLE"],["PRRT_THERAPY"," PRRT Therapy","Peptide Receptor Radionuclide Therapy (PRRT)","STRING","PATIENT"],["HAE","HAE","HAE","STRING","PATIENT"],["CLINICAL_TRIAL_DETAILS","Clinical Trial Details","Clinical Trial Details","STRING","SAMPLE"],["ENROLLMENT_ON_CLINICAL_TRIAL_BASED_ON_IMPACT","Enrollment on clinical trial based on IMPACT","Enrollment on clinical trial based on IMPACT","STRING","PATIENT"],["ENROLLMENT_ON_CLINICAL_TRIAL_BASED_ON _MPACT","Enrollment on clinical trial based on IMPACT","Enrollment on clinical trial based on IMPACT","STRING","PATIENT"],["FUNCTIONAL","Functional","Functional","STRING","SAMPLE"],["SITES_OF_METASTATIC_DISEASE","Sites of metastatic disease","Sites of metastatic disease","STRING","SAMPLE"],["RHABDOID","Rhabdoid","Rhabdoid","STRING","SAMPLE"],["IHC_BAP1","BAP1 IHC Result","BAP1 IHC Result","STRING","SAMPLE"],["BAP1_LOSS","BAP1 Loss","BAP1 Loss","STRING","SAMPLE"],["IHC_PBRM1","PBRM1 IHC Result","PBRM1 IHC Result","STRING","SAMPLE"],["PBRM1_LOSS","PBRM1 Loss","PBRM1 Loss","STRING","SAMPLE"],["FGFR_ABNORMALITY","FGFR Abnormality","FGFR Abnormality","STRING","SAMPLE"],["MYB_ABNORMALITY","MYB Abnormality","MYB Abnormality","STRING","SAMPLE"],["NF1_MUTATION","NF1 Mutation","NF1 Mutation","STRING","SAMPLE"],["RAF1_FUSION","RAF1 Fusion","RAF1 Fusion","STRING","SAMPLE"],["HISTONE_RELATED_GENES","Histone Related Genes","Histone Related Genes","STRING","SAMPLE"],["BEST_RESPONSE_TO_EVEROLIMUS","Best response to everolimus","Best response to everolimus","STRING","PATIENT"],["BEST_RESPONSE_TO_PLATINUM","Best response to platinum","Best response to platinum","STRING","PATIENT"],["BEST_RESPONSE_TO_ALKYLATING_AGENT","Best response to alkylating agent (temozolomide or dacarbazine)","Best response to alkylating agent (temozolomide or dacarbazine)","STRING","PATIENT"],["TREATMENT_EFFECT","Treatment Effect","Treatment Effect","STRING","PATIENT"],["RESEARCH_NUM","Research Number","Research Number","NUMBER","PATIENT"],["ALCOHOL","Alcohol","Alcohol","STRING","PATIENT"],["STOOL_IN_BLOOD","Stool in Blood","Stool in Blood","STRING","PATIENT"],["STOOL_BLOOD_MONTHS","Stool Blood Months","Stool Blood Months","STRING","PATIENT"],["OBSTRUCTION_WEEKS","Obstruction (Weeks)","Obstruction (Weeks)","NUMBER","PATIENT"],["BLEEDING_WEEKS","Bleeding (Weeks)","Bleeding (Weeks)","NUMBER","PATIENT"],["BOWEL_HABITS_CHANGE_WEEKS","Bowel Habits Change (Weeks)","Bowel Habits Change (Weeks)","NUMBER","PATIENT"],["CONSTIPATION_WEEKS","Constipation (Weeks)","Constipation (Weeks)","NUMBER","PATIENT"],["TENESMUS_WEEKS","Tenesmus (Weeks)","Tenesmus (Weeks)","NUMBER","PATIENT"],["PELLET_STOOL_WEEKS","Pellet Stool (Weeks)","Pellet Stool (Weeks)","NUMBER","PATIENT"],["ABDOMINAL_MASS_WEEKS","Abdominal Mass (Weeks)","Abdominal Mass (Weeks)","NUMBER","PATIENT"],["COUGH_WEEKS","Cough (Weeks)","Cough (Weeks)","NUMBER","PATIENT"],["CHEST_PAIN_WEEKS","Chest Pain (Weeks)","Chest Pain (Weeks)","NUMBER","PATIENT"],["ABDOMINAL_PAIN_WEEKS","Abdominal Pain (Weeks)","Abdominal Pain (Weeks)","NUMBER","PATIENT"],["MUCOID_STOOL_WEEKS","Mucoid Stool (Weeks)","Mucoid Stool (Weeks)","NUMBER","PATIENT"],["BORBORYGMI_WEEKS","Borborygmi (Weeks)","Borborygmi (Weeks)","NUMBER","PATIENT"],["ABDOMINAL_DISTENSION","Abdominal Distension (Weeks)","Abdominal Distension (Weeks)","NUMBER","PATIENT"],["OTHER_SYMPTOM_DETAILS","Other Symptom Details","Other Symptom Details","STRING","PATIENT"],["OTHER_SYMPTOM_DURATION","Other Symptom Duration (Weeks)","Other Symptom Duration (Weeks)","NUMBER","PATIENT"],["TRADITIONAL_HEALER_HISTORY","History of Traditional Healer","History of Traditional Healer","STRING","PATIENT"],["TIME_BETWEEN_HEALER_AND_PHYSICIAN","Time Between Healer and Physician (Weeks)","Time Between Healer and Physician (Weeks)","NUMBER","PATIENT"],["WEIGHT_LOSS","Weight Loss (Yes/No)","Weight Loss (Yes/No)","STRING","PATIENT"],["WEIGHT_LOSS_AMOUNT_KG","Weight Loss Amount (Kg)","Weight Loss Amount (Kg)","NUMBER","PATIENT"],["METHOD_OF_DIAGNOSIS","Method of Diagnosis","Method of Diagnosis","STRING","PATIENT"],["HEMORRHOIDS","Hemorrhoids","Hemorrhoids","STRING","PATIENT"],["CHEST_XRAY","Chest X Ray","Chest X Ray","STRING","PATIENT"],["CT_CHEST","CT Chest","CT Chest","STRING","PATIENT"],["CT_ABDOMEN","CT Abdomen","CT Abdomen","STRING","PATIENT"],["CEA","CEA","CEA","STRING","PATIENT"],["CEA_RESULTS","CEA Results","CEA Results","STRING","PATIENT"],["ULTRASOUND","Ultrasound","Ultrasound","STRING","PATIENT"],["T_SCORE","T Score","T Score","NUMBER","PATIENT"],["N_SCORE","N Score","N Score","NUMBER","PATIENT"],["M_SCORE","M Score","M Score","NUMBER","PATIENT"],["SURGERY_PROCEDURE","Surgery Procedure","Surgery Procedure","STRING","PATIENT"],["CHEMO_RECOMMENDED","Chemo Recommended","Chemo Recommended","STRING","PATIENT"],["NEOADJUVANT_OR_ADJUVANT","Neoadjuvant or Adjuvant","Neoadjuvant or Adjuvant","STRING","PATIENT"],["MYB_NFIB_TRANSLOCATION","MYB-NFIB Translocation","Description of translocations resulting in MYB-NFIB gene fusions.","STRING","PATIENT"],["NFIB_FUSION_OTHER","Other NFIB Fusion","Description of other NFIB fusions.","STRING","PATIENT"],["MYB_MYBL1_FUSION","MYB or MYBL1 Fusion","Description of MYB or MYBL1 fusions identified. ","STRING","PATIENT"],["MYB_MYBL1_REARRANGEMENT","MYB or MYBL1 Gene Rearrangement","Description of MYB or MYBL1 gene rearrangement(s) identified by RT-PCR/qPCR/WGS.","STRING","PATIENT"],["MYB_MYBL1_FUSION_METHOD","MYB or MYBL1 Fusion Method","Method used to validate MYB or MYBL1 gene fusions.","STRING","PATIENT"],["FUSION_OTHER","Other Gene Fusion","Description of other gene fusions identified by RT-PCR/qPCR/WGS (non-MYB/MYBL1/NFIB).","STRING","PATIENT"],["VITAL_STATUS_INTERVAL_YEARS","Vital Status Interval Years","Vital Status Interval Years","NUMBER","PATIENT"],["RECURRENCE_STATUS_INTERVAL_YEARS","Recurrence Status Interval Years","Recurrence Status Interval Years","NUMBER","PATIENT"],["PATHOLOGIC_RESPONSE","Pathologic Response","Pathologic Response","STRING","PATIENT"],["NEOADJUVANT_CHEMOTHERAPY_RESPONDER","Responder to Neoadjuvant Chemotherapy","Responder to Neoadjuvant Chemotherapy","STRING","PATIENT"],["AKT1_E17K_MUTATION_STATUS","AKT1 E17K Mutation Status","AKT1 E17K Mutation Status","STRING","SAMPLE"],["EPITHELIOID_PERCENT_OF_TUMOR","Epithelioid Percent of Tumor","Epithelioid Percent of Tumor","STRING","SAMPLE"],["MATCHED_NORMAL_ID","Matched Normal ID","Matched Normal ID","STRING","PATIENT"],["TISSUE_DIAGNOSIS","Tissue Diagnosis","Tissue Diagnosis","STRING","SAMPLE"],["CONSENSUS_CLUSTER","Consensus Cluster","Consensus Cluster","STRING","SAMPLE"],["FIBER_PER_GM_IN_LUNG","Fiber/gm Lung","Fiber/gm Lung","NUMBER","SAMPLE"],["PREOPERATIVE_TREATMENT","Pre-Operative Treatment","Pre-Operative Treatment","STRING","PATIENT"],["CHR3_FISH","FISH Test on Chr3","FISH Test on Chr3","STRING","SAMPLE"],["CHR2_FISH","FISH Test on Chr2","FISH Test on Chr2","STRING","SAMPLE"],["NF2_FISH","FISH Test on NF2","FISH Test on NF2","STRING","SAMPLE"],["NF2_STATUS_ARRAY","NF2 status 2.5M array","NF2 status 2.5M array","STRING","SAMPLE"],["NF2_FUSION","NF2 Fusion","NF2 Fusion","STRING","SAMPLE"],["HISTOLOGY_EPC_NON_SEMINOMA","Histology EPC - Non-Seminoma","Histology EPC - Non-Seminoma","STRING","SAMPLE"],["GERMLINE_TESTED","Germline Tested","Germline Tested","STRING","SAMPLE"],["EVIDENCE_FOR_LOSS_OF_HER2","Evidence for Loss of HER2","Evidence for Loss of HER2","STRING","SAMPLE"],["MYB_NFIB_TRANSCRIPT","MYB-NFIB Transcript ","MYB-NFIB Transcript description.","STRING","SAMPLE"],["FIRST_DISTANT_RECURRENCE_SITE","Site of First Distant Recurrence","Site of First Distant Recurrence","STRING","PATIENT"],["RELAPSE_SEROSA","Relapse Serosa","Relapse Serosa","STRING","PATIENT"],["SUBTYPE_DETAILS","Subtype Details","Subtype Details","STRING","PATIENT"],["BILATERAL","Bilateral","Bilateral","STRING","PATIENT"],["MULTIFOCAL","Multifocal","Multifocal","STRING","PATIENT"],["IDFS_MONTHS","Invasive Disease-Free Survival (IDFS Months)","Invasive Disease-Free Survival (IDFS Months)","STRING","PATIENT"],["IDFS_STATUS","Invasive Disease-Free Survival Status","Invasive Disease-Free Survival Status","STRING","PATIENT"],["DRFS_MONTHS","Distant Recurrence-Free Survival (DRFS Months)","Distant Recurrence-Free Survival (DRFS Months)","STRING","PATIENT"],["DRFS_STATUS","Distant Recurrence-Free Survival Status","Distant Recurrence-Free Survival Status","STRING","PATIENT"],["BCFI_MONTHS","Breast Cancer-Free Interval Months","Breast Cancer-Free Interval Months (BCFI Months)","STRING","PATIENT"],["BCFI_STATUS","Breast Cancer-Free Interval Status","Breast Cancer-Free Interval Status","STRING","PATIENT"],["BIOPSY_AT_PROGRESSION","Biopsy at Progression","Biopsy at Progression","STRING","SAMPLE"],["PRIOR_INTRAVESICAL_CHEMOTHERAPY","Prior Intravesical Chemotherapy","Prior Intravesical Chemotherapy","STRING","SAMPLE"],["SPECIMEN_CHEMOTHERAPY_STATUS","Specimen Chemotherapy Status","Specimen Chemotherapy Status","STRING","SAMPLE"],["NO_CHEMO_PROGRESSIVE","No Chemo Progressive","No Chemo Progressive","STRING","SAMPLE"],["NO_CHEMO_PROGRESSIVE_PRIOR_BCG","No Chemo Progressive Prior Bcg","No Chemo Progressive Prior Bcg","STRING","SAMPLE"],["MIBC_PROGRESSIVE","MIBC Progressive","Bladder MIBC Progressive","STRING","SAMPLE"],["GROUP","Group","Group","STRING","SAMPLE"],["TCGA_SMOKING_CATEGORY","TCGA Smoking Category","TCGA Smoking Category","STRING","SAMPLE"],["AGE_GROUP","Age Group at Diagnosis in Years","Age Group at Diagnosis in Years","STRING","PATIENT"],["SOMATIC_BRCA_WT_STATUS","Somatic_BRCA_WT_Status","Somatic_BRCA_WT_Status","STRING","SAMPLE"],["WGD","WGD","WGD","STRING","SAMPLE"],["LST","LST","LST","STRING","SAMPLE"],["HRD_LOH","HRD-LOH","HRD-LOH","STRING","SAMPLE"],["NTAI","NtAI","NtAI","STRING","SAMPLE"],["G_LOH","gLOH","gLOH","STRING","SAMPLE"],["PDX_TREATMENT","PDX Treatment","PDX Treatment","STRING","SAMPLE"],["MOUSE_STRAIN","Mouse Strain","Mouse Strain","STRING","SAMPLE"],["AGE_AT_LAST_FOLLOWUP","Age At Last Follow-Up","Age At Last Follow-up","NUMBER","PATIENT"],["RELAPSE_INTERVAL_IN_DAYS","Relapse Interval In Days","Relapse Interval In Days","NUMBER","PATIENT"],["PARITY","Parity","The number of times a female has been carried the pregnancies to a viable gestational age (parity)","NUMBER","PATIENT"],["AGE_AT_BIRTH_OF_FIRST_CHILD","Age at Birth Of First Child","Age at Birth Of First Child","NUMBER","PATIENT"],["ORAL_CONTRACEPTION_YEARS","Oral Contraception Years","Oral Contraception Years","NUMBER","PATIENT"],["MENOPAUSAL_STATUS_AT_DIAGNOSIS","Menopausal Status At Diagnosis","Menopausal Status At Diagnosis","STRING","PATIENT"],["HRT_HISTORY_YEARS","HRT History Years","Hormone Replacement Therapy History in Years","NUMBER","PATIENT"],["DCIS_GRADE","DCIS Grade","DCIS Grade","NUMBER","PATIENT"],["TOTAL_MITOSES","Total Titoses","Total Titoses","NUMBER","SAMPLE"],["LYMPHOCYTE_INFILTRATION","Lymphocyte Infiltration","Lymphocyte Infiltration","STRING","SAMPLE"],["TUMOR_BORDER","Tumor Border","Tumor Border","STRING","SAMPLE"],["CENTRAL_SCAR_FIBROSIS","Central Scar/Fibrosis","Central Scar/Fibrosis","STRING","PATIENT"],["INVASIVE_TUMOR_PERCENTAGE","% Invasive Tumor","% Invasive Tumor","NUMBER","SAMPLE"],["CIS_PERCENTAGE","% CIS","% Carcinoma In Situ","NUMBER","SAMPLE"],["STROMA_PERCENTAGE","% Stroma","% Stroma","NUMBER","SAMPLE"],["ADIPOSE_TISSUE_PERCENTAGE","% Adipose Tissue","% Adipose Tissue","NUMBER","SAMPLE"],["NORMAL_EPITHELIUM_PERCENTAGE","% Normal Epithelium","% Normal Epithelium","NUMBER","SAMPLE"],["TUMOR_PLOIDY","Tumor Ploidy","Tumor Ploidy","STRING","SAMPLE"],["SITE_SEQUENCED","Site Sequenced","Site Sequenced","STRING","SAMPLE"],["OLIGOPROGRESSION","Oligoprogression","Oligoprogression","STRING","SAMPLE"],["POD_AT_BLOOD_DRAW","POD at blood draw","POD at blood draw","STRING","SAMPLE"],["SITE_OF_TISSUE_BIOPSY","Site of Tissue Biopsy","Site of Tissue Biopsy","STRING","SAMPLE"],["METASTATIC_BIOPSY_SITE","Metastatic Biopsy Site","Metastatic Biopsy Site","STRING","SAMPLE"],["TUMOR_MSK_IMPACT","Tumor MSK-IMPACT","Tumor MSK-IMPACT","STRING","SAMPLE"],["PI_REVIEWED","PI Reviewed","PI Reviewed","STRING","SAMPLE"],["WITHDRAWAL_OF_CONSENT","Withdrawal of Consent","Withdrawal of Consent","STRING","SAMPLE"],["TIME_BETWEEN_BLOOD_DRAW_AND_BIOPSY","Time Between Blood Draw and Biopsy","Time Between Blood Draw and Biopsy","NUMBER","SAMPLE"],["EVENT_DETAILS","Event Details","Event Details","STRING","PATIENT"],["HOSPITAL_SITE","Hospital Site","Hospital Site","STRING","PATIENT"],["ETS","ETS","ETS","STRING","SAMPLE"]]
}